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Abstract
Major histocompatibility complex (MHC) class I molecules play an essential role in the
defence against intracellular pathogens. CD8+ T cells recognise antigenic peptides in
association with self-MHC, a process known as MHC restriction. In this study we
examined bovine MHC class I genes using both molecular and cellular approaches.
There is evidence for the existence of five or six classical class I loci in cattle, with the
number of genes expressed varying between haplotypes. Most alleles are putatively
assigned to a locus according to their grouping following phylogenetic analysis. Here
we applied reference strand mediated conformational analysis (RSCA), a high resolution
typing method, to four of these groups: 1, 2, 3 and 6. Using group-specific primers and
two reference strands 22 potential new alleles were identified with one probable
pseudoallele in group 1. Based on the results obtained and previous phylogenetic
analysis, groups 1 and 3 appear to be the most polymorphic.
The need for a reliable typing method for MHC class I genes in cattle can be seen
through studies of CD8+ T cell responses to Theileria parva. T. parva is an intracellular
parasite against which CD8+ CTL have been shown to be the principal effector cells in
infected cattle. Previous studies identified a clear bias in class I restriction of CTL to
either the maternal or paternal haplotype, and showed that haplotypes differ in their
ability to restrict this response. We have extended these studies using animals with well-
characterised haplotypes. We showed that the A14 and A18 haplotypes appear to be
dominant over the A10 and A31 haplotypes respectively. A14 expresses three class I
genes, D18.1, D18.4 and D18.5. Assays testing an A14-restricted CTL clone against
D18.1 and D18.4 transfected target cells proved inconclusive indicating a need for
further investigation and the inclusion ofD 18.5 in any studies.
l
Acknowledgements
I would like to thank my primary supervisor at IAH, Dr Shirley Ellis for her help and
advice throughout my project, and for her encouragement in finishing writing this thesis!
Thanks also go to my external supervisor Prof. Declan McKeever, Prof. Ivan Morrison
and Dr Niall MacHugh for their advice in establishing the Theileria work.
Recognition should also go to the compound staff, in particular Dave Aldis and Joe
Garthwaite for their care of the experimental animals.
To everyone in Lab FIB, past and present, their friendship and encouragement was a
vital part in me finishing this work and finally getting to leave Compton - thanks! To
my other friends at the institute (you know who you are!) who were always there for me
and supplied much needed chats (and pints!), I owe you a beer!
To Liam thanks for putting up with me over the years despite everything - look I've
finally finished! Biology PhDs are definitely harder than physics
Hopefully life can start getting a bit more normal now whatever that is!
Finally, the biggest thanks go to my parents to whom this thesis is dedicated. Their
constant support is fantastic and I couldn't have done it without them.
11
Declaration
This thesis is submitted for examination for the degree of Doctor of Philosophy to the
University of Edinburgh. It has not been submitted to any other university or for any
other degree or professional qualification. The work presented here is entirely my own













Chapter 1: General introduction 1
1.1 The major histocompatibility complex 2
1.1.1 Identification of the MHC 2
1.1.2 MHC - genetic location and organisation 3
1.2 Function and structure of class I molecules 5
1.2.1 Function of class I molecules 5
1.2.2 Basic structure of class I molecules 6
1.2.3 Structure of the peptide binding region 7
1.2.4 (3-2-microglobulin 11
1.2.5 Glycosylation and phosphorylation 12
1.2.6 Exon arrangement ofMHC class I genes 13
1.3 Structure and function of class II molecules 14
1.4 MHC class I - antigen processing and presentation pathway 17
1.4.1 Peptide production and the proteasome 17
1.4.2 Peptide transport into the ER 20
1.4.3 Assembly and peptide loading ofMHC class I molecules 21
1.5 MHC class II - antigen processing and presentation 23
1.6 TCR recognition ofMHC molecules 26
IV
1.6.1 aPT cells 26
1.6.2 y5T cells 28
1.6.3 TCR structure 29
1.6.4 T cell development 31
1.6.5 T regulatory cells 32
1.6.6 Natural Killer cells 33
1.7 Non-classical MHC 35
1.8 Evolution of the MHC region 36
1.8.2 Maintenance ofpolymorphism 39
1.8.3 Generation ofpolymorphism 41
1.9 Bovine MHC 42
1.9.1 Origin of cattle 42
1.9.2 Bovine MHC region 43
1.9.3 Class II region 43
1.9.4 Class III region 46
1.9.5 Class I region 47
1.9.6 Class I haplotype analysis 49
1.9.7 Polymorphism in bovine MHC class I genes 51
1.9.8 Bovine MHC class I genes and molecules 52
1.9.8.2 Promoter 53
1.9.8.3 P-2-microglobulin 53
1.9.8.4 Peptide binding region 54
1.10 Typing MHC genes 57
1.10.1 Sequence-based methods 57
1.10.2 Conformational methods 59
1.10.3 Reference strand-mediated conformational analysis - RSCA 60
1.10.3.2 Advantages ofRSCA 63
1.11 Theileria parva 64
1.11.2 Biology of the parasite 65
1.11.3 Course of the disease 68
v
1.11.4 Target cell types and pathogenicity 68
1.11.5 Immunity to T. parva 69
1.11.6 Role of cytokines 71
1.11.7 Role ofCD4+and 78 T cells 72
1.11.8 Parasite strain heterogeneity 72
1.11.9 MHC restriction of T. parva-specific CTL 73
1.11.10 Immunodominance 75
1.11.11 Consequences of immunodominance and hierarchy ofMHC class I
restriction 76
1.12 Aims of this research 76
Chapter 2: Materials and methods 78
2.1 Materials 79
2.1.1 Buffers/solutions 79
2.1.2 Bacterial growth media 80
2.1.3 Kits 81
2.2 General methods 81
2.2.1 Blood sampling and extraction ofPBM 81
2.2.2 Quantitative determination of cell viability 82
2.2.3 Genomic DNA isolation 82
2.2.4 Isolation ofmRNA 83
2.2.5 First strand cDNA synthesis 84
2.2.6 Phenol chloroform extraction 84
2.2.7 Ethanol precipitation 85
2.2.8 Polymerase chain reaction (PCR) 85
2.2.8.1 PCR program 85
2.2.8.2 PCR reactions 86
2.2.8.3 Primer design 86
2.2.9 Electrophoresis ofDNA 87
vi
2.2.10 DNA extraction from agarose
2.2.11 Ligation into the pGEM-T vector
87
88
2.2.12 Transformation of JM109 competent cells with recombinant
pGEM-T vectors 88
2.2.13 Minipreparations of purified DNA from JM109 transformed
cultures 89
2.2.14 Sequencing 89




3.2.1 Animals used in this study and details of their haplotypes 96
3.2.2 Primers designed for intron amplification 96
3.2.3 Design of group-specific primers 101
3.3 Results 102
3.3.1 Amplification and sequencing ofintrons 102
3.3.2 Presence of group-specific nucleotides 108
3.3.3 Group-specific primer design 109
3.3.3.1 Group 1 110
3.3.3.2 Group 2, 3 and 6 - primer design and testing 110
3.3.3.3 Group 2, 3 and 6 - determining group specificity 113
3.4 Discussion 121
Chapter 4: Use of RSCA for typing MHC class I genes in cattle 124
4.1 Introduction 125
4.2 Materials and methods 127
4.2.1 DNA samples 127
vii
4.2.2 PCR conditions 127
4.2.3 Preparation of reference strands 129
4.2.4 Duplex formation 129
4.2.5 Gel preparation and electrophoresis 130
4.2.6 Sample analysis 131
4.3 Results 133
4.3.1 Production of reference strands 133
4.3.2 PCR on genomic DNA samples 134
4.3.3 RSCA results - group 1 138
4.3.4 RSCA results - group 2 144
4.3.5 RSCA results — group 3 151
4.3.6 RSCA results — group 6 159
4.4 Discussion 163
Chapter 5: Analysis ofMHC class I restriction of T. /jarva-specific CTL in
heterozygous cattle 168
5.1 Introduction 169




5.2.1.3 Flow cytometry materials 174
5.2.2 Methods 175
5.2.2.1 Infection and treatment 175
5.2.2.2 Establishing homozygous and heterozygous
T. parva lines 176
5.2.2.3 CTL assays - CTL production 177
5.2.2.4 CTL assays - target labelling 178
5.2.2.5 CTL assays - effector (CTL) production 178
viii
5.2.2.6 CTL assays - assay 179
5.2.2.7 Flow cytometric analysis - one colour (indirect) 180
staining
5.2.2.8 PCR 180
5.2.2.9 Freezing cell stocks 181
5.3 Results 183
5.3.1 Conformation of expressed class I genes on cell lines 183
5.3.2 Phenotyping cell lines 183
5.3.3 CTL assays 187
5.3.3.1 Animal 313 (A 18/A31) results 188
5.3.3.2 Animal 506 (A14/A10) results 191
5.3.3.3 Animal 495 (A14/A10) results 191
5.4 Discussion 194




6.2.1 Production of transfectants 200
6.2.2 CTL clone 201
6.3 Results 202
6.3.1 Screening transfectants 202
6.3.2 CTL assays with a CTL clone 202
6.4 Discussion 205
Chapter 7: General discussion 210
7.1 Summary of achievements 211
7.2 Study of introns 1 and 3 in class I genes 211
ix
7.3 Establishing RSCA and future work 214
7.4 MHC restriction ofCTL responses to T. parva 216
7.5 Alternative methods for measuring cytotoxicity 216








1.1 Comparative map of the murine (chromosome 17) and human
(chromosome 6) MHC regions 4
1.2 Structure ofMHC class I molecules 8
1.3 Structure of the peptide binding region ofMHC class I molecules 10
1.4 Intron/exon arrangement ofMHC class I genes 14
1.5 Structure ofMHC class II molecules 16
1.6 MHC class I antigen processing and presentation pathway 18
1.7 Structure of the proteasome and the immunoproteasome 19
1.8 MHC class II antigen processing and presentation pathway 24
1.9 Interaction between a(3 T cell receptors and MHC class I and II molecules 27
1.10 Emergence of the four paralogous regions identified in the human genome 37
1.11 Comparative map of the bovine and human MHC regions 44
1.12 Peptide binding motifs of bovine MHC class I molecules 56
1.13 Reference strand-mediated conformational analysis (RSCA) 62
1.14 Life cycle of Theileria parva 66
Chapter 3
3.1 Maximum likelihood tree of full length cDNA cattle MHC class I
sequences indicating putative 'groups' or loci 95
3.2 A schematic diagram of a bovine class I gene from the promoter
region to exon 4 (alpha 3 domain) 100
3.3 Alignment of entire intron 1 sequence of 13 alleles representative of
4 putative bovine MHC class I genes 103
3.4 Alignment ofpartial intron 3 sequence of 13 alleles representative of
4 putative bovine MHC class I genes 105
3.5 Testing putative group 1 primers 111
xi
3.6 Optimisation of group 1 primers 4 and C 111
3.7 Amplification ofD 18.4 and HD1 using group 1-specific primers -
group 1 primer 4 and generic primer 4 112
3.8 Choosing putative group-specific primers for groups 2, 3 and 6 114




3.12 Alignment of sequences from A19/A10 and A17 samples amplified
with group 2 primers 118
3.13 Alignment of predicted al and a2 sequence of the product amplified
from an A10/A20 sample using group 2-specific primers with
published allele sequences 119
3.14 Alignment of predicted al and a2 sequence of the product amplified
from an A10 sample using group 2-specific primers with
published allele sequences 120
Chapter 4
4.1 Reference strands for RSCA - position and length 128
4.2 Maximum likelihood tree linking 3' sequences from 13 species of
Cetartiodactyls 137
4.3 RSCA profile with group 1 D18.4 FLR 139
4.4 RSCA profile with group 1 HD1 FLR 141
4.5 Complete a 1 sequence of new group 1 alleles 143
4.6 RSCA profile with group 2 D18.3 FLR 145
4.7 RSCA profile with group 2 D18.5 FLR 147
4.8 RSCA gel image of group 2 samples run with D 18.5 FLR 149
4.9 Partial al and a2 sequence of new group 2 alleles 150
xii
4.10 RSCA profile with group 3 D18.2 FLR 152
4.11 RSCA profile with group 3 A10 FLR 154
4.12 Partial al and a2 sequence ofnew group 3 alleles 156
4.13 RSCA profile with group 6 HD6 FLR 160
4.14 RSCA profile with group 6 MAN2 FLR 161
4.15 Partial al and a2 sequence of new group 6 alleles 162
Chapter 5
5.1 Confirmation ofMHC class I typing by PCR-SSP 184
5.2 CTL assay results from animal 313 (A18/A31) 190
5.3 CTL assay results from animal 506 (A14/A10) 192
5.4 CTL assay results from animal 495 (A 14/A 10) 193
Chapter 6
6.1 Screening of transfectants and clones for D18.1 and D18.4 expression 203
6.2 CTL assay 1 204
6.3 CTL assay 2 204




1.1 Genes identified on MHC class I haplotypes
Chapter 3
3.1 Summary of genomic DNA used in this study for sequencing of introns
and optimisation of group-specific primers
3.2 Summary of haplotypes and alleles used in this study
3.3 Primers designed for amplification of intron 1
3.4 Primers designed for amplification of intron 3
3.5 Group-specific primers
3.6 Predicted results from group-specific primer testing
3.7 Summary of group-specific primer testing results
Chapter 4
4.1 Alleles chosen as reference strands
4.2 PCR results for group-specific primers tested on untyped samples
Chapter 5
5.1 Monoclonal antibodies used for phenotyping cell lines
5.2 Primers used for typing cell lines






APC Antigen presenting cell
ATP Adenosine triphosphate
BAC Bacterial artificial chromosome
(32m [^-microglobulin
BLAST Basic local alignment search tool
BoLA Bovine leucocyte antigen
bp Base pair(s)
BSA Bovine serum albumin
cDNA Complementary DNA
CDR Complementary determining regions
cM Centi Morgan













FACS Fluorescence activated cell sorter
FBS Foetal bovine serum
FITC Fluorescein isothyiocyanate
FLR Fluorescent-labelled reference strand
g Force of gravity
HA Heteroduplex analysis
H-2 Murine histocompatibility complex


















mRNA Messenger ribose nucleic acid
MgCl2 Magnesium chloride











NK Natural killer cell
nt Nucleotide
PAGE Polyacrylamide gel electrophoresis
PBM Peripheral blood mononuclear cells
PBR Peptide binding region
PBS Phosphate buffered saline
PCR Polymerase chain reaction
PCR-SSP PCR-sequence specific primers
PCR-SSOP PCR-sequence specific oligonucleotide probes
p.i. Post infection
RBC Red blood cell
RNA Ribose nucleic acid
RSCA Reference strand mediated conformational analysis
SSCP Single-stranded conformational analysis
SDS Sodium dodecyl sulphate
TAE Tris-acetate EDTA
TAP Transporter associated with antigen processing
TBE Tris-borate EDTA
TCR T cell receptor
TE Tris-EDTA
















A alanine G glycine M methionine S serine
C cysteine H histidine N asparagine P proline
T threonine D aspartic acid I isoleucine V valine
E glutamic acid K lysine Q glutamine w tryptophan





1.1. The Major Histocompatibility Complex
1.1.1 Identification of the MHC
The MHC can be defined as a genetic region containing tightly linked genes involved
functionally with both the adaptive and innate immune systems. It was first
discovered by Gorer (1936) then further characterised by Snell (1958) as a set of
polymorphic genes encoding molecules involved in the rejection of foreign
transplanted tissue in mice. Snell proposed the name based on the evidence that this
system was the most important genetic determinant for the outcome of transplants
between individuals. Evidence for MHC in humans was provided by Dausset et al.
(1958) who found that blood from multiparous women (immunised by paternal
antigens on foetal cells) produced antibodies that agglutinated lymphocytes.
A more precise function of the MHC came through the work of Zinkernagel and
Doherty (1974). They showed that T cells are restricted by the MHC, with CD8+
cytotoxic T cells (CTL) only recognising antigens associated with self-
histocompatibility molecules. This led to the now well-established role of MHC
molecules in presenting both self and non-self antigens to T cells.
MHC genes have been found in all jawed vertebrates including the oldest group,
cartilaginous fish, but not beyond this (Flajnik and Kasahara, 2001). Instead, lower
groups such as the cyclostomes, including the hagfish and lamprey, are found to have
allorecognition loci that are not orthologous to classical MHC genes.
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1.1.2 MHC - genetic location and organisation
The MHC region in humans and mice has been extensively studied with mapping
data establishing the basic organisation of both. The human MHC, or Human
Leukocyte Antigen (HLA), is found on the short arm of chromosome 6 (band
6p21.3) while the mouse MHC, also known as the H-2 complex has been mapped to
chromosome 17. Both regions have a centromere to telomere orientation, and can be
divided into three gene clusters, classes I, II and III. Their organisation is shown in
fig. 1.1. The major difference observed between the two species is the presence of
MHC class I genes (H-2K) centromeric the class II region in mice. The genetic
linkage between the class I and II regions observed in humans and mice has also
been seen in all other species studied to date including chickens and sharks. Bony
fish appear to be the exception to this (reviewed by Kumanovics et al., 2003).
Sequencing of the HLA was completed in 1999 and provided a large amount of
information regarding the gene content of this region, including pseudogenes and
gene fragments. Within the 3.6Mb stretch are at least 224 genes, including 128 that
are believed to be expressed (MHC sequencing consortium, 1999). Approximately
40% of these expressed genes are thought to have an immunological function
(Trowsdale, 2001).
Both the class I and II regions contain genes which code for functional MHC
molecules while the class III region contains genes which code for various
components of the immune system. Six classical genes are found in humans, three in
3


























the class I region, A. B and C and three in the class II region DP, DQ and DR. Mice
also have three in their class I regions H-2K, D and L, but two class II genes, IE and
IA. Their DP equivalents are pseudogenes. Class I genes are single genes encoding
the a chain of class I molecules. Class II genes generally exist in pairs, encoding
either the a or (3 chain of the class II heterodimeric molecule although more than one
gene can encode for each chain, for example there are two DP|3 genes in humans.
The number of class I and II genes is variable amongst all species studied to date as a
result of species or order-specific amplification of genes.
These MHC genes are marked by their extensive polymorphism, the most observed
in higher vertebrates (Parham et al., 1988). The type of MHC expressed is
dependent on the haplotype i.e. the combination of alleles on each strand of DNA
(two haplotypes making up the genotype).
1.2 Function and structure of class I molecules
1.2.1 Function of class I molecules
MHC class I molecules act to present endogenously derived peptides from, for
example, viruses or intracellular parasites to CD8+ T cells thereby indicating that
something is wrong within the cell. They are constitutively expressed on the
majority of cells in the body, since all cells are susceptible to viral invasion, which
allows constant surveillance for infection. Upon recognition of the foreign peptide
by the binding of the T cell receptor (TCR) to the peptide-MHC complex, CD8+ T
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cells are stimulated to expand clonally and differentiate to CTL which then trigger
apoptosis of the target cell. Apoptosis is the preferred method of killing since this
prevents pathogen replication and release.
Two main mechanisms of apoptosis are used, the granule secretion pathway and Fas-
mediated apoptosis. During the differentiation from CD8+ T cells to CTL a large
number of modified lysosomes known as lytic granules are formed inside the cell.
Upon interaction between the CTL and target cell these granules are secreted and
delivered onto the target cell surface. Perforin is released from the granules which
produces transmembrane pores through which granzymes can enter (Young et al.,
1986). Granzymes are serine proteases which act to cleave cell proteins which in
turn activate nucleases and other enzymes thereby inducing apoptosis within the
target. In addition binding of the Fas ligand on CTL to the target causes transmission
of signals which activate death caspases (Metkar et al., 2002).
1.2.2 Basic structure of class I molecules
Investigations by Bjorkman et al. (1987a) led to the first elucidation of the crystal
structure of a class I molecule, HLA-A2. It was found to consist of a 45kDa heavy
(a) chain encoded by the MHC genes, non-covalently complexed to a small 12kDa
protein P-2-microglobulin (P2m), encoded by a gene on chromosome 15
(chromosome 2 in mice, Goodfellow et al., 1975, Smith et al., 1975). The heavy
chain has three extracellular domains al, a2 and a3 (each approximately 90 amino
acids, aa, long), a short transmembrane region of 35 to 40 aa and a cytoplasmic tail
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of approximately 30 aa. The al and a2 domains, supported by the a3 domain and
(32m, are furthest from the cell surface and are folded very similarly, both having a 4-
strand (3 sheet with an a helix at the top. The two domains interact to form the
peptide binding region (PBR), a cleft with 8 anti-parallel (3 strands supporting two
anti-parallel a helices (see section 1.2.3). The a3 domain and (32m both consist of
two antiparallel (3 sheets connected by a disulphide bond, a structure previously seen
in the constant regions of immunoglobulins (Bjorkman et al., 1987a). Although not
involved in peptide binding, a3 is important for attachment of CD8, a co-receptor on
CTL, helping to strengthen and prolong contact between the cells (Salter et al., 1989,
see fig. 1.2).
1.2.3 Structure of the peptide binding region
The cleft formed between the al and al domains was found to contain 'extra'
electron density in the crystal structure, which could not be accounted for from the
class I sequence. Bjorkman et al. (1987b) suggested this to be the site of peptide
binding because of its position at the top of the molecule and also because the
polymorphisms of the MHC molecules that determine TCR recognition are focused
here. Later work by Madden et al. (1991) allowed further speculation on this theory
by using X-ray crystallography to examine the MHC molecule HLA-B27 which
exhibited clear, interpretable electron density. They showed that the bound nonamer
peptide would be restricted at various positions by interactions between side chains
of the peptide and pockets in the cleft, and also that some kinking of the backbone
7




could be accommodated. In addition, conserved atoms at either end of the cleft
would bind the terminal ends of the peptide.
Specificity for sequence motifs in peptides bound to class I molecules is determined
by pockets in the cleft formed by the polymorphic residues of the MHC protein (fig.
1.3). The binding region has 6 pockets, A to F, with A, B, C and F being deep while
D and E are shallow (Saper et al., 1991, Matsumura et al., 1992). Differences in the
sequence of the al and a2 domains cause a change in the shape and charge of these
pockets which determines the peptides that can bind. Pocket A, at the left boundary
of the cleft, binds the amino terminal of the peptide, with its specificity determined
by four conserved tyrosine residues (positions 7, 59, 159 and 171). Pocket F binds
the carboxyl terminal with hydrogen bonds formed between the COO- group and
tyrosine, threonine, lysine and tryptophan residues (positions 84, 143, 146 and 147
respectively). The strong linkage in these pockets affects binding by determining the
position and orientation of the peptide and also restricts the length of the peptide
bound. Pocket B has been found to bind the second residue of peptides in all human
MHC structures so far known (Smith et al., 1996b). The remaining pockets interact
with peptide side chains, their importance varying depending on the allele (Jardetzky,
1996).
Generally octamers or nonamers bind to class I molecules but some variation can
occur with the peptide bulging to accommodate the extra residues. A combination of
flexibility of the polymorphic residues at the bottom of the cleft and water molecules
underneath the peptide allows for sequence diversity in the middle of the peptide,
9
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with the water molecules helping peptides to fit into the binding groove better. They
can also compensate for octamers allowing them to bind more efficiently (Smith et
al., 1996a,b).
Comparison of peptides eluted from MHC molecules identified conserved residues
amongst those from the same molecule (Falk et al., 1991). These anchor residues
which represent the allele-specific peptide motif are generally invariant or change to
closely related residues (Matsumura et al., 1992). Most alleles appear to have at
least two, usually at the second or fifth residue and the last residue of the peptide
(Rammensee et al., 1993). For example, in most human peptide binding motifs
known position two is an anchor residue with three main specificities, arginine,
proline and aliphatic residues (Rammensee et al., 1995, Smith et al., 1996a). It has
been speculated that those aa which point up from the PBR may be important for
TCR recognition and binding (Falk et al., 1991).
1.2.4 P-2-microglobulin
P2m is extremely important since the heavy chain needs association with it to enable
the protein to assemble correctly and be transported to the cell surface (Degen et al.,
1992, Sugita and Brenner, 1994). Alteration of this protein can lead to a decrease in
expression as shown by Tatake et al. (1992) who combined human MHC molecules
with mouse P2m in a P2m-null cell line and found only 20-30% expression despite
human and mouse P2m having approximately 70% homology. Altering the amino
terminal of the protein showed that this region contained the major class I regulatory
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elements. Interestingly this region also includes the major points of contact between
the P2m and the heavy chain suggesting that the problems with expression may be
due to how the whole MHC molecule is assembling (Trymbulak and Zeff, 1997).
Alteration of |32m can also lead to a reduced repertoire of peptides that can be
presented. Changing a residue at the interface between p2m and a2 from alanine to
aspartic acid was shown to affect binding of some peptides, resulting in decreased
recognition by specific CTL (Perarnau et al., 1990).
While P2m is not polymorphic in humans alleles have been identified in mice and
cattle, however these generally contain substitutions with similar amino acids or are
non-coding (Hermel et al., 1993, Ellis et al., 1995).
1.2.5 Glycosylation and phosphorylation
Both human and murine MHC molecules have a glycosylation site at residue 86
(asparagine, ASN), which lies in a loop between al and a2. This residue has a
Man9GlcNAcGlc sugar attached which is important for assembly of class I
molecules, peptide loading and cell surface expression through its association with
chaperone proteins (discussed in section 1.4, reviewed in Rudd et al., 2001). Some
studies however have shown it not to be essential. (Ploegh et al., 1981, Santos-
Aguado et al., 1987). Mice have a further glycosylation site at Asnl76 (and Asn 256
in certain alleles, Kimball and Coligan, 1983). The Asn 176 in a2 is required for
binding to the NK receptors Ly49A and C. Since this site is only found in mice it
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indicates that Ly49 has evolved simultaneously with murine class I genes (Lian et
al., 1998).
Comparison of human and murine cytoplasmic domains identified a conserved Ser-
Asp/Glu-X-Ser(P)-Leu motif which contains conserved serine residues at position
332 and 335. Serine 335 has been shown to be the site of phosphorylation in vivo in
both species (Guild and Strominger, 1984). Phosphorylation of this serine residue is
thought to be important for the modulation of class I molecule movement from the
endoplasmic reticulum (ER) to the cell surface via the Golgi and recycling at the cell
surface via endosomes (Pitcher et al., 1999). Phosphorylated class I molecules are
found on the cell surface, late intracellular compartments and recycling endosomes,
with phospohrylation thought to occur outside the golgi (Capps and Zuniga, 2000,
Lippe et al., 1991). Some viruses have adapted mechanisms to interfere with the
expression of class I molecules. For example, adenoviruses produce a protein
E3/19K which binds to class I molecules in the rough ER and prevents transportation
to the cell surface by stopping phosphorylation (Lippe et al., 1991).
1.2.6 Exon arrangement of MHC class I genes
Exon arrangement of the class I genes is well conserved amongst the jawed
vertebrates studied. Class I genes contain eight exons and a 3' untranslated region
(fig. 1.4). Exon one encodes the leader peptide of approximately 30 nucleotides.
This is involved in directing the construct to the ER and is also important for
providing peptides for the non-classical MHC molecule HLA-E to present and
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helping it to reach the cell surface. Exons two, three and four code for the al, a2
and a3 domains respectively. Exon five corresponds to the transmembrane domain
that anchors the MHC molecule to the cell surface. The cytoplasmic region is
generally encoded by exons 6, 7 and or 8 although complete excision of exon 7 has
been observed in H-2D (Fahrner et al., 1987).
Figure 1.4: Intron/Exon arrangement of MHC class I genes
Figure 1.4 shows a schematic diagram of the arrangement of introns and exons in a
MHC class I gene and the regions of the molecule that the exons code for.
Exon 1 2 3 4 5 6 7 8 UTR
NH2 al a2 a3 TM CYTOPLASMIC
1.3 Structure and function of class II molecules
MHC class II molecules act to present exogenously derived peptides to T cells
expressing the CD4+ co-receptor (T helper cells). These peptides originate from
pathogens ingested by phagocytic and B cells or residing in macrophage vesicles.
Two types of CD4+ cells exist, Thl and Th2. Thl cells act to produce cytokines
including IL-2 which activates macrophages allowing them to take up pathogens by
phagocytosis and destroy them. In contrast Th2 cells secrete IL-4 which encourages
the maturation and differentiation of B cells which then produce specific antibodies.
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Class II expression is consistent but limited to professional antigen presenting cells
including macrophages, dendritic cells and B cells and the thymic epithelium but can
be induced on other cell types by cytokines, including interferon-y.
MHC class II molecules have a similar overall structure to class I molecules despite
relatively low sequence homology (fig. 1.5, Brown et al., 1988). The a and (3 genes
in the class II region code for a and P chains which join by disulphide bonds to form
heterodimers. The a chain has a molecular weight of 30-34kDa while the P chain
ranges from 26-29kDa. Each chain contains two extracellular domains, al and a2,
pi and P2 anchored by a transmembrane and cytoplasmic region. The two
membrane proximal domains, a2 and p2, have immunoglobulin like structures
similar to a3 and P2m, while al and pi are similar to the al and <x2 domains of a
class I molecule, al and pi interact to form a super domain which is extremely
similar to the PBR of a class I molecule having a floor of eight antiparallel P sheets
with an alpha helix contributed by each chain as walls (Brown et al., 1993, Stern and
Wiley, 1994).
Class II molecules can bind longer peptides than class I since the residues involved
in binding the ends of peptides in class I molecules are absent here, so no binding of
the terminal ends takes place. Instead peptides are bound along their length in the
middle of the cleft by conserved residues and allowed to extend out at either end.
Like class I molecules these structures also have pockets in the binding region which
side chains of the peptide extend into. These pockets are lined with polymorphic
residues which determine the sequence ofwhich peptides can bind (Jardetzky, 1996).
15
Figure1.5:StructureofMHCclassIImolecul s ThestructureofMHCclassIImoleculi hownnsch maticfoig r1.5a.Aribbodiagr mowingthrimensional structurei hownnfig.1,5b.T epeptid -bindingialsoindicat d. (Figure1.5bwastakenfromhttp://webmed.unipv.it/immu ology/mhcstr.html) 16
1.4 MHC class I - antigen processing and presentation pathway
The production of mature MHC class I molecules presenting peptides can be divided
into three steps; degradation of protein to produces antigenic peptides, transportation
of peptides into the ER lumen, and assembly of heavy chain with (32m and peptide to
form stable molecules (fig. 1.6).
1.4.1 Peptide production and the proteasome
The proteasome is a large endo-peptidase found in the cytosol, which has broad
proteolytic activity and is the key enzyme for intracellular protein degradation
(Goldberg and Rock, 1992). It has a cylindrical structure consisting of four stacked
rings each containing seven subunits, with the proteolytic sites buried on the inside
of the structure preventing indiscriminate degradation of cytosolic proteins (fig. 1.7).
Three of the subunits 8, Z and X found in the inner rings have protease activity.
Upon IFNy stimulation of cells these subunits are replaced by low molecular mass
polypeptide 2 (LMP2), LMP7 and multicatalytic endopeptidase complex like-1
(MECL-1) forming an immunoproteasome (Griffin et al., 1998).
The role of the proteasome in antigen processing has been suggested by the fact that
the genes encoding LMP2 and 7 are found in the MHC class II region adjacent to the
transporter associated with antigen processing genes, TAP1 and TAP2 (Glynne et al.,
1991, Martinez and Monaco, 1991, Kelly et al., 1994). In addition, both human and
mouse knock-out cells deficient in either or both LMP 2 and 7 were found to have
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impaired antigen presentation (Fehling et al., 1994, van Kaer et al., 1994, Cerundolo
et al., 1995). Despite these observations it is possible for human cells to compensate
for loss of proteasome function as seen in EL-4 cells which can develop resistance to
proteasome inhibitors (such as lactacystin) by overexpression of an alternative
proteolytic molecule (Glas et al., 1998).
Differences in the cleavage patterns are observed between normal and
immunoproteasomes, with immunoproteasomes having higher activity in cleavage of
peptides with hydrophobic and positively charged carboxyl terminals which are ideal
for presentation by class I molecules (Driscoll et al., 1993). As a result LMP2 and 7
may act to increase the availability of specific groups ofpeptides for class I binding.
1.4.2 Peptide transport into the ER
The peptides produced by proteasome are released into the cytosol and pass into the
lumen of the ER via the TAP complex. This complex consists of TAP1 and TAP2
subunits, which interact to form a heterodimer. They are very similar in structure
both lying in a head-head/tail-tail orientation with three domains, heterodimeric
peptide binding domain facing onto the cytosol, heterodimeric pore domain through
which the peptide travels to enter the ER and a nucleotide binding domain on each
(Vos et al., 1999, 2000). These molecules were found to be part of a superfamily of
transporter proteins known as the ATP binding cassette or ABC family, which rely
on ATP binding to the nucleotide binding domains to function. Binding of ATP to
TAP2 induces a (probably considerable) conformational change in the complex
20
allowing ATP to bind to TAP1 and the pore to open (Knittler, 1999). Hydrolysis of
ATP at TAP2 also powers peptide transfer (Williams, Au Peh and Elliott, 2002).
The TAP complex is vital for MHC class I function since TAP deficient cells do not
express class I molecules on their surface. This phenotype can be rescued by
addition of functional genes (Spies and DeMars, 1991).
Through a combination of peptide libraries, competition binding assays and assays
using peptides with an N-glycosylation site at one end and a tyrosine residue for
radio-iodination at the other it was possible to show that TAP is selective in the
peptides it transports preferring to transport 8-16 amino acid peptides, with 9 to
12mers transported with highest efficiency (van Endert et al., 1994, Koopman et al.,
1996). When considering that proteasomes also preferentially produce peptides of
approximately this length it shows that selection is occurring at a number of stages in
the antigen processing and presentation pathway to ensure provision of peptides of
optimal length for binding to MHC class I molecules.
1.4.3 Assembly and peptide loading ofMHC class I molecules
In the ER newly produced heavy chain is initially found associated with two
chaperone proteins, calnexin (a 64.5kDa phosphorylated transmembrane protein) and
Erp57. These molecules interact to aid in folding of the heavy chain, with Erp57, a
thiol-dependent oxido-reductase encouraging disulphide bond formation between a2
and a3 (Farmery et al., 2000). This then allows the heavy chain to associate with
P2m followed by substitution of calnexin with another chaperone protein, calreticulin
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(Sadasivan et al., 1996). As with calnexin, calreticulin also helps Erp57 in
completing the folding of the MHC molecule. Calreticulin is also though to have a
role in retention of empty MHC molecules within the ER as shown by a mutant
HLA-A2 molecule which had lost its ability to associate with calreticulin but is
capable of leaving the ER without a bound peptide (Lewis and Elliott, 1998). This
calreticulin/Erp57/class I complex then associates with tapasin.
Tapasin is a 48kDa type 1 transmembrane protein with an ER retention signal, coded
for by a gene resident in the MHC class II region in humans (Grandea and Van Kaer,
2001). It acts to bridge class I/p2m complexes to TAP by having a heavy chain
binding site in its N-terminal region and a TAP binding site in its C-terminal region
(Bangia et al., 1999). Tapasin is also thought to increase the amount of, and
encourage peptide binding to TAP (Sadasivan et al., 1996, Ortmann et al., 1997).
Tapasin has been shown to be essential for class I processing through investigation of
a defective cell line 721.220 which has a functional TAP complex yet expresses only
a small amount of MHC class I. When soluble tapasin was added this allowed
reconstitution of normal class I assembly and normalised antigen presentation
(Grandea et al., 1995, Lehner et al., 1998).
Binding to TAP ensures that the MHC complex is in a region high in concentration
of specific peptides to ensure peptide loading. However there is some evidence to
show that binding to TAP is not an essential event. Analysis of interactions of
various MHC molecules with TAP showed that while the majority ofHLA-A and C
molecules studied bound to TAP effectively HLA-B molecules were more variable,
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with a large proportion binding very ineffectively or not at all (Neisig et al., 1996).
The authors suggested that by having two sets of MHC molecules, some associated
to TAP and others free in the ER, this mechanism would ensure that the majority of
peptides were able to bind to a class I molecule as quickly as possible.
Once the MHC class I molecule has bound a specific peptide it dissociates from TAP
and enters the Golgi secretory pathway whereupon it is transported to the cell surface
for expression. A lack of specific peptides within the ER can result in retention of
the molecule and continued association with the TAP complex (Neisig et al., 1998,
Knittler et al., 1998).
1.5 MHC class II - antigen processing and presentation pathway
The majority of peptides presented by MHC class II molecules are derived from
external antigens that have been taken up by the cell by receptor mediated
endocytosis or phagocytosis and broken down along the endocytic pathway by
endocytic proteases. MHC class II molecules are loaded with these peptides within
endosomal compartments (fig 1.8, Unanue, 1992).
Following translation the class II heavy chains are translocated into the ER where
they bind to an invariant chain molecule (Ii). This is a transmembrane glycoprotein
whose expression is generally limited to antigen presenting cells (Reber et al., 2002).
A portion of this is inserted into the peptide-binding region, which allows completion
of class II folding. The Ii also acts to prevent peptides from binding to class II
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Figure 1.8: MHC class II antigen processing and presentation pathway
MHC class II molecules are assembled in the ER along with an invariant chain then
moved into the endocytic pathway where the invariant chain is broken down to CLIP
which blocks the PBR. In a vesicle HLA-DM acts to remove CLIP and facilitates











molecules in the ER and provides signals targeting the class Il-Ii complex into the
secretory pathway and then into an endosome (Teyton et al., 1990, Lamb et al.,
1991).
Endosomes are membrane-bound vesicles formed by invaginations of the cell
surface, which contain extracellular and surface-bound molecules such as bacteria.
Following internalisation these endosomes become part of the vesicle system which
transports materials to and from the cell surface. The interior of endosomes
increases with acidity as they move through the cytosol and accumulate proteases
that act to break down the endosome contents (Blum and Cresswell, 1988). In the
endosome the invariant chain is degraded by proteases to a CLIP peptide (class II-
associated invariant chain peptide). DM, a nonclassical class II molecule, is believed
to catalyse the dissociation of CLIP from class II molecules leaving the PBR free to
bind peptides within the endosome. DM also acts to stabilise the MHC molecule
following CLIP release and is believed to help in the removal of peptides that do not
fit well into the pocket, ensuring that only peptides with high affinity are bound (van
Ham et al., 1996). Another MHC class II non-classical molecule, DO, modulates the
peptide loading by DM. Cell surface expression of the MHC-peptide complex
occurs when the endosome fuses with the cell membrane.
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1.6 TCR recognition of MHC molecules
The specificity of the T cell response to infection requires recognition of antigenic
peptides bound to MHC class I or II molecules by the TCR (fig. 1.9). Two types of
TCR exist consisting of disulphide-linked heterodimers of either a(3 or y§ chains.
1.6.1 <*p T cells
The majority of T cells in the peripheral blood are aP T cells which play a direct role
in antigen recognition and determine the outcome of an immune response. aP TCRs
are present on the cell surface in conjunction with the CD3 complex, one CD3y, one
CD38 and two CD3e proteins. Two copies of another protein, the ^ chain, are also
involved. Together these proteins form the functional TCR complex, with CD3 and
the t, chain being important for internal signalling, ap T cells can be divided into
two groups depending on the co-receptor they express. CD4+ cells recognise MHC
class II with the CD4 co-receptor binding to the P2 domain of the MHC molecule.
CTL recognise MHC class I, with the CD8 co-receptor binding to the a3 domain of
the MHC molecule. CD4 and CD8 help to increase the avidity with which the TCR
binds the MHC/peptide complex and reduce the flexibility of interaction between the
two surfaces helping to activate the T cell more efficiently. They both also recruit
tyrosine kinases to their cytoplasmic domains which are important components of the
signalling pathway, enhancing signalling transduction following stimulation of the
TCR (reviewed in Gao and Jakobsen, 2000).
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1.6.2 yd T cells
yd T cells were originally discovered in 1986 by Brenner et al. but to date, despite
study in a number of species, their function still remains unclear. In rodents and
mammals yd T cells represent less than 10% of the T cells in the body, with the
majority of these residing within mucosal sites such as the skin and gastrointestinal
tract (Haas et al., 1993). In direct contrast ruminants have been shown to have large
numbers of yd T cells especially in new born calves where they make up to 50% of
the circulating Peripheral Blood Mononuclear cells (PBM, Hein and Mackay, 1991).
The reason for this variance is not known but possible suggestions include selective
advantage or as a result of a biochemical event occurring around gestation (Howard
et al., 1999).
yd T cells are a heterogeneous population, with their functions differing depending
on their location and local environment, the structure of their TCR and how and at
what stage they become activated during an immune response (Carding and Egan,
2002).
Recognition of antigen by yd T cells occurs in a different manner from that of aP T
cells with no antigen processing or MHC restriction required (Schild et al., 1994).
As a result yd T cells are not constrained to bind to MHC and so are able to recognise
a greater variety of antigen, yd T cells in the blood tend to respond to antigens
constitutively expressed on the surface of microbial pathogens and host cells such as
non-protein phosphorylated nucleotides and alkylamines and homologues of a heat
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shock protein (Tanaka et al., 1995, O'Brien et al., 1992). In comparison y8 T cells in
tissues respond to induced antigen such as MHC class I related chain MICA and
MICB which are expressed by cells during periods of stress (Bauer et al., 1999).
Studies on y8 T cells identified two principal functions, production of cytokines and
chemokines and cytotoxicity. They are believed to have both effector and
regulatory roles in the immune response which is supported by the kinetics of the y8
T cell response. Following infection a first wave of y8 T cells are seen along with
the innate immune response. These produce pro-inflammatory cytokines and
chemokines helping to control the natural killer cells and macrophages and also
development of the adaptive response. Later on in the infection the cells then act to
downregulate inflammation through the inhibition of a(3 CD8+ T cell migration and
responses and killing of activated macrophages (Hayday, 2000, Bom et al., 1999,
Guan et al., 2002).
1.6.3 TCR structure
The TCRs are polypeptides very similar to immunoglobulins. Their genes are
assembled in a similar manner consisting of interchangeable V (variable), J (joining)
and C (constant) gene segments. In addition the (3 and 5 chains also have D
(diversity) segments. Specific V, D and J segments fuse to form a complete V
region, which then combines with the C region creating a functional chain. This
combination of different gene segments along with the addition of nucleotides where
they join acts to increase the diversity of the T cell repertoire. Unlike
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immunoglobulins however, TCRs do not undergo somatic hypermutation and affinity
maturation to increase their affinity for antigen, instead they have more J segments
and junctional diversity (Davis and Bjorkman, 1988). When these chains fold the
variable region is found distal to the cell surface. This region is equivalent to the
hypervariable region in immunoglobulins, with three folds known as
complementarity determining regions (CDR) providing the points of contact to the
MHC peptide complex.
The crystal structure of a TCR bound to a MHC molecule has been determined for a
number of human and mouse models (reviewed in Garcia et al., 1999). These
showed that all six CDR loops interact, with the CDRls interacting with the peptide
and the a helices of the MHC molecule, CDR2s just the helices and CDR3s
primarily the peptide but with some contact on the helices as well. On a wider
perspective the variable domains of the polypeptide chains lie in a diagonal
orientation above the PBR, with the variable portion of the a chain (Va) lying over
the N-terminus while VP is over the C-terminal. Interactions with the peptide vary
between the mouse and human models with the human TCRs having more intimate
contact with the peptide (although this is thought to reflect the antigenicity of the
peptide used since a self-peptide involved in thymic selection was used in the murine
model).
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1.6.4 T cell development
Following production in the bone marrow T cell precursors must migrate, via the
blood, to the thymus to complete their development before entering circulation as
functional cells. These precursors have no CD4 or CD8 receptors and the TCR is not
fully formed. Once in the thymus the TCR genes become rearranged with the
expression of a preTCR receptor. The cells then proliferate followed by another
round of rearrangement which results in cells expressing a(3 or y5 receptors. The a(3
T cells then go on to express both CD4 and CD8. These double positive cells are
found in the inner cortex of the thymus where they are surrounded by a network of
cortical epithelial cells which express MHC/self peptides on their surface. Initially
only a small proportion of these T cells have TCRs specific for self-MHC. If
interaction between these cells and the epithelial cells occurs within three to four
days of cells gaining their receptors then a positive signal is delivered to the T cell
allowing it to mature. If no such signal occurs then the cell dies by apoptosis and is
removed by macrophages. This positive selection also determines the fate of the T
cells, with those interacting with class I MHC molecules becoming CD8+ cells,
while those that interact with class II molecules become CD4+ cells.
Following on from this the cells that have survived go through a negative selection
process. In the cortico-medullary junction they are mixed with professional antigen
processing cells (APC) such as dendritic cells. T cells which bind to these APC with
high affinity are removed, since these could become alloreactive if allowed into
circulation. This process ensures the release into circulation of a repertoire of T cells
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that recognise selfMHC molecules but which do not bind with a high affinity such as
to cause autoimmunity (reviewed in Anderson, Hare and Jenkinson, 1999). In
addition the combination of many types of self peptide and a large TCR repertoire
ensures a diverse array of T cells leave the thymus.
1.6.5 T regulatory cells
The process of T cell activation is under tight control to prevent or reduce reactivity
to self antigens and limit the response to pathogen-derived antigen as uncontrolled
responses to these can lead to the development of autoimmune disease and infection.
While thymic selection described in section 1.6.4 ensures that the T cells released
into the system are self tolerant another system exists in the periphery to help control
the T cells - T regulatory (Treg) cells. Two populations of regulatory cells exist,
natural and inducible. Natural Treg cells have a CD4+ CD25+ phenotype and
develop in the thymus before migrating to the periphery (Sakaguchi et al., 2001).
Within the thymus their development appears to depend on the strong TCR
interaction and co-stimulation through CD28. Once in the periphery repeated co-
stimulation through CD28 is required to ensure survival of this cell population
(reviewed in Bluestone and Abbas, 2003). These cells are anergic but are able to
suppress the activation and proliferation of CD4+CD25- and CD8+ T cells, possibly
by cell to cell contact through the TCR following recognition of self-antigens on
APC (Cozzo et al., 2003). There is also evidence for the involvement of CTLA4
(CTL antigen 4, a marker on the Treg cell) which binds to CD80/86 on the APC and
delivers a negative signal for T cell activation (Read et al., 2000)
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Inducible Treg cells can be produced from naive CD4+CD25- and CD8+CD25- T
cells in the periphery when they interact with antigen presented by a population of
dendritic cells. Unlike natural Treg cells inducible Treg cells act by producing
immunosuppressive cytokines including IL-10 and TGFp. These cytokines cause
reduced expression of MHC and co-stimulatory molecules and suppress
inflammatory cytokine release by the APC. These changes in APC function then
result in decreased proliferation and cytokine production by Thl, Th2 and CD8+ T
cells which are reacting to the peptides presented on the surface of the APC
(reviewed by Wills, 2004).
1.6.6 Natural Killer Cells
Another type of cell within the body which also interacts with MHC class I
molecules is the Natural Killer (NK) cell. These cells are classed as lymphocytes
and are derived from the same common progenitor cell as T cells (Rodewald et al.,
1992) but are considered to be a fundamental part of innate immunity, becoming
activated through constitutively expressed receptors prior to clonal expansion and
differentiation of T cells.
Two families of NK receptors have been identified, Ig-like receptors and C-type
lectins. These are polymorphic, polygenic families encoded in two regions, the LRC
(leukocyte receptor complex) and the NKC (natural killer complex) respectively.
These regions are orthologous in both humans and mice (reviewed in Barten et al.,
2001). Ig-like receptors include human killer cell Ig-like (KIR) receptors and Ig-like
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transcripts (ILTs). C-type lectins include the murine Ly49 receptors and NKG2
receptors, the majority of which are found as heterodimers in association with CD94
on both murine and human cells. Within both families are activatory and inhibitory
receptors which tend to occur in pairs on the cells surface, comprising one of each
set. Inhibitory receptors have ITIM (immunoreceptor tyrosine-based inhibition
motifs) in their cytoplasmic domains which transduce inhibitory signals into the cell
(Long, 1999). Activatory receptors have truncated cytoplasmic tails and so lack this
motif instead coupling with an ITAM (immunoreceptor tyrosine-based activation
motifs)-bearing adapter molecule DAP 12 in the transmembrane allowing positive
signals to be passed into the cell for activation (Isakov, 1998). The balance between
the two types of receptors determines the outcome of the NK cell response.
NK cells act to monitor the health of cells in the body by determining the level of
class I molecules on the cell surface as loss or a decrease in class I expression is
frequent in tumour and infected cells (Ljunggren and Karre, 1990). Direct
interaction between Ly49 and KIRs with classical MHC molecules causes an
inhibitory signal to be sent to the NK cell stopping the cell becoming activated.
CD94/NKG2 heterodimers interact with the non-classical MHC molecules HLA-E in
humans and Qalb in mice (Braud et al., 1998, Vance, 1998). Analysis of these
molecules has shown that they present the leader peptides of classical MHC
molecules thereby allowing the NK cells to detect class I expression indirectly.
NKG2D is an NK cell receptor only distantly related to the other NKG2 receptors.
Present also on NK, y5 and activated CD8+ T cells it is expressed as a homodimer
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and is found associated with the activating adapter protein DAP10 (Wu et al., 1999).
Like yd T cells NKG2D ligands are MICA and MICB (and retinoic acid early
inducible receptors in mice). Since these factors are found on stressed or
tumorigenic cells this allows the NK cell to be activated even when there is no
decrease in class I expression (Bauer et al., 1999, Cerwenka, 2000).
1.7 Non-classical MHC
Following discovery of the classical class I genes in the class I region other genes
were identified which showed significant homology to the classical genes but
differed in both polymorphism and expression. These genes were called non-
classicals or class lb. In the mouse the non-classicals were termed Qa and TL and
mapped telomeric to the classical genes (see fig. 1.1). These genes encoded unusual
molecules, for example, Qa2, which is attached to the cell surface by a
glycophosphoinositol anchor, and Q10, which is a soluble protein. In humans three
non-classicals were initially identified, HLA-E, F and G. The molecules were found
to be structurally similar to classical class I molecules including association with
P2m suggesting key roles in immunological recognition although they have limited
polymorphism and tissue distribution. Further investigation of both genomes
identified other class I like molecules both within and outside the MHC region,
including other chromosomes.
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1.8. Evolution of the MHC region
As discussed above, the MHC region is highly complex, containing approximately
224 genes, only a proportion of which are directly involved in the immune system
(the MHC sequencing consortium, 1999). How such a set of genes came to be
associated together, in such a distinct configuration, has been the subject of much
interest. Analysis of the subunits of the proteasome in humans led to the discovery
that a section of chromosome 9 (q33-q34) to which one of the subunits Z mapped,
contained at least ten genes which had high homology to those found in the MHC
region. Thus it appeared that these two regions were paralogous i.e. they contained
closely linked pairs of duplicated genes (Kasahara et al., 1996a, Kasahara, 1999a,
Katsanis et al., 1996). Further paralogous regions were also identified on
chromosome 19pl3.1-13.3 and chromosome Iq21-q25/pl l-p32 (Katsanis et al.,
1996, Kasahara et al., 1997).
To date more than 20 gene families have been identified across the paralogous
regions (see fig. 1.10 for examples). It should be noted that the regions are not exact
replicas of each other, with deletions following gene inactivation, inversions and
intrachromosomal translocations all taking place following establishment of the
region (see below, Kasahara et al., 1999b). Regions paralogous to the MHC were
also identified in the mouse genome (Kasahara et al., 1996b, Katsanis et al., 1996)
however these are more disjointed than the humans, possibly as a result of more
rearrangements.
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Figure 1.10 : Emergence of the four paralogous regions identified in the human
genome
This figure shows the believed relationship between the paralogous regions with the
estimated emergence time for each class of vertebrates indicated in million years ago
(MYA). Paralogous genes present in each of the regions are shown on the same line
with blank spaces indicating the no genes for that group have been identified.
Adapted from Kasahara et al., 1997).



















There are two arguments for how these paralogous regions have evolved. One
dictates that block duplication of sections of or whole chromosomes has occurred
resulting in the inheritance of all members (Kasahara et al., 1996a, Kasahara, 1999a,
Abi-Rached et al., 1999). The other argues against this, instead suggesting that
selective pressure has acted to group these genes, which have arisen by individual
duplication, for some functional reason (Hughes, 1998). The former is the more
widely accepted opinion since it is difficult to imagine a mechanism that could cause
such a large amount of gene manipulation to occur.
Since all jawed vertebrates have a MHC region it is likely that the duplications
giving rise to these paralogous regions occurred in a common ancestor prior to the
divergence of this group. Furthermore it appears that jawless fish appear to have two
paralogous regions which would indicate that the first round of duplication took
place in an ancestor to all vertebrates, with a further round occurring after the
division ofjawed and jawless groups (reviewed in Flajnik and Kasahara, 2001).
It has been suggested that the duplications forming the MHC paralogous regions
could be part of a much larger genome-wide duplication. A hypothesis exists that
genome duplication occurred in vertebrates early in evolution to produce the
complex genomes now seen (Ohno, 1973). The timings of these duplications and the
number of duplications match those of the paralogous regions indicating this as a
distinct possibility for their evolutions.
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Recent work by Amadou (1999) identified the presence of non-MHC genes in the
class I region of humans and mice which appeared to define a framework, with the
areas in between determining class I permissive regions. Examples of these genes
include ZNF173 which encodes a nucleic acid binding protein (Chu et al., 1995) and
MOG, myelin oligodendrocyte glycoprotein. Some of these anchor genes have also
been identified in the MHC region of cattle (Archibald, 2002). Although the class I
genes evolved independently in both species the anchor genes are conserved and
their order maintained indicating that they may have existed in this order in a
predecessor of humans and mice. This may be useful when considering how the
class I region has evolved. It is important that the framework contains genes with
essential functions to warrant conservation.
1.8.2 Maintenance of polymorphism
The MHC genes are the most polymorphic loci identified in the animal kingdom.
Indeed it was this characteristic rather than their function which was first discovered
(reviewed in Hughes and Hughes, 1995). The elucidation of their role in presenting
peptides, with different alleles presenting a different panel of antigens, led the
authors to suggest that heterozygote advantage would occur in a population under
threat by various pathogens, thereby acting to increase diversity in the MHC
(Zinkernagel and Doherty, 1974). The evolution of methods allowing in-depth
sequence analysis has supported this theory, with patterns of nucleotide substitutions
indicating that both the MHC class I and II genes are under overdominant selection
which acts to maintain polymorphism within a species. Two main pieces of evidence
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point to this. Firstly in neutrally evolving loci it would be expected that fixation of
nucleotides would occur over time as a result of genetic drift with an allele fixed at
each locus with approximately 100% frequency and the others all at low frequencies.
However with MHC loci there are no dominant alleles found, instead there is a large
number of alleles all of intermediate frequency, although it should be noted that in
some cases, for example isolated populations, higher frequencies of particular alleles
can occur (Maruyama and Nei, 1981). Secondly, comparing patterns of nucleotide
substitutions it would be expected that a higher proportion of synonymous (non-aa
altering) mutations than non-synonymous would occur since these are likely to be
deleterious and thus removed. This is the case for the majority of the MHC gene
sequences (both class I and II) with the exception of the peptide-binding region
where the opposite occurs indicating that this region is under selection, acting to
increase polymorphism in both mice and humans (Hughes and Nei, 1988).
The fact that selection is acting at the PBR, encouraging an increase in the diversity
of peptides that can bind means it is reasonable to assume that the evolution of the
system has been influenced by pathogens which may be driving an increase in
polymorphism. Unfortunately there is little actual evidence to support this theory.
Evidence for long lasting polymorphisms, including those prior to speciation, have
been identified, for example, between humans and chimps (Lawlor et al., 1988).
These can only be supported by selection since neutral polymorphisms are not likely
to survive that long (Takahata and Nei, 1990).
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1.8.3 Generation of polymorphism
Comparison of MHC class I sequences in humans and mice indicates that diversity
was generated by point mutations which were then propagated by intra- and/or inter-
locus-specific recombination. Recombination alone can play a role but a basic level
ofpolymorphism needs to be in place for this method to have any effect.
Intra-locus recombination has been identified in HLA-A and B and to a lesser extent
in HLA-C (Parham et al., 1988, Yeager and Hughes, 1999) as shown by the presence
of locus-specific characteristics. Both large (involving whole exons) and small scale
recombinational events have been identified in HLA-A and HLA-B while HLA-B
has been found to have undergone recombinational events twice as often as HLA-A,
with these more likely to be in the PBR. As a result HLA-B has more alleles
(Hughes et al., 1993).
In contrast little or no interlocus recombination has been identified in humans.
However, in mice and rats this is relatively frequent (Weiss et al., 1983) leading to a




1.9.1 Origin of cattle
The ancestor of modern day cattle is the aurochs, or Bos primigenius. These existed
as distinct populations in central and northern Europe, Asia (Bos nomadicus) and
possibly North Africa {Bos opisthoriomalus), each ofwhich were evolving in distinct
conditions with different endemic pathogens. These animals are now extinct,
thought to have died out approximately 2000 years ago (Bradley et al., 1996).
Modern cattle are believed to have their roots in two main areas of domestication, in
the Near East and Northern India and Pakistan. The first domestication events are
believed to have taken place approximately 10,000 years ago. Analysis of
mitochondrial DNA shows there to be two main lineages of cattle which diverged
between 200,000 and 1 million years ago, one containing all European {Bos taurus)
and African {Bos indicus) breeds and the other the Asian B. indicus breeds (Loftus et
al., 1994). The African and European breeds are believed to have diverged between
180 and 250,000 years ago. It is not clear whether B. indicus and B. taurus are
distinct species or related subspecies although they appear to be subspecies based on
their ability to interbreed and from studies into their evolution (Lewin et al., 1999).
These animals can be differentiated by the presence of a hump on B. indicus cattle.
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1.9.2 Bovine MHC region
The bovine MHC or BoLA system was located to chromosome 23 (BTA23) by in
situ hybridization using a cloned sequence derived from a pig MHC class I gene
(Fries et al., 1986). It has the same basic organisation as human and mouse with
class II, class III and class I in a centromere to telomere orientation (fig. 1.11). One
major difference exists however in that the class II region is divided into two
sections, termed class Ha and class lib, by a genetic distance of 17cM (Andersson et
al., 1988, Hess et al., 1999). Comparison of the gene order between humans, cattle
and mice indicates that this division is likely caused by a single large chromosomal
inversion (Band et al., 1998). Gallagher et al. (1994) found that families related to
the bovines including Giraffidae and Antilocaprodae had similar banding patterns on
their BTA 23 homologues indicating that these animals may also have the class II
division.
1.9.3 Class II region
Investigation of the classical class II genes in cattle has been relatively
straightforward due to the high levels of homology that exist between class II genes
in mammals. The class Ha region contains the genes DR and DQ which code for
functional class II molecules. These genes were originally identified using human
class II probes on Southern blots (Andersson et al., 1988, Andersson and Rask,
1988). No cattle homologues of the DP genes have been found suggesting that these
have been deleted from the genome. DP genes are also absent from ovine MHC
43

























indicating that this may be a common feature of the ruminant MHC (Deverson et al.,
1991). Possibly as a compensatory mechanism it has been shown that approximately
half of the common haplotypes in cattle have duplicated DQ genes which are
expressed (Glass et al., 2000).
The DR region consists of a monomorphic DRA gene and at least 3 DRB genes.
DRB1 is known to be a pseudogene as shown by the presence of a number of stop
codons within its sequence (Groenen et al., 1990) while DRB2 is transcribed, but at
low levels. In contrast DRB3 is actively transcribed, expressed at high levels and is
polymorphic, particularly in the PBR region with at least 60 alleles identified (Van
Eijk et al., 1992). Each haplotype contains one DR gene pair, DRA and DRB3.
Analysis of the DQ region containing polymorphic DQA and DQB genes shows it to
be highly variable with the number of DQ genes varying between haplotypes. Three
haplotypes have been described with different DQA genes, DQA1, DQA1 and 2,
DQA2 and 3 with at least two DQB loci found (Andersson and Rask, 1988).
Variation in the number ofDQB genes expressed has also been described (Marello et
al., 1995).
The class lib region contains the LMP2, LMP7 and TAP2 genes along with the non-
classicals DOB, DOA, DIB and DYA, which show limited homology to human class
II genes (Stone and Muggli-Cockett, 1990, van der Poel et al., 1990). The functions
of these are currently unknown but it has been shown that DYA and DIB are
transcribed at low levels in dendritic cells (Ballingall et al., 2001). DYA and DIB
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have also been identified in sheep and goats but not pigs, humans or mice suggesting
it to have been produced by gene duplication following divergence of these groups
and be ruminant specific. Recently it has been shown that these genes form a pair
similarly to other class II genes since they are closely linked, separated by
approximately 18kb (Ballingall et al., 2004). As a result the authors suggested that
DIB be renamed DYB to reflect this close association. Analysis of the products of
these genes shows them to code for class II a and (1 chains which, although similar to
classical chains, differ by 16 unique aa in the peptide binding region.
1.9.4 Class III region
Little information is available regarding the class III region in cattle probably due to
a lack of interest in the genes residing here. Its position between class I and II was
determined based on the finding that the linkage disequilibrium between a class III
gene C4 and either class I or II genes was approximately equal. Five genes have so
far been identified, C4, Bf, CYP21, HSP70 and TNFa. C4 and Bf are complement
proteins while CYP21 is a 21 hydroxylase. These are also components of the human
MHC and were mapped to the bovine MHC by linkage analysis (Andersson et al.,
1988, Teutsch et al., 1989) and analysis of somatic cell hybrids (Skow et al., 1988).
The presence of HSP70 and TNFa was shown by the fact that they co-localise with
CYP21 using fluorescent in-situ hybridisation (FISH) indicating tight linkage
(McShane et al., 2001).
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1.9.5 Class I region
The MHC class I region is more difficult to study than class II due to the mix of
expressed genes, pseudogenes and gene fragments found here. Initial studies of the
class I region used alloantisera produced by skin grafting or lymphocyte inoculation
in microlymphocytotoxicity assays for identifying class I genes (Spooner et al, 1979,
Ennis et al., 1988). By 1987 25 distinct specificities had been identified by this
method and approved by the International BoLA workshop. This number was
subsequently extended to 50 (Bernoco et al., 1991). Further studies led to the
limitations of serology for typing the bovine class I genes being uncovered. Testing
antisera on single gene transfectants it was shown that the sera were detecting only
one gene on a haplotype with any others being serologically blank. As a result it was
originally assumed that all specificities mapped to the same locus. It was also found
that some sera were cross-reactive between alleles for example A10 and JSP1 which
differ by 15 aa (Pichowski et al., 1996). Some of the antisera used recognise more
than one haplotype, indicating that they are specific for a conserved region between
alleles, for example the w6 sera recognises the haplotypes A17, A18 and A19. Thus
while serology it useful for determining the frequency of specificities it is clearly not
specific enough to allow complete characterisation of haplotypes.
The development of biochemical and molecular techniques allowed more in-depth
analysis of the class I region and provided evidence for the existence of more than
one class I locus. Ennis et al. (1988) were the first to adapt such methods. They
used a HLA-B probe to screen a cDNA library produced from a bovine B cell line.
From this they identified two long clones, BL3-6 and BL3-7, which appeared to code
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for all the characteristics of MHC class I proteins including phosphorylation and
glycosylation sites. Examination of the 3'untranslated region (3'UTR) of these
clones showed them to have 86% homology, approximately 10% lower than that
observed for alleles from the same locus in humans and mice, suggesting that these
sequences were derived from different loci.
Serological evidence for two classical class I loci was provided by Toye et al.
(1990). They transfected genomic DNA from an animal homozygous for
wl0/KN104 into L cells then screened the transfectants with monoclonal antibodies
specific for each specificity. From this they identified two populations, one
expressing KN104 and one expressing wlO indicating that these specificities are
products of different genes. Further work on this haplotype was carried out by
Bensaid et al. (1991). They produced a cDNA library from a MHC homozygous
animal from which two distinct cDNA strands were isolated and cloned. When these
clones were used as probes in Northern blots on mRNA from the transfectants
mentioned above, each of the clones were found to be specific for one or other
transfectant, conclusively showing that wlO and KN104 are products of two different
genes. Following on from this they were able to map the genes to within 210kb of
each other using field inversion gel electrophoresis (FIGE).
Evidence for a third locus was provided by Garber et al. (1993) through phylogenetic
analysis of the class I sequences available at this time. He found that the sequences
appeared to fall into two groups, with the exception of the allele KN104 which was
equally similar to both groups. Given that KN104 is encoded by a separate gene to
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the other specificities (Bensaid et al., 1991) and had been shown to be important in
MHC restriction of T cells against the parasite Theileria parva (Goddeeris et al.,
1990) it can be taken that this allele codes for a functional MHC molecule and thus
there are at least 3 classical class I loci. More conclusive evidence for a third locus
was provided by Garber et al. (1994) who used reverse-transcriptase Polymerase
Chain Reaction (PCR) and RACE (rapid amplification of cDNA ends) PCR to
identify six cDNA clones from a heterozygous animal.
1.9.6 Class I haplotype analysis
Despite attempts to investigate the class I region in cattle the exact number of class I
genes has not yet been determined. In 1996 Ellis et al. initiated a series of studies
using a herd of cattle that had been specifically bred to produce MHC-homozygous
animals expressing common serologically defined class I specificities. Using a
combination of cDNA cloning, sequence analysis and transfection/expression studies
they investigated individual common haplotypes in great detail. Four class I
haplotypes were characterised, A18, A31, A14 and Al 1. Two of the haplotypes had
two classical genes, A31 and All, with the Al8 haplotype found to express only one
gene. The A14 haplotype was found to have three transcribed genes conclusively
showing that there are at least three classical class I loci in cattle. The genes
identified on each of the haplotypes are summarised in table 1.1.
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A14 D18.1, D18.4, D18.5
The presence of locus-specific characteristics within class I coding sequences from
humans and primates allows relatively easy locus assignment with all the sequences
falling into distinct groups representative of loci when compared phylogenetically
(Knapp et al., 1998, Parham et al., 1989). Studies of cattle sequences have not
identified such characteristics within the coding region (Ellis et al., 1999, Holmes et
al., 2003) with analysis of 22 class I sequences failing to fall into such distinctive
groups (see fig. 3.1). Instead there appeared to be five or six potential groups of
alleles. The pattern of distribution of these alleles does match the haplotype
configurations identified, with alleles on the same haplotype not grouping together
suggesting a different origin i.e. products of different loci. A study of the promoter
region of a proportion of these alleles found that they also appeared to fall into the
previously observed groups (Smith, 2000).
Together these data provide evidence for the existence of five or six classical class I
genes in cattle, of which two or three are polymorphic. Interestingly it can be seen
through haplotype comparison that not all of the genes are expressed in all
haplotypes, with the number of expressed genes varying between one and three and
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no gene consistently expressed. Whether all genes are present and a proportion
turned off, or deletions have occurred to remove them from the genome has not yet
been determined.
The variation in class I haplotype composition observed in cattle does not in itself
appear to be particularly unusual. Variation has also been observed in the bovine
class II DQ region and the murine and rat class I genes (Joly et al., 1996,
Wroblewski et al., 1994). Rather, the standard three gene expression seen in humans
appears to be unusual and in no way represents the situation in all mammals.
However cattle may be unique in the level of variation seen, in particular the fact that
none of the genes identified are found on all haplotypes.
1.9.7 Polymorphism in bovine MHC class I genes
Since the total number of class I genes and assignment of alleles to loci has not been
confirmed it is difficult to comment on the level of polymorphism in cattle. To date
approximately 40 alleles have been identified by various groups, 30 of which have
been submitted to the BoLA database (www.projects.roslin.ac.ulc/bola). Given that
the majority of studies have been done on inbred herds or very small numbers of
animals it is possible that the polymorphism may be quite extensive. Analysis of
available BoLA class I sequences showed that, like humans, dN is greater than ds in
the al and a2 regions while the opposite is seen in the remainder of the sequence
which indicates that the PBR is under selection to maintain diversity (Garber et al.,
1993).
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Through comparison of the coding sequence from all bovine MHC class I alleles it is
possible to see a patchwork of substitutions with shared motifs between alleles. This
shows that segmental exchange was involved in creating diversity of the class I loci.
In depth analysis using statistical packages showed that interlocus recombination has
also taken place, with two alleles, BL3-7 and D18.4 changing groups in both
neighbourhood joining and maximum likelihood phylogenetic trees constructed with
different gene sections (Holmes et al., 2003). Furthermore the authors were able to
locate the breakpoints within the sequences. Other alleles were also found to move
position on neighbourhood joining trees but maximum likelihood trees did not
support this. It is a possibility that the interlocus recombination observed with the
bovine MHC class I genes may account for the failure of distinct gene-specific
groups to form when alleles are compared.
1.9.8 Bovine MHC class I genes and molecules
Analysis of MHC class I transcripts isolated from bovine PBM showed them to
contain the characteristic features of functional MHC molecules when compared to
those from other species (Ennis et al., 1988, Garber et al., 1993). These include
cysteine residues in a2 and a3 for intramolecular disulphide bonds (positions 101
and 164 and 203 and 259 respectively) and an N-linked glycosylation site in al at
position 86 which is also found in human and murine class I molecules (Ploegh et al.,
1981). A conserved potential site for phosphorylation was identified in all the
transcripts at serine 333 in the cytoplasmic domain.
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Through the use of immunoprecipitation bovine MHC class I molecules have been
shown to consist of a 44kDa heavy chain and a 12kDa P2m molecule (Hoang-Xuan et
al., 1982). These sizes are comparable with human and murine class I molecules
(Creswell et al., 1973).
1.9.8.2 Promoter
Initial attempts to sequence the promoter region of an MHC class I gene identified
essential components including the enhancer A/ Interferon Response Sequence (IRS)
region, enhancer B, TATA and CAAT boxes for RNA Polymerase II binding and a
transcription initiation site (Harms and Splitter, 1995), all of which are found in the
human promoter region. Surprisingly, comparison of HLA-A2 and a bovine
promoter (BoLAenh-9) showed that while both were capable of driving transcription
they shared only 59% homology (Harms and Splitter, 1994).
1.9.8.3 Bi-microglobulin
The sequence of bovine P2in was originally elucidated by Groves and Greenberg
(1982). Comparison to the published human, murine, rabbit and guinea-pig
sequences showed the bovine sequence to be one aa shorter due to missing a
conserved valine at position 49. Overall comparison of sequences shows that bovine
P2m has between 24 and 32 aa differences from these species with guinea-pig and
mouse being most different. A total of 48 residues are completely unchanged
however, showing that P2m is a highly conserved molecule between species.
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Further work on bovine P2m was carried out by Ellis et al. (1995). They also
sequenced P2m but found that the sequence differed by 3 aa to that previously
obtained suggesting that allelic variation was occurring as with the murine P2m
(Hermel et al., 1993). Following on from this they sequenced the majority of the
coding region of P2m from a range of European, African and Indian animals. The
European and Asian animals all had identical sequences to that previously found by
this group. Of the six African animals studied two also had this sequence. Two
allelic variants were identified in the remaining animals, each carrying at least one of
the variants. One animal was found to have all three variants, which the authors
suggested could indicate the presence of two genes for P2m. Alternatively it could be
chimaeric since this animal is a twin. One of the variants identified had a non-coding
change while the other had this plus a coding change. It is possible that these
changes may affect the binding of P2m to an MHC molecule.
1.9.8.4 Peptide binding region
It is generally accepted that CTL play an important role in the immune response
against intracellular pathogens. In cattle there is evidence for their action against
Theileria parva, respiratory syncytial virus and bovine herpes virus (Eugui and
Emery, 1981, Gaddum et al., 1996, Splitter et al., 1988). CTL specifically recognize
the combination of antigenic peptides attached to self-MHC molecules and respond
accordingly. A major impetus in the drive towards vaccine design is the
identification of epitopes recognized by CTL which could then be produced
synthetically and used to induce a CTL response.
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As discussed previously peptides bound to MHC class I molecules are typically
nonamers. Despite the low level of different MHC molecules expressed by an
individual, each type of molecule is able to present an array of peptides. These
peptides are limited only in the requirement for specific anchor residues located
along the peptide which determine the peptide binding motif of each class I
molecule. Thus by determining the anchor residues it is possible to predict the
sequences of peptides that should bind. This is usually done by eluting and
sequencing self peptides from the class I molecules which bind in the absence of
antigenic peptides. An increase in the frequency of a residue at any position suggests
preferential binding and indicates this to be an anchor residue. This data should also
provide some information about the affinity of the peptide for the MHC molecule
and also the affinity ofCTL for the peptide and MHC combination.
To date the peptide binding motif has been determined for HD1, HD6, HD7, D18.3
and an unknown gene from an animal typed serologically as A20 (Gaddum et al.,
1995, Hegde et al., 1995, Bamford et al., 1995). Further motifs are also available for
A10 and KN104 (unpublished data, S. Ellis personal communication). These motifs
are summarised in fig. 1.12. Surprisingly neither HD1 nor HD6 have an anchor
residue near the carboxy terminal which is unusual when compared to most motifs.
HD7 has a tyrosine anchor residue at position 10 which suggests it may be able to
present larger peptides than normal.
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Figure 1.12: Peptide binding motifs of bovine MHC class I molecules
The peptide binding motifs ofHD1, HD6, HD7, D18.3 and A20 has been determined by
elution and sequencing of self peptides. Anchor residues are shaded in red, with
auxiliary anchor residues which were also identified but in reduced frequency shaded in
blue. Other preferred residues are shown in green.
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1.10 Typing MHC genes
Polymorphisms of the human MHC system have been traditionally detected by
complement mediated microcytotoxicity. While this method is still widely used
(Kurz et al., 1999) it is not able to accurately define all MHC class I antigens due to
lack of specificity and reagents. Typing now relies on either sequence-based or
conformational methods or a combination of both. Examples of both are discussed
below.
1.10.1 Sequence-based methods
Three main approaches can be included in this grouping; PCR using sequence-
specific primers (PCR-SSP), PCR followed by probing of gels with an
oligonucleotide probe (PCR-SSOP) and direct sequencing. These methods generally
rely on the identification of a particular motif within the target sequence. Evolution
ofMHC class I genes through both inter- and intra-locus recombination has resulted
in each allele consisting of a unique combination of sequence motifs, but with motifs
shared between alleles (Parham et al., 1995). As a result, targeting a particular
section of sequence can prove difficult. The presence of pseudogenes and gene
fragments within the MHC region can also hinder this. In terms of practicality with
such a large number of alleles (309 HLA-A, 563 HLA-B and 167 HLA-C,
IMGT/HLA database, www.ebi.ac.uk/imgt/hla) in the MHC class I region the
requirement for reagents such as allele-specific primers means the process can
become unwieldy, with many reagents required for typing an unknown sample. In
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addition the system needs to be constantly reviewed to incorporate new allele-
specific polymorphisms that can be used for a specific primer or probe. It is possible
to directly sequence every sample using for example locus-specific primers but this
approach is not only time consuming and expensive but also has the added problem
of discerning to which allele the sequence belongs to in a heterozygous individual
(cis/trans distinction). Sequence-based typing and the other PCR-based systems are
also subject to interference from PCR errors and intra-PCR and intracloning
recombination which further adds to their unreliability (Ennis et al., 1990, Longeri et
al., 2002).
PCR-SSP has been successfully used to type for a panel of MHC class I alleles in
cattle using allele-specific primers (Ellis et al., 1998). These primers were tested on
animals of known haplotype which carried either the target allele, alleles with high
levels of homology to the target, or unrelated alleles. In all cases these primers were
able to amplify a product in an allele-specific manner. However the authors did
speculate on the intrinsic usefulness of such a system since it is likely that the alleles
included in this represent only a small proportion of the total polymorphisms in the
bovine MHC class I. However with research concentrating on inbred herds and
small numbers of animals this method is applicable for small scale typing. The use
of PCR-based typing systems is also limited due to potential problems with class I
allele sequence variation between breeds, including breed-specific differences in the
class I types represented (Bull et al., 1989).
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1.10.2 Conformational methods
The problems associated with sequence-based typing have been largely overcome
through the use of conformational methods which are based on the behaviour of
DNA as it moves through a polyacrylamide gel. Two widely used examples of this
are single strand conformation polymorphism techniques (SSCP) and heteroduplex
analysis (HA). With SSCP DNA is normally amplified in a group-specific manner
(i.e. using primers that amplify a range of alleles so as to reduce the number of
primers required), then denatured and run on a non-denaturing polyacrylamide gel.
Alternatively, single strands are produced by having one primer in excess in the
PCR. After the low concentration of the other primer is used the reaction continues
producing only the target strand (asymmetric PCR). Differences in sequence
between samples cause the single strands to fold differently with intrastrand base
pairing leading to loops and compaction which affects their mobility through the gel
(Orita et al., 1989). The bands can be visualised in a variety of ways including the
use of radiolabels or fluorescent tags on the primers in the PCR, or by silver or
ethidium bromide staining. It is important that the conditions are optimised to ensure
optimal migration since the differences between samples may be subtle. This
method is particularly useful in, for example, comparing the class I alleles between
donors and recipients for bone marrow transplants by comparing the banding
patterns. The advantages of SSCP include the fact that this is a simple method with
no difficult reactions and is relatively inexpensive. However this method is limited
in its use since only small fragments (up to 300bp) can be analysed (Sheffield et al.,
1993). In addition it has been observed that single strands with identical sequences
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can adopt multiple conformations meaning banding interpretation can be difficult.
The reproducibility is also poor with inter and intra gel variation occurring.
HA has been successfully used for analysing class I genes (Martinelli et al., 1996),
although its main application is for screening potential bone marrow donors.
Duplexes are formed between, for example, a test sample and a known control
sample during the final stages of PCR along the length of which are regions of
complementarity and also differences depending on how similar the sequences are.
At positions where the sequences do not match the DNA bulges or loops out of the
duplex which affects the electrophoretic mobility of the duplex. These
heteroduplexes can be detected as extra slow moving bands in polyacrylamide gels
compared to homoduplexes. Under defined conditions each duplex has a unique
conformation with no multiple conformations occurring due to the increased stability
of duplexes compared to single strand DNA. This technique has the same
advantages as SSCP but can analyse longer fragments. Problems include the
inability to distinguish samples that differ by only one or two aa and difficulty in
distinguishing heteroduplexes from homoduplexes due to the strong intensity of the
homoduplex signal.
1.10.3 Reference strand-mediated conformational analysis - RSCA
This method was designed at the Anthony Nolan Research Institute in 1998
(Arguello et al., 1998a) to combine the advantages of HA with a laser-based
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detection system and computer analysis packages which allow the detection of alleles
which differ by only one nucleotide (Arguello et al., 1998b).
RSCA uses a fluorescently labelled locus-specific reference strand (FLR) produced
by PCR with locus-specific primers. The fluorescent tag is introduced by labelling
the 5' end of the forward primer. The primers amplify the entire exons 2 and 3 and
intron 2. This should allow detection of all alleles since the majority of
polymorphisms are located here. The FLR is then hybridised to the test sample
amplified with the same, but unlabelled, primers. The duplexes formed are then
loaded and run on a non-denaturing polyacrylamide gel in an automated DNA
sequencer, with the laser only detecting the duplexes with the label attached. This
overcomes the problems of interpreting the complex banding patterns observed in
HA and SSCP. Markers or size standards are included in each of the lanes and the
duplexes are assigned a mobility value relative to the marker as determined by an
analysis package such as Genescan (Applied Biosystems, Cheshire). For each
sample tested the number of duplexes identified corresponds to the number of alleles
present in the sample since each duplex generated will have a unique mobility i.e.
heterozygous samples give two heteroduplexes plus the FLR homoduplex while
homozygous samples give only 1 heteroduplex. There is a possibility that the
inclusion of the intron sequence may affect the mobility of the duplex with any intra-
allelic polymorphisms being misinterpreted as a new coding polymorphism. This
does not appear to be the case however since analysis of 3800 alleles from different
samples identified only one case of this (Arguello et al., 1998b). A diagram of this
method is shown in fig. 1.13.
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1.10.3.2 Advantages of RSCA
RSCA has been designed in such a way as to overcome the disadvantages associated
with other conformational methods discussed previously. The use of known
reference strands allows the conformation of duplexes to be manipulated, with the
use of different references meaning it should be possible to identify all allelic
variants. The inclusion of a fluorescent label and the laser detection system has a
number of advantages. In other methods variation in signal intensity can mean that
some samples are not detected and this also prevents direct comparison between two
samples. RSCA is much more sensitive allowing the detection ofweak signals. It is
also possible to compare between samples differing in signal intensity with the
analysis package compensating for lane to lane variation. In addition much less
DNA is required than with HA and SSCP since the resolution of duplexes is
inversely proportional to the amount ofDNA loaded.
Problems with inter- and intra-gel variability are eliminated by the inclusion of a
marker or size standard in each lane since the ratio of mobility of each duplex is
constant in relation to the standard regardless of lane variation. This means that it is
possible to normalise the samples across and between gels.
Resolution of samples is also a problem associated with both HA and SSCP. DNA
samples all migrate at different rates depending on their size with bigger fragments
moving more slowly through gels. Since resolution depends on how far the DNA
has migrated during electrophoresis large samples will be poorly resolved. With
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RSCA all samples are detected after they have migrated the same distance (by having
a fixed detection system) so removing this problem. Similarly, it is very difficult to
resolve heteroduplexes and homoduplexes in HA where the test sample is very
similar to the reference strand since the homoduplex signal will be much more
intense. By varying the ratio of the reference strand to the test allele in RSCA it is
possible to reduce the homoduplex signal and increase the heteroduplex signal
thereby allowing detection.
RSCA has been shown to be highly reproducible, with a minimum amount of
variation ofmobility values observed between gels (Arguello et al., 1998b).
1.11 Theileria parva
Theileria parva is a tick-borne apicomplexan parasite which infects domestic cattle
(Bos taurus and Bos indicus) and buffalo (Syncerus caffer, Morrison et al., 1989).
Prevalent in sub-Saharan Africa, it causes a severe lymphoproliferative disease
known as East Coast Fever which results in the death of up to 1 million cattle a year
and severe economic losses, estimated to be around US $168 million per year
(Mukhebi et al., 1995). Some animals can recover from infection and are found to
have solid immunity to challenge with the same strain of parasite (Burridge et al.,
1972). Infection in buffalo is less devastating, forming a persistent infection with no
clinical signs of disease. As a result the buffalo acts as a reservoir of infection
(Norval et al., 1992). Control of infection has largely relied on treatment of animals
with acaricides to prevent ticks from attaching. The reliability of this method has
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dropped however due to reduced public spending by governments, increased costs of
acaricides and poor control over management of treatments (Dolan, 1999). As a
result the development of alternative methods, such as vaccination, would prove
invaluable.
1.11.2 Biology of the parasite
Theileria parasites are obligate intracellular parasites belonging to the phylum
Apicomplexa which includes the Plasmodium and Eimeria parasites (reviewed in
Irvin and Morrison, 1987). The life cycle of this parasite is shown in fig. 1.14. T.
parva is transmitted by the three host tick Rhipicephalus appendiculatus which
delivers the parasite to its main host when taking a blood meal. On entering the
blood stream, the infective stage, sporozoites, quickly infect lymphocytes. This
initial interaction is a chance event since the parasites are non-motile. Parasites are
thought to bind and enter the cell by receptor-mediated endocytosis (Fawcett et al.,
1984) with a zippering process occurring between the two membranes allowing
complete internalisation of the parasite (Shaw, 1999). Unlike a number of other
intracellular parasites, T. parva does not remain within a parasitophorous vacuole but
instead lies free within the cytoplasm. The contents of the rhoptries and
microspheres, organelles within the parasite, are released which separate the parasite
and host membranes, followed by the establishment of a host-derived microtubule
array around the parasite (reviewed by Shaw, 2003).
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Figure 1.14: Life cycle of Theileria parva
Taken from Shaw, 2003
In the tick host In the mammalian host
On taking a blood meal sporozoites are released from the tick and enter the blood
stream where they infect lymphocytes (a). Within the cell the parasite multiplies to
form a schizont which stimulates the cell to divide with the parasite passing into both
daughter cells (b). Some of the schizonts undergo merogony releasing merozoites
which infect RBC (c). Some Theileria parasites but not T. parva can undergo
replication in the RBC (d). Infected RBC are taken up by a tick when it next feeds.
Within the tick the merozoites differentiate to gametes which then fuse to form
zygotes (e). These pass into the epithelial cells of the gut (f) and further differentiate
into kinetes which migrate to the salivary glands (g). Sporozoite production is
induced when the tick next feeds (h).
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Over the next 24 to 48 hours the parasite multiplies forming a multinucleated
schizont. This stimulates the host cells to undergo blastogenesis during which the
schizont associates with the mitotic spindle and divides, with parasites passing into
both daughter cells (Hulliger et al., 1964). T. parva is able to immortalise the cells in
which it resides meaning that infected lymphoblasts (produced in vivo or in vitro) can
be grown continuously in vitro as parasitised cells (Brown et al., 1973).
Multiplication is largely by clonal expansion with infected cells disseminating
throughout the lymphoid tissues rapidly followed by extensive lysis of both infected
and uninfected cells.
The life cycle within the animal is completed when some of the macroschizonts
differentiate to microschizonts. Merogony then takes place, with merozoites released
which infect erythrocytes forming piroplasms. When a tick next feeds it ingests
infected red blood cells with the bloodmeal. Within the tick gut these cells are lysed,
releasing the piroplasms, which differentiate to male and female gametes, then fuse
to form zygotes. The zygotes then invade the gut epithelial cells and develop to
motile kinetes. These are released into the haemocoel and migrate through the
haemolymph to the salivary gland where sporogony takes place, resulting in the
production of large numbers of sporozoites (Mehlhorn and Schein, 1984, Fawcett et
al, 1982).
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1.11.3 Course of the disease
Once animals are infected, several days lapse prior to the appearance of the parasites
as schizont-infected lymphocytes in the lymph nodes draining the site of infection
but by day ten to fourteen parasites are evident in most lymphoid tissues (Morrison et
al., 1989). Extensive damage of lymphoid cells ensues with a large drop in the
number of circulating lymphocytes. Death can occur three to four weeks after the
initial infection (Morrison et al., 1987). Animals which die from infection are found
to have large numbers of parasitised cells in their lymphoid system with an overall
decrease in lymphocytes in both the circulating pool and lymphoid tissue (Irvin and
Morrison, 1987, Jarrett et al., 1969, Emery, 1981).
1.11.4 Target cell types and pathogenicity
Early studies on the cell type infected by T. parva were restricted to the use of
parasitised cells taken from infected cattle and cell lines. Using reagents specific for
bovine antibodies, T. parva-infected cells were tested and found not to express any
surface immunoglobulins (slg), suggesting that the parasite infects T cells (Duffus et
al., 1978). Pinder et al. (1981) tested a panel of lectins and monoclonal antibodies
on T. parva-infected cell lines in an attempt to further classify the surface phenotype.
They found that the parasitised cell lines were positive for markers found only on a
subpopulation of T cells.
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The development of lymphocyte-sorting techniques utilising lineage-specific
monoclonal antibodies was able to show that in vitro T. parva is capable of infecting
and transforming ap T cells, y§ T cells and B cells (Baldwin et al., 1988). Following
infection of PBM with high concentrations of sporozoites, parasitised B cells were
evident in large numbers for the first week but were quickly overgrown by T cells
(Morrison et al., 1996). Also in vivo studies showed that parasitised cells taken from
animals given a lethal dose of T. parva predominantly expressed T cell markers
(Emery et al., 1988) with three populations observed, CD4+ CD8-, CD4+ CD8+ and
CD4- CD8+. Together these data show that T cells dominate the infection.
1.11.5 Immunity to T. parva
Investigation into the immune response against T. parva has been greatly aided by
the development of the infection and treatment regime. Animals are inoculated with
a lethal dose of viable sporozoites, generally obtained from a cryopreserved stabilate,
and simultaneously treated with oxytetracycline (Radley et al., 1975). As a result
animals are able to mount an immune response and recover, displaying only mild,
asymptomatic infections. These animals are immune to challenge with the same
isolate but small numbers of infected cells are evident in the draining lymph node at
approximately the same time as in susceptible animals. This suggests that immunity
does not prevent infection of cells but rather acts against the infected cells.
A sporozoite-specific antibody response can be detected in the serum of animals
undergoing heavy challenge in endemic areas (Musoke et al., 1982). In vitro studies
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have shown that, amongst others, the p67 surface protein induces antibodies that
prevent sporozoites from infecting cells (Musoke et al., 1984). This humoral
response is not thought to play a role in the response of naive cattle to T. parva
however (Morrison, 1996).
Considering the intracellular location of the parasite and the fact that attempts to
identify parasite-derived antigens on the surface of lymphocytes have failed
(Morrison and McKeever, 1998), it seems likely that the major immune response
produced against T. parva is cell-based.
Evidence for such a response was provided by Muhammed et al. (1975) who found
that transferring serum from an immune animal to a naive animal did not transfer
protection to T. parva. However when leucocytes were transferred, the naive animal
was able to make a response and recover from infection (Emery, 1981). Infection
and treatment has been shown to result in the production of a strong cytotoxic
response in cattle around the time of remission of infection. PBM taken from calves
immunised with T. parva then challenged four weeks later with either the same
isolate or with sporozoites adsorbed on autologous PBM were tested for cytotoxicity
on a range of target cells in a standard 5'Chromium release assay. Results showed
that both challenge protocols produced CTL against autologous cells but not against
allogeneic or xenogeneic infected cells. Thus there appeared to be a specific set of
cytotoxic cells that develop following challenge that appear to be genetically
restricted (Eugui and Emery, 1981).
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These cytotoxic cells are now known to be part of the CD8+ subset of lymphocytes
as shown by transfer studies between identical calves produced by embryo splitting.
One calf from each set was immunised and samples of efferent lymph lymphocytes
taken over a length of time following challenge with a lethal dose of parasites
(McKeever et al., 1994). These efferent lymph cells were then depleted of CD4+ T
cells, y5 T cells and B cells and transferred daily to the infected calf that had been
infected. This allowed the animal to control the emerging parasitosis and recover. In
contrast the control animals developed severe symptoms. To rule out the possibility
of any remaining factors in the transfer samples other than CD8+ cells that may be
affecting the results, CD8+ cells were also removed. Transfer of the remainder did
not provide protection. These results clearly show that protection against T. parva is
mediated by CD8+ cytotoxic T cells.
1.11.6 Role of cytokines
Whether CD8+ T cells mediate protection alone is not known, however to date none
of the cytokines tested including interleukin (IL)-l, IL-2 and IL-4 were able to
inhibit the proliferation of infected cell lines (Preston et al., 1992). Some inhibition
of early development of the parasite within the cell may occur (Morrison and
McKeever, 1998).
The cytokines produces by infected cells have been found to vary, with only IL-10
constitutively expressed (McKeever et al., 1997). IL-2-like components produced by
transformed cells have also been identified (Brown and Logan, 1986). Both of these
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cytokines may have a role in encouraging proliferation (Morrison and McKeever,
1998).
1.11.7 Role of CD4+ andyS T cells
Following immunisation, parasite-specific CD4+ T cells have been detected which
are thought to be capable of lysing infected cells (Baldwin et al., 1987, McKeever et
al., 1999). In addition, CD4+ T cells are known to produce IL-2, which can then act
directly on CD8+ cells allowing them to proliferate and lyse infected cells. This
rapid CD8+ response can then allow early control of the infection.
y8 T cells have also been shown to be involved in the immune response to a primary
T. parva infection. They are able to proliferate in response to lymphoblasts and lyse
infected cells but in an MHC-unrestricted manner. This response can be detected
before the CD8+ T cell response (Morrison et al., 1995) and is thought to be as a
result of the y8 T cells recognising stress proteins on the infected cell surface
(Daubenberger et al., 1999).
1.11.8 Parasite strain heterogeneity
Heterogeneity was originally detected in cross-protection studies where animals were
immunised with one isolate of parasite, then challenged with another. Generally it
was found that animals were protected from the isolate with which they had been
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immunised but varied in their susceptibility to others. In addition protection against
one strain was not always reciprocal (Radley et al., 1975).
Using rare cutting enzymes and pulse-field gel electrophoresis differences between
isolates were identified showing that there is heterogeneity between strains (Morzaria
et al., 1990). A major problem with cross-protection studies is the presence ofmore
than one population within a stock for example the Marikebuni stock is thought to
contain at least five strains (Taracha et al., 1995). In contrast, the Muguga stock is
known to be highly homogenous (Morrison, 1996).
1.11.9 MHC restriction of T. /wrva-specific CTL
As with the human system, the MHC in cattle has been shown to restrict the ability
of T cells to recognise antigens. Three CD8+ clones isolated from PBM from an
animal infected with T. parva (Muguga stock) were tested for cytotoxicity against 32
infected cell lines. Only cells with the KN104 specificity were killed, with both
autologous and allogeneic cells affected. Administration of specific antibodies and
alloantisera to the expressed specificities blocked killing, confirming the
involvement of MHC class I molecules in restricting cytotoxicity (Goddeeris et al.,
1986a).
In order to investigate this restriction further, the CTL derived from ten immunised
animals were tested for cytotoxicity on a panel of parasitised cells with matched or
mismatched specificities. In all cases killing of mismatched cells was minimal, with
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cells from nine out of ten animals preferentially killing cells sharing BoLA
specificities. Within this, there was a clear bias towards killing of one specificity
over another with a hierarchy of preferentially killed cells evident overall (Morrison
et ai, 1987).
Further work involved the combination of a limiting dilution assay with statistical
analysis to allow the quantitation ofmemory CTL precursors (CTLp) in the blood of
immunised MHC heterozygous animals expressing known specificities. T cells from
these animals were restimulated in vitro with parasitized cell lines then tested for
cytotoxicity against a panel ofMHC homozygous targets in an Indium oxine release
assay. Based on the isotope release values and the number of T cells per well it was
possible to determine the CTLp frequency specific for each target. In most cases the
CTLp were almost entirely restricted to one haplotype, with the A6, KN8 and
A10/KN104 haplotypes appearing dominant overall. Within these, A10/KN104 was
dominant over KN8 while A6 was dominant over both (Taracha et al., 1995).
Furthermore it was found that the CTLp of Muguga-immunised animals were
restricted entirely by the KN104 specificity, with all but one animal producing a
strain-specific response. This one animal was found to also produce CTL capable of
reacting to Marikenbuni 3219, a strain of the Marikebuni stock. The presence of
cross-reactive KN104-restricted CTLp in this animal suggests that its class I
molecules are capable of presenting conserved antigens between strains of parasites.
T. parva is a large complex parasite and so it would easily be assumed that a wide
range of antigenic peptides would be available for presentation. However these
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results seem to point to a limited repertoire, with restriction being controlled by only
one type of MHC molecule in most animals (Taracha et al., 1995). In addition,
animals which were shown to have KN104-restricted, strain-specific CTL responses
following immunisation with the Muguga strain developed cross-reactive CTL after
challenge with Marikebuni 3219, a proportion of which were also restricted by
KN104. Two identical calves were also infected, one with the Muguga strain and
one with Marikebuni 3219. The Muguga infected animal was found to produce a
strain-specific response and the other a cross-reactive response, despite both being
restricted by KN104 (Taracha et al., 1995). Since these animals are genetically
identical this shows that the Muguga infected animal is capable of responding to
determinants in both strains of parasite, but for some reason produces a strain
specific response.
1.11.10 Immunodominance
In an attempt to explain the above results it has been suggested that
immunodominance is occurring whereby different MHC-peptide combinations differ
in their ability to elicit an immune response, with some being dominant over others.
The variation in specificity following challenge with Marikebuni 3219 suggests there
are either a limited number of dominant determinants or the immune response is
focused on only a few of the most dominant (Morrison, 1996). Possible reasons for
immunodominance include levels of expressed MHC class I molecules, affinity for
peptide binding and variations in the concentrations of peptides, possibly as a result
of competition in the antigen processing pathway.
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1.11.11 Consequences of immunodominance and hierarchy of MHC Class I
restriction
These results have important implications for both vaccine design and breeding
programmes. Theoretically it appears that vaccines should be directed to those
conserved antigens (rather than strain-restricted epitopes) resulting in cross-reactive
responses. In addition, by identifying the dominant MHC types that provide
protection it may be possible in the long term to introduce breeding strategies to
ensure that these dominant haplotypes are distributed among herds at risk. However
it must be noted that these experiments were carried out on a limited number of
animals and may not be representative of the general cattle population.
1.12 Aims of this research
Available evidence suggests that the bovine MHC class I system may be the most
complex of all mammals studied to date with variable numbers of haplotypes and a
lack of defined loci. Based on phylogenetic analysis and comparison of haplotypes,
there appears to be six classical class I genes in cattle, none ofwhich are consistently
expressed. In addition, the number of classical genes on a haplotype can vary, with
three genes the most found so far. The principle aim of this project was the
establishment of an effective method for typing bovine class I alleles based on the
RSCA method described in section 1.10.3. This would allow not only typing of
known alleles but also detection of new ones. In addition it would provide us with
another tool for future investigation of, for example, the variability of haplotype
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composition within herds and determination of levels of polymorphism for each
gene.
Within this study we aimed to establish and optimise RSCA for a number of the
bovine class I genes followed by a small study on untyped animals to prove that the
method was working. We proposed that the introns adjacent to exons 1 and 2 of
class I genes would contain locus-specific nucleotides around which primers could
be designed for locus-specific amplification and then used in conjunction with
published protocols to attempt to type class I genes.
A second component of this study focussed on the function of MHC class I
molecules, investigating the genetic restriction ofCTL in response to the intracellular
parasite of cattle T. parva. Previous studies found the CTL response to be almost
entirely restricted by either the maternal or paternal haplotype and by analysis of a
panel number of heterozygous animals a hierarchy of dominance was determined. At
the time of these studies little information was available regarding nature of the class
I genes present on the different haplotypes. The second aim of this project
concentrated on continuing this work, testing the hypothesis that CTL from our
animals would also show a bias in MHC restriction. In addition since the haplotypes
being investigated have been fully characterised and their classical class I genes
identified we could further investigate dominant haplotypes using newly available
techniques and resources such as monoclonal antibodies and transfection methods in
an attempt to define the genes responsible for restricting the immune response.
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Chapter 2
General materials and methods
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This section lists those methods that were used routinely throughout this project.
Specific methods are described in more detail in the individual results chapters. All
materials were obtained from Invitrogen (Paisley, Scotland) unless otherwise stated. All
kits were used according to the manufacturers' guidelines.
2.1. Materials
2.1.1 Buffers/solutions
All buffers and media were prepared using MilliQ ion-exchange purified water (Media
department, LAH, Compton). Chemicals were obtained from BDH Laboratory Supplies,
Poole, England.
Buffer Reagents
Tris-acetate/EDTA (50xTAE) 2M Tris base, 1M glacial acetic acid,
0.05M EDTA (pH 8.0)
Tris-Cl/EDTA (TE) lOmM Tris-Cl, ImM EDTA (pH 8.0)




Gel loading buffer (6x)
Reagents
0.25% bromophenol blue, 0.25% xylene cyanol
FF, 30% glycerol in water
Phosphate buffered saline (PBS) 0.15M NaCl, 2.5mM KC1, lOmM Na2HP04,
2mM KH2PO4 (pH 7.4)
2.1.2 Bacterial Growth Media
Luria-Bertani (LB) medium 1% bactotryptone, 0.5% bacto yeast extract,
0.5% NaCl
SOB medium 2% bactotryptone, 0.5% bacto yeast extract,
lOmM NaCl, 2.5mM KC1, lOmM MgCl2,
lOmM MgS04
SOC medium As SOB plus 20mM glucose
LB agar plates were prepared by adding 15g of Bacto-agar to 1 litre of LB medium.
This was then supplemented with 0.5mM IPTG and 80pg/ml ofX-gal prior to plating.
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2.1.3 Kits
QiaAmp DNA blood minikit Qiagen UK Ltd., Crawley, UK
Qiagen gel extraction kit
Qiagen miniprep kit
Dynal mRNA extraction kit Dynal A.S., Oslo, Norway
Invitrogen first strand cDNA synthesis kit
2.2 General methods
2.2.1 Blood sampling and extraction of PBM
Venous blood was collected from animals into syringes containing 100IU of Heparin
sodium (Leo Laboratories Ltd., Bucks) for every 10ml of blood collected. Using glass
pipettes blood was slowly layered on top of histopaque 1083 (Sigma, St Louis, USA) at
a ratio of 5:3 in a sterile 50ml Falcon tube. Samples were carefully loaded into a
refrigerated centrifuge (Heraeus multifuge 3 S-R) and spun at 2000xg, 4°C for 40
minutes (min) without the brake applied. This allows the samples to separate into the
following layers; plasma and platelets at the top, then lymphocytes (visible as a cloudy
white interface), then histopaque and red blood cells (RBC). Lymphocytes were
removed using a pastette, ensuring no RBC were taken up, and transferred to a clean
25ml Universal tube.
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PBM were then washed by centrifugation with phosphate buffered saline (PBS, media
department, IAH, Compton) at 400xg for 5 min, then 2 to 3 times more at 300xg for 5
min. On the final wash the cells were resuspended in 10ml of PBS and counted using a
haemocytometer (see section 2.2.2). For cDNA and genomic DNA extraction purposes
cells were pelleted in 15ml Falcon tubes (~5 x 106 cells) and all liquid removed prior to
snap freezing on dry ice. Samples were then stored at -80°C until required.
Alternatively cells were pelleted and all PBS removed before resuspension in culture
media for use in cell culture.
2.2.2 Quantitative determination of cell viability
The number of live cells present in a sample was determined by dye exclusion with
Trypan Blue (Sigma). Cells were mixed with Trypan Blue at a 1:1 ratio and counted
using a Neubauer haemocytometer. Taking into account the dilution factor, 100 cells
per 16 square grid is the equivalent of lxlO6 cells per ml. At least two grids were
always counted to enable a good estimation.
2.2.3 Genomic DNA isolation
Genomic DNA was prepared from lymphocytes using the QIAamp DNA blood mini kit
(Qiagen). Briefly, 5xl06 cells (either frozen pellet or fresh) were lysed with 20pl
Qiagen proteinase (20mg/ml) followed by addition of a high salt containing binding
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buffer. This solution was then passed through a QIAamp spin column containing a silica
gel membrane, allowing the DNA to bind to the membrane. The columns were washed
twice to remove residual contaminants and the DNA eluted from the column in 200/xl
elution buffer (lOmM TrisCl, 0.5 mM EDTA) and stored at -20°C. 5xl06 PBM
produced approximately 6pg DNA.
2.2.4 Isolation ofmRNA
Messenger RNA was extracted from lymphocytes using the Dynal mRNA direct kit.
This is based on the system of Edmonds (1971) which follows the principle that since
most eukaryotic mRNA's carry poly A (adenine) regions at their 3' ends they can be
separated from the RNA by affinity chromatography on oligo (dThymine, dT) cellulose
i.e. oligo dT's linked to a supporting matrix. This kit utilises magnetic beads coated with
oligo dT's. 5xl06 cells were lysed in Dynal lysis binding buffer (lOOmM Tris-HCl pH
7.5, 500mM LiCl, lOmM EDTA pH8 1% LiDS, 5mM dithiothreitol, DTT). The lysate
was then passed repeatedly through a 21-gauge needle using a 1ml syringe to shear the
DNA and mixed with the oligo dT-coated beads to isolate the mRNA. The beads were
then fixed by a magnet and washed with various buffers to remove any non-poly A
RNA's and other residual components. mRNA was then eluted in 20pl of lOmM Tris-
HCl. 5 x 106 lymphocytes produced approximately 2pg RNA for use in cDNA
synthesis. Sterile conditions were adhered to throughout this procedure to prevent the
addition of RNases.
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2.2.5 First strand cDNA synthesis
First strand cDNA was produced using the Invitrogen Superscript™ first strand synthesis
kit immediately following mRNA isolation. An RNA-dependent DNA polymerase
reverse transcriptase (Superscript™ II RNase H~) and poly dT primer act on the mRNA
producing a hybrid mRNA-cDNA molecule, followed by phenol-chloroform extraction
to remove proteins and purify the DNA. The mRNA is removed later during the first
stages of PCR. First strand cDNA was produced by adding approximately 2pg ofmRNA
to 5x first strand buffer (lOOmM Tris-Hcl pH 8.4, 250mM KCl, 15mM MgC^), lOmM
dNTP mix-lOmM each dATP, dCTP, dGTP, dTTP (Amersham Biosciences, N.J., USA),
0.1M DTT and 50U reverse transcriptase to a final volume of 25pl followed by
incubation at 37°C for 1 hour.
2.2.6 Phenol chloroform extraction
The mRNA-cDNA solution was made up to 100pi with DEPC water (media department,
IAH, Compton) and an equal volume of phenol chloroform added (one part phenol to
one part chloroform). This was vortexed until a white emulsion formed, centrifuged at
15000xg for 5 min in an IEC micromax benchtop microfuge (IEC, MA, USA) to
separate the aqueous and organic phases and the top aqueous layer removed to a clean
eppendorf. An equal volume of chloroform was added to this, vortexed and the top layer
removed to a fresh tube for DNA precipitation.
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2.2.7 Ethanol precipitation
10% 3M Sodium acetate (Sigma) and 2.5x volume 100% cold ethanol was added to the
DNA solution (approximately lOOpl) and incubated at -20°C overnight to precipitate the
DNA. This was then pelleted by centrifugation (15000xg for 15 min) and washed once
with 300pl of 70% cold ethanol to remove any residual salts. Excess ethanol was
carefully removed and the pellet allowed to dry at room temperature. Following this, the
DNA was resuspended in 20pl ofTE buffer and stored until use at -20°C.
2.2.8 Polymerase chain reaction (PCR)
2.2.8.1 PCR program
PCR was employed throughout this project for amplification of specific regions within
MHC class I sequences. The standard program used was as follows with the annealing
temperature (X) adjusted for optimal annealing of primers: 95°C for 5 min, 30 cycles of
95°C for 30 seconds (s), X°C for 50s, 72°C for 1 min with a final extension step of 72°C




Standard reactions contained 1.5 mM MgCh, lx PCR buffer, 0.25mM of each dNTP's
(Amersham), 1 pM of each primer, 0.5 units of Taq polymerase and 6ng DNA with
DEPC-treated water (media department, IAH, Compton) to a final volume of 25 or 50pi.
2.2.8.3 Primer design
Primers were designed according to the following criteria:
(1) Length between 18 and 30 nucleotides, with a GC content between 40% and 60%.
(2) The annealing temperature (Tm) of the primers should be between 55°C and 75°C,
with both primers of a pair having similar temperatures. Tm is estimated by the
following calculations:
4(G+C) + 2(A+T) for primers of less than 20 base pairs (bp)
62.3°C + 0.41°C (%GC) - 500/length - 5°C for more than 20 bp
(3) The 3' base of the oligo should be a G or C if possible, preferentially with an A or T
before it. This increases the specificity of binding and reduces the formation of
hairpin structures or primer dimers.
(4) There should be low complementarity between members of a primer pair.
(5) There should be no inverted repeat sequences or self-complementarity sequences
greater than 3 bp to prevent the formation of hairpins structures which can stop
oligos from annealing to the target DNA.
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All oligos were ordered from either MWG Biotech (UK) Ltd. (Milton Keynes, UK) or
Invitrogen.
2.2.9 Electrophoresis of DNA
PGR products were premixed with 6x gel loading buffer and loaded onto 1% agarose
gels containing 0.5pg/ml Ethidium Bromide. Gels were run in lx TAE buffer at 5V/cm
with the running time determined by the agarose concentration and the predicted PGR
product size (Sambrook et al, 1989). Samples were run alongside a cpX174 Hae III
digest marker or a 1Kb plus DNA ladder (Sigma) to allow the products to be sized. Gels
were visualised under UV light using a UVP transluminator and the images recorded on
a UVP GDS5000 camera/printer system.
2.2.10 DNA extraction from agarose
Bands of the correct size that required sequencing were cut with the gel with a scalpel
blade, and DNA recovered using the Qiagen gel extraction kit. This works on a similar
principle to those kits already described, with the agarose digested by the enzyme
agarase followed by binding of the DNA to a spin column. The bound DNA was then
washed with a range of buffers of varying pH and salt concentrations prior to elution in
30pl of elution buffer (lOmM Tris-HCl pH 8.5). Eluted samples were then stored at -
20°C.
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2.2.11 Ligation into the pGEM-T vector
Purified DNA was ligated into the pGEM-T vector system according to manufacturers
instructions with recommended controls also included (Promega UK Ltd., Southampton,
UK). This vector has a multiple cloning site within the p-galactosidase gene with
"sticky" thymidine overhangs ideal for the insertion of PCR products generated by the
Taq enzyme used. Insertion of DNA interrupts the coding sequence P-galactosidase
allowing recombinant clones to be detected by white/blue selection. pGEM-T has two
bacteriophage promoters in opposite directions which flank the cloning region (Short et
al, 1988). These primers, T7 and SP6, can be used as primers for specific sequencing of
the inserted product. 3 pi ofDNA (approximately 20ng) was added to 2x T4 DNA ligase
buffer, 50ng of PGEM-T vector and 3U of T4 DNA ligase, mixed by pipetting and
incubated overnight at 4°C.
2.2.12 Transformation of JM109 competent cells with recombinant pGEM-T
vectors
2pl of each ligation reaction was added to 50pl of JM109 competent cells (Promega) in
15ml Falcon polypropylene tubes and the tube gently flicked to allow mixing. The cells
were incubated on ice for 20 min, heat shocked at 42°C for 50 s and then placed directly
back onto ice for 2 min to allow entry of the plasmid. 900pl of SOC medium was added
to each tube and the cells incubated for 1 hour at 37°C in an orbital-shaking incubator
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(150rpm). Samples were plated out in duplicate (lOOpl) on LB plates containing
ampicillin, IPTG and X-gal, the plates inverted and incubated overnight at 37°C. White
colonies (indicating positive ligations) were then picked using a sterile pipette and
placed in 50ml Falcon tubes containing 5ml LB and 100p.g/ml ampicillin. Samples were
then grown overnight at 37°C with shaking.
2.2.13 Minipreparations of purfled DNA from JM109 transformed cultures
Purified DNA was extracted from the transformed cultured using the QIAprep spin
miniprep kit (Qiagen). This works by using alkaline lysis and SDS detergent (Birnboim
and Doly, 1979) to lyse the bacteria and denature chromosomal DNA and proteins with
plasmid DNA being released into the solution. The denatured material was then
removed by centrifugation and the supernatant applied to a Qiagen spin column. The
column was washed several times and the DNA eluted in lOmM Tris-Cl (pH 8.5). This
was stored at -20°C until further use.
2.2.14 Sequencing
DNA was sequenced using an ABIPrism 377 automated sequencer (Applied Biosystems,
Warrington, UK) with a 14-hour program based on the dideoxy method. Reactions were
set up with the BigDye™ Terminator Cycle Sequencing Ready Reaction kit (Applied
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Biosystems) as follows: 2pl of Big Dye, lpl of milliQ water, lpmol of primer (either
forward or reverse) and 125ng DNA to a final volume of 5pi.
These reactions were run under the following conditions: ramp of l°C/s to 96°C, 96°C
for 10 s, l°C/s to 50°C, 50°C for 5 s, l°C/s to 60°C, 60°C for 4 min, repeat for 25
cycles. DNA was precipitated by adding lpl of 3M ammonium acetate (pH 4.6) and
25pi of 95% ethanol, incubating at room temperature for 15 min then centrifuging at
2900xg for 30 min. Supernatants were removed and the pellets washed with 70%
ethanol, then allowed to dry. Sequencing reactions were resolved on denaturing
polyacrylamide gels by the zoology department, University of Oxford, Oxford. Results
were analysed using the GCG 10/Wisconsin Package Version 10.3 (Accelrys Inc., San
Diego, CA) and Genedoc (http://www.psc.edu/biomed/genedoc) programs.
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Chapter 3
Identification and testing of group-
specific primers for use in RSCA
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3.1 Introduction
To date typing ofMHC class I genes in cattle has been greatly hampered by the lack
of information available, with only a relatively small number of alleles identified and
sequenced. In addition, since the total number of classical class I loci has not been
confirmed, assignment of alleles to loci is difficult. A PCR typing system was
previously devised at Compton which utilised allele-specific primers based on
coding sequences obtained from a herd containing a few well characterised MHC
haplotypes (Ellis et al., 1998). While this method is useful for typing individual
animals in such a herd, the requirement for cDNA and large number of primer pairs
makes it inappropriate for wide-scale typing, both in terms of cost and time.
Identification of new alleles if other animals were introduced to the herd would also
prove difficult.
A typing system termed reference strand-mediated conformational analysis (RSCA)
has been designed at the Anthony Nolan Research Institute. This allows rapid and
easy typing of MHC class I and II genes for assessing histocompatibility between
patients and donors for bone marrow and other organ and tissue transplants (Arguello
et al., 1998, Corell et al., 2000). This method has also been successfully used in
sheep, dogs and cats for typing the functional DQB and DRB genes respectively,
allowing identification of both known and previously undiscovered alleles
(Feichtlbauer-Huber et al., 2000, Kennedy 2000, Kennedy et al., 2003). RSCA and
its advantages are discussed in greater detail in section 1.10.3.2. Samples to be typed
are amplified by PCR from genomic DNA using group or locus-specific primers,
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which negates the need for a large number of primer pairs required by systems such
as PCR-SSP. It is important that these primers amplify polymorphic regions of the
genes to ensure detection of all possible alleles. In humans, sequencing of introns 1
and 3 surrounding the polymorphic exons 2 and 3 of the classical loci identified so-
called 'locus-specific characteristics' i.e. conserved nucleotides amongst alleles from
a locus. Primers designed around these bases were shown to have excellent locus
specificity which was confirmed by hybridisation of the PCR products with 10
oligonucleotide probes specific for both classical and non-classical MHC class I
genes (Cereb et al., 1995). These primers have been successfully used in RSCA for
locus-specific amplification and are now routinely used for typing (Arguello et al.,
1998, Turner et al., 1999, Turner et al., 2001).
In order to use RSCA as a typing method in cattle we had to initially determine if the
introns flanking exons 2 and 3 in bovine MHC class I genes also contain locus-
specific characteristics around which primers could be designed. Only five full
length class I genomic sequences are currently available from the Genbank database;
BSA, BSX, BSC, BSF and BSN which correspond to published cDNA sequences
(Garber et al., 1993, 1994). As a result, no studies on bovine introns have taken
place.
Since we cannot assign alleles to loci accurately we have instead inferred which
alleles are derived from the same locus based on a combination of phylogenetic
comparisons of coding sequence (Ellis et al., 1999), mapping data and detailed
analysis of haplotypes using MHC-homozygous animals. These will be referred to
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throughout as groups and are indicated in fig. 3.1. Five main groups are evident
including one group with a single allele, KN104. It is not clear if the alleles HD6,
MAN2 and 3349.1 are a subgroup of group 1 or instead form their own group but
analysis of intron sequences may make this situation clearer. For this reason we have
chosen to refer to these alleles as group 6. Choosing two representatives from each
group (and one from group 4) we aimed to sequence introns 1 and 3 and attempted to
identify any residues which may be group-specific. The alleles chosen are indicated
in table 3.2 with their corresponding haplotypes shown. Following on from this,
potential group-specific primers would be designed and tested against a range of
genomic DNA samples prior to use in RSCA. It was hoped that not only would this
information be useful for typing but would also later provide data to help in the
process of locus identification. In addition, it is important to study introns since they
are likely to provide information on how polymorphism has been generated, and will
allow investigation into how alleles are related to each other (Kotsch and Blasczyk,
2000).
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Figure 3.1: Maximum likelihood tree of full length cDNA cattle MHC class I
sequences indicating putative 'groups' or loci
Comparison of available full length cDNA sequences for bovine MHC class I alleles
shows that they appear to fall into 5 to 6 groups which may be indicative of class I loci.




3.2.1 Animals used in this study and details of their haplotypes
All work described in this chapter used genomic DNA which had been prepared from
PBM (section 2.2.3). Blood samples were obtained from animals at the IAH farm,
Compton which are part of an inbred herd. These animals were chosen based on
their MHC haplotypes, which had been inferred by a combination of PCR-SSP
typing, serology, flow cytometry and parentage. The animals and their
corresponding haplotypes are listed in table 3.1, with a summary of the haplotypes
and characterised alleles given in table 3.2.
3.2.2 Primers designed for intron amplification
Primers for allele-specific intron amplification were designed based on the coding
sequence of the alleles listed in table 3.2. The location of these primers is shown in
fig. 3.2. All primers were obtained from either Invitrogen (Paisley, Scotland) or
MWG (Germany). To ensure specificity primers for introns 1 and 3 were designed
with one or more allele-specific nucleotides at the 3' end for forward primers and the
5' end for reverse primers. The primers used are summarised in table 3.3 and 3.4.
The PCR conditions employed are described in section 2.2.8.
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Table 3.1: Summary of genomic DNA used in this study for sequencing of
introns and optimisation of group-specific primers























Table 3.2: Summary of haplotypes and alleles used in this study
This table lists the common haplotypes found within the herd at IAH, Compton and
their corresponding expressed classical MHC class I genes. Haplotypes not fully
characterised are marked with a question mark. The accession number relates to the
full length coding sequence from the Genbank/EMBL databases. The alleles
included in the intron study are highlighted and colour coded to indicate those from
the same group/gene. Group 1 are shown in red, group 2 in green, group 3 in blue,
group 4 in and group 6 in purple.














Table 3.3: Primers designed for amplification of intron 1
F= forward primer, R= reverse primer
Allele Primer name Sequence (5' - 3') Tm (°C)
D18.1 F Prom 2 GGA CTC TGC TTC TTC CCA 51
RD18.1 (L) TCG AGG CCG GGC CGG GA 49
D18.2 F D18.2intlforsp3 TCC TCC TGC TGC TCT CGG 60.5
R D18.2intlrevsp2 TAG CCG ACT TCC AGG TAC 56
D18.3 F D18.3intlforspl CCA CTG GGT GTT CAG TTC 56
R D18.3intlrevsp2 GTC GCT GTC GAA CCG TGT 58.2
D18.4 F Prom 3 CCC GGA CTC TGC TTC TCG 55
R D18.4(L) TTC CTT CTC TAT CCA CGG 49
D18.5 F Prom 2
R D18.5(L) TGT GAA CTG CGT GTC GTC CA 47
HD1 F Prom 3
RHD1 (L) CCC GGA CTC TGC CTT CTC G 59
HD6 F Bov21(a/g) ATG G(A)GG CCG C(G)GA A(G)CC
98
R HD6(L) CCT CGG ATC CCG GGC GT 55
HD7 F Prom 2
R HD7(L) TCG TCC ACG TAG CCG ACA 53
A10 F A10intlprom4 AGG TCT CCA CCG ACC CGT 60.5
R AlOintlrevsp CAG GCT CAC TCG GAA AAA T 54.5
MAN2 F Promoter* TCA AGG GCG GTG TCT GGG 60
RMAN2intl revsp GCG TTT TCC TTG GAG ATT TGA 55.9
*Designed by N Barker
Table 3.4: Primers designed for amplification of intron 3
F =forward primer R= reverse primer
Allele Primer name Sequence (5'-3') Tm
(°C)
D18.1 F D18.4int3(5') AAG GTT ATG CTG AGT CTT TGA 54
R genint3(3') TGC CAG GTC AGT GAG ATC TCC 61.8
D18.2 F D18.2int3forsp2 AAG TGG GAG GCG GGA GGT GCT 60.5
R D18.2int3revspl GGT CTG GTC CTC CCC ATT 58.2
D18.3 F D18.3int3forsp2 AAG TGG GAG GCG GCA GGT GAG 65.7
R D18.3int3revspl TCT GGT CCT CCC CTT CGT 58.2
D18.4 FD18.4int3(5') AAG GTT ATG CTG AGT CTT TGA 54
R D18.4int3revspl CAG CTA CTA CGA GGA GAA CCA 59.8
D18.5 F D18.5int3(5') CAG GTG CTG CGG AGG GCG AGA 67.6
R genint3
HD1 F HDlint3forspl CAG GTG ATG CGG AGA GAT TCA 59.8
R FIDlint3revspl GGT CTG GTC CTC TCC ATT 56
HD6 F HD6int3forsp3 GAA CTA CCT GGA GGG CAC 58.2
R HD6int3revsp2 ACC TCA GGG TGA CCT CAT 56
HD7 F HD7int3(5') CAG GTG CTG CGG AGA GAT TAA 59.8
R genint3
A10 F A10int3forspl GTG AAG CTG AGG TAC AGA 53.7
R A10int3revsp5 CGG TCA GAG ATG GGG TGA TGC 63.7
MAN2 F MAN2int3forsp2 CGC CTC CTC AGC GGG TTC ACG 67.6
R genint3
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3.2.3 Design of group-specific primers
Group-specific primers were designed based on conserved residues in introns 1 and 3
between representative alleles from the same group. In the case of group 1 a generic
primer in exon 3 had been designed prior to availability of intron 3 sequences: this is
group-specific when used in conjunction with group 1 primer 4. These primers are
listed in table 3.5. Primers 2a and 6e consist of a mixture of two primers with one
nucleotide difference reflecting the difference in sequence between the two alleles
analysed. These bases are highlighted in red and explained below the table.
Reactions were run under the conditions described in section 2.2.8.1 with the
exception of group 1 which used the following PCR program: 98°C for 20s, 35
cycles of 96°C for 20s and 68°C for lmin 30s then a final step of 72°C for 5 min.
101
3.3 Results
3.3.1 Amplification and sequencing of introns
Using primers located in the surrounding exons or promoter regions we were able to
successfully amplify introns 1 and 3 of ten bovine MHC class I alleles. The positions
of these primers are shown in fig. 3.2. At least 3 clones of each sample were
sequenced in both directions and a consensus made. Fig. 3.3 shows the whole of
intron 1 while fig. 3.4 shows the first 420 bases of intron 3 in which any locus
specificity should reside. Three other bovine MHC class I alleles, BSX, BSN and
BSA which appear to fall into groups 1, 2 and 3 respectively (see fig. 3.1) have also
been included (Garber et al., 1993, 1994).
The presence of a large number of non-classical genes, pseudogenes and gene
fragments within the MHC region made specific amplification from genomic DNA
particularly difficult, with extensive optimisation and re-designing of primers
required before the correct product was obtained. Where possible genomic DNA
from cattle homozygous for class I was used. Initially it was hoped that the
combination of an allele-specific and a generic primer would work so as to reduce
the number of primer pairs required. This approach had some success with two
forward primers, Prom 2 and 3, amplifying five of the alleles in conjunction with
their specific reverse primers for intron 1 and genint3 amplifying intron 3 for four
alleles with specific forward primers. Primers were designed to include at least one
allele-specific base and also to amplify enough exon sequence to allow comparison
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with coding sequences from databases to ensure we had the correct product. Where
incorrect product was obtained this was usually due to mispriming. These products
were not studied any further other than to compare them to the other classical class I
alleles present on the haplotype to determine if the primers were amplifying the
wrong allele.
A comparison of the introns amongst the ten alleles shows the presence of a number
of indels (insertions/deletions), which is surprising considering the non-dynamic
nature of introns, although this could be due to the alleles representing different loci.
These tend to occur mainly around strings of base repeats for example intron 1
position 73 (fig. 3.3). This suggests a sequencing error however reanalysis of at least
three clones shows these indels to be real. In intron 1 one main insertion occurs,
between HD7 and D18.1 at position 291. Phylogenetic analysis of full length coding
sequence without the PBR suggests D18.1 to represent a locus with little
polymorphism since it has relatively few similarities to other alleles identified so far.
However when just the PBR sequences are analysed D18.1 is found near HD7 from
group 2 (Ellis et al., 1999). In intron 1 these alleles share a number of bases that are
not found in any of the others studied but in contrast few similarities are observed in
introns 3. This suggests that HD7 may represent an intermediate allele that has
arisen by interlocus recombination between groups 2 and 4.
Analysis of intron 3 (fig. 3.4) shows a large group-specific deletion for group 2 at
position 152, the significance of which is unknown. The largest insertion amongst
the sequences is seen in intron 3 for D18.4 and HD1 where approximately 590 bases
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have been added (data not shown). This insertion is also seen in the full-length
sequence of BSX, another member of group 1 but not in any other sequences
(Archibald, 2002) suggesting it to be locus-specific. Further investigations are
required in order to confirm this. Attempts are currently being made by our
laboratory to design a locus-specific probe around this insertion for screening of
genomic DNA samples in southern blots, concentrating initially on haplotypes where
we believe the gene to be absent e.g. A18. This should hopefully provide an
indication as to whether genes are silenced or absent between different haplotypes.
3.3.2 Presence of group-specific nucleotides
Analysis of introns 1 and 3 shows the presence of a number of conserved nucleotides
between members of the same group. The inclusion of BSA, BSN and BSX in the
alignments allows speculation on the locus-specificity of the nucleotides highlighted
in figs 3.3 and 3.4. In most cases these are shared with the BS sequences however
there a few cases where the base is only shared by two of the alleles for example in
intron 1 at bases 60 and 61 where BSX differs from HD1 and D18.4. There are also
a number of bases shared between BSX and either HD1 or D18.4 but not both for
example position 238 in intron 1. This indicates that caution should be taken when
assuming specificity of bases if only two alleles from each group are sequenced.
Where possible the group-specific primers designed here included all members of the
group but emphasis was placed on including the alleles found within the herd at
Compton since no functional information is available about the BS sequences and
they may not represent true alleles. This was particularly the case with group 3
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where BSA was quite diverse from D18.2 and A10 (and all the other alleles included
here) and had a number of unique insertions and deletions.
As discussed in the introduction, there is no clear indication that group 6 is a true
group. In intron 1 a number of bases were found to be conserved amongst both the
group 1 and group 6 members (shown in dark blue). Primers were designed around
these and tested on a panel ofDNA with a conserved reverse primer but were found
to be non-specific (data not shown). The lack of conserved bases in intron 3 and the
remaining coding sequence prevents a specific reverse primer for group 1 and 6
being designed. As a result of this it is necessary to consider group 6 separately.
3.3.3 Group-specific primer design
The primers chosen for group-specific amplification are summarised in table 3.5.
Table 3.5: Group-specific primers
This table lists those primers that have been tested and shown to have group-
specificity.
Group Primer name Sequence (5'-3') Tm (°C)
Group 1 F Group 1 primer 4 TGC GAG GGG ACC GCC CGA 65.1
R Generic primer C AGC GCA GGT CCT CGT TCA 58.2
Group 2 F 2a GAA CRA GCG ACC CCG ACT* 59.4
R 2c CAA GTG GGG CAA CTG GTC 58.2
Group 3 F 3c TCG ACC GCT TCC ATC TCG 58.2
R3e GAA CAG GCC TTG AGA GAC 56
Group 6 F6d TCA TTG ACC CTC CGC CCA 58.2
R6e GGC GCT GTT YCC ACA GGC** 61.7
* R = A or G ** Y = C or T
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3.3.3.1 Group 1
Prior to sequencing intron 3 we attempted to design sets of group-specific primers
using forward primers based around the specific bases identified in intron 1 with
generic primers located at the 3' end of exon 3. Five forward primers were designed
for group 1 and initially tested with three reverse primers at 55°C (using the PCR
program described in section 2.2.8) on four samples, two positive for D18.4 and HD1
and two negative for both. Of the fifteen possible combinations only two sets
appeared to be specific, primer 4 with generic primer a or c (see fig. 3.5). Attempts
were then made to optimise this primer pair to the conditions for RSCA previously
described (Arguello et al., 1998). A combination of the PCR reaction and program
described in sections 2.2.8.1 and 3.2.3 were found to provide optimal results with
distinct, clean products only observed from samples positive for group 1 alleles (see
fig. 3.6). We then tested primer 4 and generic c against a panel of genomic DNA
samples with a range of haplotypes to confirm the specificity (see fig. 3.7). From
this PCR only two amplicons were observed in samples positive for D18.4 and HD1,
confirming this primer pair as being group-specific.
3.3.3.2 Groups 2, 3 and 6 - primer design and testing
Similar approaches were initially taken to design primers in exon 3 for groups 2, 3
and 6 but no primer combinations allowing group-specific amplification were found.
Sequencing of intron 3 (fig. 3.4) showed a number of group-specific nucleotides
around which further primers could be designed.
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Figure 3.5: Testing putative group 1 primers
Group 1 primer 4 was tested with 3 reverse generic primers a, b and c on four genomic
DNA samples, two positive for group 1 alleles (A 14 and A31) shown in lanes marked 1
and 2 and two negative in lanes 3 and 4 (A 10 and All). PGR products were run on a
1% agarose gel at 5V/min for 40 min.
Figure 3.6: Optimisation of group 1 primers 4 and c
The primer pair 4 and c were tested using combinations of the PCR programs (P) and
reactions (R) described in sections 2.2.8.1 (PL) and 2.2.8.2 (RL) and Arguello et al.,
1998 (PA and RA) on two positive (A 14 and A31, lanes 1 and 2) and two negative
(A10/A20 and A10, lanes 3 and 4) samples.
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Figure 3.7: Amplification of D18.4 and HD1 using group 1-specific primers -
groupl primer 4 and generic primer C
Group 1 primer pair 4 and c were tested on a panel of genomic DNA samples carrying
different haplotypes to ensure they amplified only group 1 alleles (A14 and A31
haplotypes). 1: phi x 174 ladder, 2: A18/A10, 3: A10/A10, 4: Manus DNA, 5: chicken
DNA (negative control), 6: A17/A17, 7: A18/A18, 8: A18/A17, Lane 9: A31/A31, 10:
A11/A14, 11: A10/A20, 12: All/All, 13: A10/A10, 14: no DNA control
1078bp"M
872bp pi
Four forward and reverse primers were designed for group 2, three forward and two
reverse for group 3 and four forward and reverse for group 6 giving sixteen possible
combinations for groups 2 and 6 (A-P) and six for group 3 (A-F). These primer
combinations were initially tested on three samples, two positives for alleles from
that group and one negative. The annealing temperature in each reaction was chosen
as an intermediate between the values for each of the primers given by MWG.
As can be seen from fig. 3.8 the results of the different primer combinations were
quite variable, with some working extremely well e.g. group 6 pair I while others
gave multiple banding patterns, smearing, or amplified a product from the 'negative'
sample e.g. 6H, 21. Two primer pairs for groups 6 and 3 and one for group 2 were
identified as being potentially group-specific since they only amplified single bands
of the correct size in the 'positive' samples. These were pairs 61 and 6M, 3B and 3F
and 2A. A further eight pairs for group 6 and two for group 2 were kept in reserve
since it was possible they could be optimised to increase their specificity.
3.3.3.3 Group 2, 3 and 6 - determining group specificity
Primer pairs 6M, 2A and 3F were chosen for further study. As with the group 1
primers we attempted to confirm the group specificity by testing the pairs against a
panel of genomic DNA samples positive for a range of haplotypes. The expected
results from these tests are shown in table 3.6, with the actual results shown in figs
3.9 to 3.11 and summarised in table 3.7.
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Figure 3.8: Choosing putative group-specific primers for groups 2, 3 and 6
Primer pairs for groups 2, 3 and 6 were tested on three genomic DNA samples, two
positives and one negative as described in section 3.3.2.2. PCR products were then
run on a 1% agarose gel at 5V/cm for 40 min. The results of each primer pair are
labelled with those chosen for further investigation marked by an asterix (*). Those
kept in reserve are marked by a double asterix (**). Samples in the first two lanes of
each set should be positive and the third lane negative.
W * „
i II i i i I I i I i i I
6E 2C** 2F 2A* 2B** 2E 2J 2D 2K 2H 21
* | 9 9 #
ii #
i i I I
[ 2G 6B 6C 6H 6F 2L 3E 3F* 3A 3B*
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Table 3.6: Predicted results from group-specific primer testing
Primers were tested on a panel of genomic DNA samples with known haplotypes to
confirm group-specificity. This table shows the predicted results with X marking
those haplotypes that we believe to be positive for each group. Haplotypes marked
with a question mark indicates them to be partially characterised, with only some
alleles identified.
PREDICTED RESULTS HAPLOTYPE
GROUP PRIMERS A14 A31 A18 A10 A20 A17 A11 A19
1 X X ? ? ?
2 X ? ? X X
3 X ? ? X ?
6 X ? X X
Figures 3.9-3.11: PCR results for testing putative group-specific primers
Primer pairs 2A, 3F and 6M were tested on a panel of genomic DNA samples
carrying a range of haplotypes to determine their specificity. PCR products were
then run on a 1% agarose gel at 5V/cm for 40 min. Samples marked in red were











w * m m
1 < 1 1 < ^
a b c d e f abed e a b c d
A = A14 B = A11
C = A19/A10 D = A17
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4 D = A17
Table 3.7: Summary of group-specific primer testing results
This table summarises the results of the PCRs shown in fig. 3.9 to 3.11. Samples
which gave a positive result when tested with the different group-specific primers are
indicated by X.
TEST RESULTS SAMPLES - MHC CLASS I HAPLOTYPES
GROUP PRIMERS A14* A31* A18* A10* A10/A20 A17* A11* A19/A10
1 X X
2 X X X X X X
3 X X X X
6 X X X
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Primer pair 2A correctly amplified products from the A14 and A11 samples, which
have the group 2 alleles D18.5 and D18.3 respectively. In addition they amplified a
product from an A19/A10 sample. The A19 haplotype is known to carry the allele
MAN8 which appears to be a group 2 allele based on phylogenetic analysis (see fig.
3.1). When al and a2 of the A19/A10 product was sequenced it was found to be
identical to MAN8 except for 1 aa difference suggesting either an error in this or the
database sequence (fig. 3.12). Alternatively this may be an allelic variant ofMAN8.
Amplicons were also obtained with samples A17*, A10* and A10/A20. Sequencing
of these products was carried out in order to determine which MHC class I alleles
were being amplified. A17* was found to have the same MAN8 allele as the
A19/A10 animal, including the variant aa, which does indicate that there is an error
on the database (fig. 3.12). We believe this to be the first finding of a shared allele
between class I haplotypes in cattle. Blast screening of the two new sequences from
A10/A20 and A10 against the Genbank database showed them both to be bovine
MHC class I sequence. The sequence found in A10/A20 was found to be most
similar to BL3-7, another group 2 allele which suggests that we have identified a new
class I allele from group 2. The absence of this sequence from other samples with
the A10 haplotypes shows that it is almost certainly present on the A20 haplotype.
A pile-up of this predicted coding sequence (al and a2) against other group 2
sequences indicates this to be a true class I allele since the majority of amino acid
substitutions are also found in other alleles (see fig.3.13). The new sequence from
A10 was found to be similar to MAN2 (group 6) and an African allele E55.2 (group
2). Again it appears to be a real allele when compared to other coding sequences
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(fig. 3.14). This sequence was surprising in two ways. Previously it was believed
that the main A10 haplotype within the herd (derived from a known bull) carried
only one gene - JSP.l. Further investigations of other A10 animals using the group
2 primers have also detected this allele showing that A10 is not a single gene
haplotype as believed. It may be that low levels of transcription have resulted in the
failure to detect this previously since the majority of investigations have been carried
out on cDNA. It was also interesting to note that the new allele was not also found on
the A10/A20 sample however this may be due to the fact that only 3 clones were
sequenced (at least 6 clones were sequenced when other A10 positive animals were
tested). It should be taken into consideration however that although this resembles a
classical class I allele only a portion of sequence was analysed. It may be that it is
not a full length sequence and so is not expressed.
Primer pairs 3F and 6M correctly amplified samples positive for alleles from each
group as expected. Both pairs also amplified from an A14 homozygous sample.
Sequencing of these products showed the sample to contain JSP.l, 3349.1 and
MAN2, which suggests that either the sample had either been incorrectly typed or
contaminated. This sample was removed from the stock of genomic DNA and not
included in any further assays.
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Sequencing of introns 1 and 3 from ten alleles, representative of five of the six
phylogenetic groups evident from bovine MHC class I sequences revealed a number
of potentially group-specific nucleotides for four of the groups. Primers designed
around these bases were tested and found to have good group specificity since not
only are they correctly amplifying known alleles they are also capable of identifying
new unknown alleles as shown by the group 2 pair. This allows us to develop RSCA
as a method for typing MHC class I genes in cattle.
It is unclear at present whether these groups are good representatives of the loci that
exist in the bovine MHC - this should become more evident when RSCA has been
used a number of times to type a larger number of animals. It may be that the
primers designed here are specific only for the alleles that the introns were sequenced
from. This could be resolved however by testing them on samples containing other
alleles from the groups (see fig. 3.1) or by sequencing introns 1 and 3 from these to
determine if the group-specific bases are present.
While the group 1 primers have been optimised it may be that optimisation
(particularly annealing temperature) is required for the other pairs. Unfortunately
time restrictions prevented this. It would be ideal to normalise the pairs to the same
PCR program to enable all samples to be run together to make the process more
efficient. It is also important that a specific reverse primer be designed for group 1 in
intron 3 since we may be missing alleles by not amplifying the whole ofal and a2.
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The presence of a large number of group-specific bases in the introns, while useful,
is slightly surprising considering how the different alleles are created. In humans
new MHC class I alleles arise primarily as a result of intra-locus recombination.
Since introns are not under selection these recombinational events followed by
fixation through genetic drift lead to homogenisation of the introns over time with
the maintenance of any locus-specific nucleotides (Parham et al., 1989, Cereb et al.,
1997). In contrast, phylogenetic analysis of varying regions of the class I sequences
and direct comparison of sequences suggests that some degree of inter-locus
recombination between MHC class I genes is occurring in cattle, particularly around
exons 2 and 3 (Ellis et al., 1999, Holmes et al., 2003). It would therefore be
expected that any locus specificity would be lost over time but this does not appear to
be the case. HD7 is the exception however. As mentioned in the results section,
HD7 normally groups with D18.3 and D18.5 when full length sequences are used for
phylogenetic analysis (group 2) but is more similar to D18.1 across al and a2
regions. A comparison of introns 1 and 3 from this allele show it to be most like
D18.1 in intron 1 but then reverts back to a group 2 phenotype in intron 3. This
suggests that HD7 is the product of inter-locus recombination, and as a result has no
group 2-specific nucleotides in intron 1.
More recent studies also found evidence of interlocus recombination occurring in the
allele D18.4 (Holmes et al., 2003). D18.4 is considered to be a group 1 allele when
full length and 3' sequence is included for phylogenetic analysis. However when
only 5' sequence is used D18.4 is found to group more closely to D18.1. This
sequence incorporates exons 3 and 4 encoding the a2 and a3 domains. It would be
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interesting to include each of these exons separately in analysis to see if there is a
difference since group 1-specific bases are found in intron 3 which lies between the
two exons. It would be expected that exon 3 is more like other group 1 sequences
and exon 4 more like D18.1 showing a recombination occurring somewhere in intron
3. The position of D18.4 and D18.1 have been mapped on a BAC contig derived
from an A14 homozygous animal and are believed to be less than 130kb apart (Di
Palma et al., 2002). This small genetic distance could allow unequal crossing over to
occur between chromosomes resulting in the (recombinational) pattern observed.
Aside from the identification of group-specific characteristics, examination of the
intron sequences could provide important information to gain an understanding of the
evolutionary mechanisms that have resulted in the generation of polymorphism
within the PBR. Unfortunately the lack of alleles identified and sequenced so far,
along with problems with locus assignment, currently prevent this. It would prove
interesting to investigate this further when more information becomes available to
determine, for example, if lineages involving groups of alleles from the same locus
are evident as with human alleles, since these are indicative of alleles of similar
origin (Gomez-Casado et al., 1999, Eisner et al., 2002). The best approach would
include phylogenetic analysis of the introns separately and together and also with
different sections of the corresponding allele coding sequences. Comparison of
bovine and human introns may also provide some useful data although they are likely
to be quite different based on work by Cereb et al. (1997) who found that
chimpanzee Patr-B and HLA-B intron 2 sequences formed two distinct species-
specific groups when compared phylogenetically.
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Chapter 4




One of the major aims of this project was to develop a method for typing the MHC
class I genes in cattle. This not only allows us to type a large population of unknown
animals quickly but should also generate data indicating how polymorphic the genes
are and how much genetic diversity there is within a population. The requirements
for such a system are largely for research purposes at present, but there are a number
of factors that could result in typing having a significant economical effect.
In-depth analysis of the small inbred herd at Compton identified the presence of a
haplotype with a single class I gene, A18 (Ellis et al., 1996). Assuming this is a
'normal' MHC class I gene i.e. restricted in the number of peptides it can present,
then it would be expected that animals with only this haplotype would be at a distinct
disadvantage compared to others in terms of the range of antigens they can present.
Thus it is important to determine how common these single gene haplotypes are.
This is worrying when considering that current breeding strategies in the UK rely
heavily on artificial insemination using a relatively small number of bulls
(approximately 100, Cogent website, www.cogentuk.com) as donors. It may be that
selecting for positive traits such as milk and meat production has an adverse effect on
the MHC, resulting in a reduction of diversity of the MHC repertoire within herds,
particularly ifmany bulls carry haplotypes like A18. As a result the herds in Britain
and elsewhere are potentially becoming more susceptible to pathogens.
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The recent move toward epitope-based vaccines based on peptides presented by class
I molecules makes it important to be able to type large numbers of animals to ensure
that any vaccines developed will be efficacious on a wide scale. It may also be
possible to define BoLA supertypes where several alleles share overlapping peptide
specificities.
Lastly there is some evidence from a number of species to suggest that MHC
compatibility between mother and foetus can lead to foetus rejection or problems
during the pregnancy (Joosten et al., 1991, Wegman, 1987, Ober, 1992). This could
potentially have a large impact on the number of calves being born, particularly
where embryo transfer and artificial insemination are used and no information
regarding compatibility between the dam and bull is available.
Chapter 3 described how a range of specific primers were designed and tested for
four of the groups in cattle which we believe to be indicative of MHC class I loci.
Using these primers we aimed to establish the RSCA method within the laboratory
for typing known alleles and also potentially for the detection of new class I alleles.
This chapter describes the processes required to do this and also shows the method
being used to type a panel of unknown samples obtained from a range of breeds
including Charolais, Simmental, Holstein Friesian and some African Bos indicus
samples from Africa. Four buffalo sequences were also included to determine if this
method was applicable for typing MHC class I in related species.
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4.2 Materials and methods
4.2.1 DNA samples
Genomic DNA was extracted from PBM obtained from animals in the farm herd at
IAH as described in section 2.2.3 (NB these animals are not inbred). Other samples
were provided by Dr. P. Chavatte-Palmer (INRA, France), Dr. W. Gerner
(Tuebingen, Germany) and Dr. N.D. MacHugh (formerly ILRI, Kenya, now
University of Edinburgh).
4.2.2 PCR conditions
Fragments containing exons 2 and 3 were amplified from the unknown samples
using the group-specific primers described in chapter 3. Reactions were set up as in
section 2.2.8.2 and run under the following conditions:
Group 1: 98°C for 20s, 35 cycles of 96°C for 20s, 68°C for lmin 30s and a final
extension step of 72°C for 5 min
Group 2 and 3: 95°C for 5 min, 30 cycles of 95°C for 30s, 58.3°C for 50s, 72°C for 1
min with a final extension step of 72°C for 5 min.
Group 6: As group 2 and 3 but 59.8°C as annealing temperature.
The sizes of the products and their locations are shown in fig. 4.1.
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4.2.3 Preparation of reference strands
Two alleles were chosen from each group to act as reference alleles, these are listed
in table 4.1. Alleles were amplified from genomic DNA using the group-specific
primers as described above, ligated into the pGEM-T vector, transformed into JM109
competent cells and sequenced with T7 and SP6 primers (sections 2.2.12 - 2.2.15).
Sequences were then compared to Genbank-derived coding sequence using the GCG
10 program to ensure amplification of the correct product. Minipreparations of
bacterial clones containing the correct products were stored at -20°C to form a
reference bank. Fluorescent labelled reference (FLR) strands for each group were
produced as in the PCR above except that the forward primers had a FAM label
attached (MWG Biotech, Germany). A 1/100 dilution of the minipreparation DNA
in water was used as the template DNA.
4.2.4 Duplex formation
3pi of PCR product was added to lpl of FFR, vortexed to mix then run at the
following program to allow the formation of duplexes: 95°C for 4 min, 55°C for 5
min, 15°C for 3 min. Samples were then centrifuged at 300xg for 1 min to ensure all
reagents were at the bottom of the tube. 0.5pl of 2500-ROX Genescan size standard
(Applied Biosystems) and 2pl of Ficoll loading buffer (15% Ficoll and 0.25%
bromophenol blue, both Sigma) were then added to each sample which was vortexed
then centrifuged.
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Table 4.1: Alleles chosen as reference strands
This table lists the alleles chosen from each group as reference strands with their
Genbank accession number also given. The alleles were amplified with their
corresponding group-specific primers, the products sequenced to ensure accurate
amplification and the minipreparations stored at -20°C for use in RSCA.









4.2.5 Gel preparation and electrophoresis
0.2mm, 12% non-denaturing polyacrylamide gels were used to separate the duplexes.
48cm plates were cleaned thoroughly with Alconox (Alconox Inc., NY., USA)
dissolved in warm tapwater, and then rinsed with hot tapwater, MQ water and finally
100% ethanol to remove all gel residue and dust. Plates were then assembled and
raised at a slight angle from the horizontal to aid gel pouring. Gels were prepared by
adding 7.2ml Long Ranger™ gel solution (Cambrex Bioscience, ME, USA) to
46.8ml Milli-Q water and mixing for 5 min with 2g of Amberlite (Sigma). The gel
solution was then filtered through a 0.2pm Nalgene filter with 6ml of lOxTBE and
de-gassed for 20 min. 450pl of ammonium persulphate and 50pl TEMED (both
Pharmacia Biotech, Sweden) was added to polymerise the gel, which was swirled to
mix then poured between the plates using a 50ml syringe. A 36-well, square-tooth
comb was then secured into the top, the gel sealed and damp towels placed at the
bottom to stop the gel shrinking.
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After two hours the comb was removed and the sample loading area cleaned to
remove excess acrylamide. The laser read area on the plates was carefully cleaned
with damp kimwipes to remove any dust and the gel cassette placed into an
ABIPrism 377 automated sequencer. A plate check was then carried out to ensure no
interference of the laser detection was occurring. 3pi of duplex sample was loaded
onto the gel using capillary tips and electrophoresed for 10 hours at 20 watts (1800
volts, 60 milliamps). Temperature was maintained during electrophoresis at 40°C.
4,2.6 Sample analysis
Samples were analysed using the Genescan software from Applied Biosystems.
Duplexes are observed as blue peaks due to the FAM label while the size standard
shows up as red peaks (ROX label). Initially one lane was chosen and the peaks of
the standard within this were assigned sizes (in kb) based on information from
Applied Biosystems. This was then used to normalise the standard in each of the
other lanes to ensure correct and accurate sizing of products in each sample. Not
only does this allow comparison of samples run on the same gel but also allows
different gels to be compared, thereby removing the need for controls to be run on
each gel. Following on from this each of the blue peaks were assigned a size. In
each lane the homoduplex of the reference strand should be the first duplex to run
past the laser, since it will be smaller than any heteroduplexes formed, and is
visualised as the first blue peak in the analysis package. This duplex should have a
size approximately equal to the original PCR product. An arbitrary mobility value is
131
then assigned to each of the heteroduplexes observed by subtracting the homoduplex
size from the heteroduplex size.
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4.3 Results
4.3.1 Production of reference strands
The choice of alleles for reference strands can greatly affect the outcome of RSCA.
Ideally at least two references should be used per locus, with these alleles having
quite diverse sequences. This should allow detection of all or most alleles at this
locus since they should differ by a number of nucleotides from at least one of the
references. Due to lack of availability of sequenced alleles we were restricted in our
choice of references. Two alleles were chosen from each group which are known to
be true alleles coding for functional MHC class I molecules and for which a full
coding sequence is available. These alleles are listed in table 4.1.
In humans reference strands are derived from a panel of homozygous B-
lymphoblastoid cell lines that are readily available (Marsh et al., 1997). Since no
equivalent is available for bovine samples we chose to form a bank of
minipreparation DNA containing each reference allele. This approach has also been
successfully used for typing MHC genes in cats (Kennedy et al., 2003). Alleles
were amplified from the minipreparations using the group-specific primers so that
exon 2 and 3 of the alleles were included and the sequences compared to Genbank to
ensure that the products were correct and no PCR errors were incorporated. The
sequences of the reference strands are shown in appendix a with the group-specific
primers highlighted.
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4.3.2 PCR on genomic DNA samples
The products used in the RSCA process are derived by PCR of bovine class I genes
from genomic DNA with group-specific primers. Since the expressed MHC class I
loci can vary between haplotypes and therefore between samples it is presumed that
all four sets of primers will not work on every sample. As a result it was decided to
run the PCR products on agarose gels to confirm the presence of an amplicon prior to
running the RSCA gel. PCR was carried out on a range of untyped DNA samples
from European cattle breeds including Holstein Friesians, Normandy cattle,
Simmentals, Charolais and Brown Swiss cattle. DNA from partially characterised
Bos indicus cattle was also included along with some buffalo DNA. The results of
these PCRs are summarised in table 4.2.
The pattern of positives was found to be quite variable, with no sample positive for
all groups. This indicates that the primers are behaving in a specific manner and also
provides more evidence for the variable nature of the haplotypes in different breeds.
Since these PCR reactions were carried out on genomic DNA it suggests that rather
than all loci being present on all haplotypes and some silenced, some genes appear to
be deleted. Alternatively it may be that the genes are all there but that their introns
have changed, which is possible as the primers are relying on only a few specific
bases. Another possibility is that the primers designed are specific for the alleles
sequenced in chapter 3 but not for all alleles of the group.
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Table 4.2: PCR results for group-specific primers tested on untyped samples
Group-specific primers for groups 1,2,3 and 6 were tested on a panel on untyped
samples from various breeds in PCR reactions carried out as described in section
4.2.2.
Breed Sample Group






















4188 X X X
Normandy B755 X X
B818 X X
B668 X X X
Charolais B891 X X
Rouge des pres B822 X








Brown Swiss 813 X X
Simm/HF cross 252 X
Brown Swiss 129 X X
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Previously it was thought that gene silencing was occurring to produce the variable
haplotypes. Southern blot analysis of DNA derived from animals homozygous for
the A14 and A10 haplotypes following digestion with random-cutting enzymes
showed them to have approximately the same number of bands. This suggested that
no large deletions were occurring in the A10 haplotype that was believed to have
only one MHC class I gene (Stephen Archibald, personal communication). This can
now be explained with the results from chapter 3 where we found that the A10
haplotype does appear to have another class I gene which may or may not be
expressed.
While the majority of the samples included were positive for two or more groups the
buffalo samples included were found to be positive only for group 3. This is
surprising since previous phylogenetic analysis which included two buffalo
sequences found one of them to group with D18.1 and the other with group 1 (see
fig. 4.2, Holmes et al., 2003). While it is difficult to conclude anything from this
with such a small number of samples and the relation of the animals unknown it
indicates that buffalo have at least some similar genes to cattle and that variable
haplotypes are likely to occur. However it is likely that we are missing genes in
these animals probably as a result of differences in the intron sequences.
It was interesting to note that groups 1 and 6 appeared to be mutually exclusive and
not found on the same haplotypes, which might suggest that they actually represent a
single locus. As discussed in chapter 3 no distinct groups are evident when
phylogenetic analysis of coding sequence from a range of class I alleles is carried
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Figure 4.2: Maximum likelihood tree linking 3' sequences from 13 species of
Cetartiodactyls
This tree was adapted from Holmes et al., 2003. Pig sequences were chosen to root
the tree due to their divergence from the other species included. Cattle class I alleles








































































out. Instead we have had to group alleles based on loose associations. It was unclear
however whether the three alleles HD6, MAN2 and 3349.1 were part of group 1 or
formed a separate group. Phylogenetic trees constructed with 3' (Holmes et al.,
2003) or full length sequence found these alleles formed a sub-group of group 1
whereas inclusion of 5' sequence shows them to be more diverse. Comparisons of
the intron 1 sequences identified a number of conserved bases between the HD6 and
MAN2 and the group 1 alleles (see fig. 3.3) but none were found in intron 3. As a
result we chose to separate these alleles to a new group, group 6. An alternative
view is that the primers designed for group 6 could be lineage-specific rather than
locus-specific which might explain why such a small number of positive results were
obtained. Clearly more samples need to be studied and alleles identified in order to
investigate this group further.
4.3.3. RSCA results - group 1
Of the 32 samples tested with the group 1 primers twelve were found to be positive.
These samples were analysed by RSCA using both the D18.4 and HD1 FLRs. In
addition, samples positive for D18.4 and HD1 were included to assign a mobility
value for each using the alternative reference strand. Examples of the traces obtained
are shown in fig. 4.3 (D18.4 FLR) and fig. 4.4 (HD1 FLR).
When a sample positive for HD1 was duplexed to D18.4 FLR a mobility value of
96.2 was obtained. By comparing this value to those obtained for the remaining
samples it can be seen that 98 and 99 have similar values (96.2 and 95.9 respectively)
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Figure4.4:RSCAprofilewithroup1HD1LR Sampleswereamp ifi dithgroup1primersndthoductntestoRSCAgeldu l xHD1FLR.
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Mobility Value: D18.4-96. 9183- El82 526.1 E55-522.3 9163- 122.3 1069-73.9 B818- 862.1
4B:HDIrefB
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showing these to have the HD1 allele or a slight variant. This is supported by the
fact that no heteroduplex is observed when the samples are run with the HD1 FLR
(not shown). 98 and 99 have previously been typed as either A31* or A31/W12A.
This result confirms the presence of the A31 haplotype but does not exclude W12A
about which relatively little is known, although it is believed to carry a group 1
allele. Sequencing of a large number of PCR clones would be required to detect the
presence of further group 1 alleles other than HD1 in these animals.
When the 101315 and 089 samples were run with the D18.4 FLR they were found to
have mobilities of 97.1 and 90.7. When considering the values above and the slight
variation seen it is likely that these samples are allelic variants of HD1. When run
with HD1 FLR, a heteroduplex was formed with 089 (showing it to be different to
HD1) but not with 101315. Sequencing of these samples (see fig. 4.5) showed 089
to differ by four aa to HD1 in the al region while 101315 differed by three. This
clearly shows the importance of having more than one FLR since with the HD1 FLR
alone 101315 would have been typed as positive for HDL
When the remainder of the samples were run with both of the FLRs 9183, 9163,
B818 and 1069 all appeared to have new group 1 alleles while El82 and E55 had
similar mobility values indicating they may have the same allele. Sequencing of the
al region of the latter two supported idea (fig. 4.5), although a2 would need to be
sequenced to confirm this. The other sequences were similar to each other, with the
majority of the amino acid changes appearing to be real since they are also found in
either HD1 or D18.4. The presence of the KN and TAL motifs in a few of
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these sequences would suggest that sub-groups or lineages of alleles are present
within group 1. In contrast to the others B818 had an extremely diverse sequence
suggesting this to be a pseudoallele. It would be interesting to sequence the
remainder of this product to see if the intron and a2 sequences are also highly
variable.
It should be noted that some of the sequences analysed here were sequenced directly
from the PCR product without cloning which prevents identification of any PCR
errors and any other sequences that may be present (although these should have been
visible in the RSCA traces as another heteroduplex peak).
4.3.4. RSCA results - group 2
Nineteen positives were obtained for group 2 of which ten were later sequenced.
These samples were run with both D18.3 and D18.5 FLRs (see fig. 4.6 and 4.7 for
examples). As with group 1, D18.3 and D18.5 positive samples were included to
determine mobility values for these alleles. These were found to be 168.4 and 227.4
respectively. Based on the RSCA profiles alone we were successfully able to type
sample 1069 as carrying D18.5, which was confirmed by sequencing. As with the
samples typed as HD1 some variability in mobility values was observed, with 1069
having a mobility value of 228.6 compared to 227.4. While these values only differ
by 0.8 units larger differences were seen with the African sample T3.5. When this
was run against D18.5 FLR a mobility of 158.1 was obtained compared to 168.4 for
a D18.3 positive sample. However when T3.5 was sequenced it was found to match
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Figure4.6:RSCAprofilewithroup2D18.3LR Sampleswereamp ifi dithgroup2primersnthoductsntesoRSCAg ldu l x dD18.3FLR. jg|l^|lOQQ110021345007001809 02 BB5:d183ref8253
Mobility Value D18.5-227.4 1069-228.7 9100-no peak 0161-367.6 8253-no peak
145
Figure4.6cont'd
Mobility Value 9163-nopeak D409-no peak T3.5-nopeak G310-300.3 813- 49.5&375.
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Mobility Value D18.3-168.4 T3.5-1 8 G310-262.7
147
D18.3 in the whole of al and a2. This larger difference is possibly due to the fact
that the D18.3 positive sample used to get a mobility value was the D18.3 FLR.
Since four times the amount of fluorescence was detected than in normal samples
(lpl of FLR with 3pi of labelled sample compared to 3pl of unlabelled sample) this
would affect how the signal was detected which probably results in the distorted peak
observed in fig. 4.7. This heteroduplex peak can be seen as a large dye blob on the
actual gel image (see fig. 4.8).
From the remaining RSCA profiles samples 0161, G310 and 813 appeared to have
new group 2 alleles. Sequencing of the al and a2 regions of the PCR products
showed them to have quite diverse sequences from the other animals (see fig. 4.9).
Flowever when these sequences were compared to all available bovine class I
sequences the different aa were also found in other alleles showing that we have
found real alleles. This indicates that the group 2 primers are specific and capable of
amplifying diverse alleles rather than lineages of alleles.
Through sequencing we were able to identify a further five samples positive for
D18.3 which had been suggested by the absence of a heteroduplex peak in their
RSCA profiles with the D18.3 FLR (fig. 4.9). Interestingly these included another
African animal, D409. Both T3.5 and D409 have been typed previously by
serology as A10, KN104/A7 and A6/A7 respectively. Since neither the A10, KN104
or A6 haplotypes are believed to have group 2 genes it is likely that D18.3 is derived
from A7.
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Figure 4.8: RSCA gel image of group 2 samples run with D18.5 FLR
This figure is a standard RSCA gel image which was generated by the ABIPrism 377
collection package. It is representative of the results obtained when samples amplified
with group 2 primers are duplexed to the D18.5 FLR. Duplexes are shown as blue
bands, with the Genescan 2500-Rox standard shown in red. In lane 10 (highlighted) the
D18.5 FLR was duplexed to D18.3 FLR to obtain a mobility value for D18.3. The band
is much more intense than the others due to the excess of fluorescence which is shown

















D18.3:QEMYGCYVGPDGRLLLGFMQFAYDGRDYIALNEDLRSWTAADTAAQITKRKWEAAGEAERQRNYLEGRCVEGLRRYLENGKDTLLRA 9100: 8253: 9163: T3.5: B818a: B818b: D409: D18.5:.W.S..DR .GA..G 1069: G310:DF.R..R.DE.Y .SLA 0161:DR....DTWWA ... 813: 813:DN..G
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The high incidence ofD 18.3 amongst such a small set of samples indicates this may
be a common allele in herds however it should be noted that three of the animals
were from the Compton herd and are likely to be related.
4.3.5. RSCA results - group 3
18 of the 32 samples tested were positive with the group 3 primers. These were run
on RSCA gels with A10 and D18.2 FLRs and from these results we chose to
sequence 15 of the products. When the A10 and D18.2 alleles were tested with the
FLRs they were found to mobility values of 121.7 and 239.6 respectively. Based on
the RSCA profiles shown in fig. 4.11 we were able to type 9159, 9183 and 9100 for
A10. When the 9159 and 9100 samples were sequenced (fig. 4.12) 9159 matched
A10 exactly confirming the RSCA typing of this sample. In contrast 9100 was found
to have two aa differences from A10 despite having the same mobility value as 9159
and no heteroduplex forming with A10. Similarly sample 4188 was typed as positive
for D18.2 with the A10 FLR (fig. 4.10) but resulted in a peak when run with the
D18.2 FLR. Sequencing of this product showed 4188 to be similar to D18.2 in al
and a2 but with fourteen aa changes (see fig. 4.12). These data show the need for
more diverse reference strands to allow better distinction of alleles in RSCA
although it may be that this problem could be resolved by repeating the samples. It
also shows that there is a need to combine sequencing with RSCA at this early stage
of development to confirm the typing of samples with confusing RSCA profiles.
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Fig4.11cont'd
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When both reference strands were run with four buffalo samples (buff 1-4) double
peaks were observed for samples buff 1 and buff 3 and single peaks for buff 2 and 4.
The samples all appear to share the same allele based on the mobility values, with
buff 1 and buff 3 having a second variant of this. When the products were sequenced
(fig. 4.12) buff2 and buff 4 were identical with one aa difference at position 100 from
buff 1 and buff 3 which only differ from each other at position 69. Even though the
PCR products were cloned and sequenced no second sequence corresponding to the
extra peak in the traces for samples 1 and 3 was found. To determine if this extra
peak is true it is necessary to repeat the initial PCR on these samples and sequence
larger number of clones.
As with the buffalo sequences double peaks were also found for 129 and G310
indicating the presence of two group 3 alleles in these samples. However, despite
cloning and sequencing, only one sequence was obtained from each of these. Again
it is necessary to repeat these samples to identify further sequences. D409 also has
two heteroduplexes when tested with by RSCA and was the only such sample we
were able to identify two sequences from, D409 and D409b (fig. 4.12). These
sequences differ by seven aa indicating them to be different alleles. D409b differs
from the remainder of the sequences shown so this may potentially be a pseudoallele.
To confirm this is real allele it is necessary to compare the sequence obtained to that
of other class I alleles to determine if any of the aa are found in other sequences.
Sequencing of range of products typed two samples, 8253 and 9163 as having D18.2
while a further five potential new alleles were also identified from 4188, 0161, 8392,
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129 and G310 (fig. 4.12). These sequences share many aa with A10 and D18.2
indicating them to be true alleles.
Comparing the sequences obtained it can be seen that the buffalo sequences are very
similar, sharing all their aa with the other alleles identified with the exception of a
single valine at position 69 in the buffalo 1 sequence. This indicates that the group-
specific primers (and RSCA) may be applicable for typing class I genes in buffalo
and other related species.
4.3.6 RSCA results - group 6
Only six of the 32 samples amplified with the group six primers of which two were
later sequenced. From the RSCA traces using HD6 and MAN2 FLRs (figs 4.13 and
4.14) animal 252 typed as having MAN2 which was then confirmed by sequencing
(fig. 4.15). None of the samples appeared to have HD6 although sample G277 did
not work when run on the RSCA gel. Sample T3.5 was found to have a variant of
another group 6 allele 3349.1 with only one aa difference identified. Sample 813 had
two heteroduplexes with MAN2 but only one with HD6 which would suggest the
sample is heterozygous with A18 as one of the haplotypes. This does not appear to
be the case however as neither of the duplexes has a mobility value similar to HD6
when run with the MAN2 reference strand.
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Previous attempts to study the polymorphism of cattle MHC class I genes relied upon
serological methods, flow cytometry using specific antibodies and clonal sequencing
from cDNA amplicons. In this chapter we successfully used the group-specific
primers designed in chapter 3 for RSCA for typing the most complex class I system
studied to date. As well as correctly typing a number of samples using this method
we were also able to distinguish alleles differing by only a few nucleotides and
identified new alleles or allelic variants for groups one, two and three by sequencing
PCR products. Assuming these groups are representative of loci then it would appear
that the majority of animals tested here have only two of these genes (although they
may have others such as D18.1, HD7 and KN104 which were not included in this
study). Only two animals were positive for all three groups.
A number of new alleles were detected for each group which all appear to be real i.e.
their aa substitutions are also found in other previously identified alleles. Only the
allele amplified from B818 with group 1 primers appears false. This could be further
investigated by designing allele-specific primers and testing cDNA from this animal.
The pattern of aa distribution between the sequences amplified by a set of primers
appears to be more diverse than that observed with human alleles of the same gene
(http://www.ebi.ac.uk/imgt/hla/). When more sequences have been identified it
should be possible to align all the allele sequences available and identify shared
motifs between genes which should give us some idea as to how the alleles have
been generated. Also, by inclusion of the intron sequences we may be able to
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identify break-points in the sequences where recombinations between the genes have
taken place.
There were some discrepancies between the RSCA profiles and the sequencing
results e.g. group 3 primers with 129 and G310 where two heteroduplexes were
formed but only one sequence obtained from the clones. It is likely that we are
missing some alleles, particularly since not all of the PCR products were cloned,
instead just sequenced directly from product due to time restrictions. These would
need to be cloned in future in order to confirm the sequences.
The method used to generate FLRs has also previously been used by Kennedy et al.,
(2003). They were able to choose a 'rare' cat DRB allele based on previous analysis
and included a lion allele to ensure optimal detection of alleles. In addition they used
five FLRs in total to reduce possible detection of the FLR allele in animals. Based
on this, future work could include the use ofbuffalo or other related species alleles as
FLRs for each of the groups. For group 1 the sequence from B818 could also be
used as a FLR since this was very different from the other alleles identified. It will
be possible to include more than two FLRs once the new alleles have been confirmed
as real by amplification from cDNA. Another alternative is to generate artificial
FLRs (using techniques such as those used to produce primers) which would allow
us manipulate the compatibility between the FLR and test samples.
One of the major points to arise from the attempts at RSCA is the level of variability
of mobility values observed which made it difficult to type some samples as the
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limits of this variance was unknown. This variability is not unusual however and has
been detected in all the other RSCA systems used. In all cases it was found that
intra-gel variance is relatively low but increases between gels, probably as a result of
differences in gel composition. Kennedy et al. (2002, 2003) used a program called
Genotyper (Applied Biosystems) in addition to Genescan which enables them to
place 'bins' or confidence limits on known alleles based on the level of variance
detected over numerous runs. By doing so it allows easier assignment of alleles and
increases confidence in the typing without the need for further sequencing. In order
to develop RSCA further for cattle it is important to incorporate a similar system in
order to increase the accuracy of typing between gels.
With a number of samples such as sample 9183 with the HD1 FLR (fig. 4.4) there
was a problem with resolution of heteroduplexes with the level of fluorescence
detected only slightly above background. This could be overcome by increasing the
amount of labelled primer used resulting in excess labelled strand. By doing so the
level of fluorescence observed should be greater. Less FLR could also be used to
increase the resolution of the heteroduplex peaks compared to homoduplex peaks. In
these experiments we did not quantify the amount of DNA used at any point which
further affects the size of the heteroduplexes formed and the resolution of samples,
for example where we have more of one product than another. When the
concentration of DNA is too high the bandings on the gels become smeared which
affects how the analysis package reads the gels while in some samples no
heteroduplex peaks were detected at all even though sequencing identified them as
positive for that particular group. Future work should ensure that the amount of
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DNA present in each sample and FLR is determined and the quantity used optimised
for all assays. This is particularly important considering the small volumes ofDNA
used in RSCA, where there is an increased need for accuracy.
Investigation of more samples should lead to a greater understanding of the bovine
class I system. Based on results from cat and dog studies (Kennedy et al., 2002,
2003) it is likely that variation between breeds in allele frequency and distribution
will be identified. Indeed comparison of class I serological specificities between east
African and European animals has identified differences in specificity frequencies
(Kemp, Spooner and Teale, 1988). It may be the case that cross-breeding of cattle
that have been derived from different ancestors and have different class I genes has
lead to the introduction of genes into the MHC, resulting in the variable number of
genes per haplotype observed or alternatively breeds may have lost some of their
class I genes over time. The study of both pure breed and cross-breed animals may
allow us to investigate these ideas further.
In conclusion, RSCA is a simple method allowing rapid and easy typing of the class I
genes with high resolution. We have shown its application for cattle, allowing
comparison of individual animals and providing new information about the bovine
class I genes. By incorporating the adjustments suggested and with further
optimisation this could quickly be used for wide scale typing of animals, although
there is clearly a need to continue sequencing new alleles. It is also important that
we extend the method to incorporate the other genes to ensure full typing of animals
i.e. group 4 which includes D18.1, found on the A14 haplotype, and E223.2, an
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African allele and group 5 includes KN104, also African, and an allele identified
from an Indian animal. This requires the sequencing of their introns 1 and 3 to
identify any group-specific bases followed by primer design and testing.
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Chapter 5
Analysis of MHC class I restriction of




Theileria parva is an apicomplexan parasite capable of infecting and multiplying in
bovine lymphocytes. Following development to the schizont stage the parasite
induces division of the host cell and passes into daughter cells by association with
the mitotic spindle. In susceptible cattle this leads to a disease status marked by
extensive parasitosis throughout the animals followed by lymphocytolysis and
leukopaenia (Morrison, 1996) with death occurring around three weeks post infection
(p.i.). Some animals can recover from infection and have been shown to be immune
to challenge with a homologous strain of parasite (Burridge et al., 1972).
Experimental investigation of T. parva infection has been greatly aided by the
development of infection and treatment regimes whereby animals are given a
sublethal dose of parasite (normally in the form of ground-tick stabilate) with
simultaneous treatment with oxytetracycline (Radley et al., 1975). Animals are
observed to develop mild parasitosis indicated by an increase in temperature and
swelling of the draining lymph node but recover between ten and fourteen days p.i..
Challenge of animals infected in this manner indicates that they maintain high levels
of strain-specific immunity even at three years p.i. (Burridge et al., 1972).
The major mechanism in the immune response against T. parva is widely believed to
be CD8+ cytotoxic T cells (CTL) which can be detected at low levels in peripheral
blood during recovery from infection. CTL isolated from immune animals have been
shown to lyse autologous T. parva infected cells in vitro but not allogeneic cells
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indicating genetic restriction of the immune response (Eugui and Emery, 1981).
While little was known about the MHC class I in cattle at this time the authors were
able to suggest this as a possible mechanism of restriction by comparison to mouse
experiments. Immunisation of various strains of mice with Lymphocytic
Choriomeningitis (LCM) virus resulted in the production of specific CTL which
were shown to only kill infected targets which shared at least one H-2k haplotype in
a "'Chromium release assay (Zinkernagel and Doherty, 1974).
The role ofMHC class I molecules in restricting CTL in cattle was later confirmed
by Goddeeris et al., (1986b) who showed that lysis of target cells by CTL clones
carrying the same class I specificity could be blocked using the monoclonal antibody
W6/32 (Barnstable et al., 1978) which sees a non-polymorphic region on MHC class
I molecules. Differences in the ability of MHC class I haplotypes to restrict the
immune response to T. parva became evident following studies involving animals
carrying a range of specificities. In most cases restimulated CTL (both bulk cultures
and CTL clones) from immune heterozygous animals were found to be restricted by
one haplotype over the other when tested for cytotoxicity against a panel of targets
(Goddeeris et al., 1990, Morrison et al., 1987). Comparison between animals
identified a continual bias amongst haplotypes with for example CTL from most
A6/KN104 animals killing targets expressing the A6 specificity in preference to
KN104 targets. This resulted in the definition of a so-called 'hierarchy of
dominance' amongst the specificities studied with A6 being the most dominant.
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Most of this groundbreaking work involved African Boran (Bos indicus) cattle,
which can be distinguished from European (Bos taurus) cattle by the presence of a
hump. While the disease occurs in Boran cattle it is found to be particularly severe
in European breeds introduced to Africa for milk and meat production and so it is
important to study the CTL response in European cattle in an attempt to identify any
dominant class I alleles which may provide some protection against T. parva.
All animals included in previous studies had been typed by serology using specific
alloantisera in microlymphocytotoxicity assays. This method of typing has since
been shown to be extremely limited, with specificities assigned in no way indicating
the full range of ME1C class I molecules expressed on bovine cells. Extensive
characterisation of cattle at IAH, Compton using a combination of serology, 1D-
isoelectric focusing and PCR-SSP has allowed us to determine the number of
classical class I genes and their corresponding alleles found in common haplotypes.
Using this information we aimed to examine MHC restriction in cattle (Bos taurus)
expressing a combination of haplotypes, namely A14/A10 and A18/A31. These
haplotypes are variable in the number of classical I genes expressed, with A14
expressing three, A31 two and A18 expressing one. Although A10 was also
previously believed to express only one class I gene, recent experiments (see chapter
3) indicate this haplotype may express another class I gene. Further investigations
are currently taking place to characterise this gene in more detail. Initially CTL
would be tested against cell lines expressing one or other haplotypes to determine if
one haplotype restricted the response more than the other as previously observed.
Following on from this various methods would be employed to look at restriction
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through individual genes (see chapter 6). In this way we hoped to be able to identify
those genes important in restricting the response to T. parva which could eventually
aid vaccine design through identification of parasite epitopes presented. This
information would also be important when considering future breeding plans for
European cattle in areas affected by T. parva.
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5.2 Materials and methods
All cell culture methods were carried out as described by Goddeeris and Morrison
(1988) with minor adaptations. All materials were obtained from Invitrogen
(Paisley, Scotland) unless stated. Incubations took place at 37 °C in a humidified
incubator (Jouan Ltd., Derby) with 5% CO2 in air.
5.2.1 Materials
5.2.1.1 Media
Tissue culture media consisted of RPMI 1640 medium supplemented with 5x104
units penicillin, 50mg streptomycin and 146mg glutamine (in final volume of
500ml), 10% foetal bovine serum (FBS, Australian origin) and 0.05M 2-
mercaptoethanol (2-ME). Cytotoxicity media was made up of RPMI 1640 media as
supplemented above with 5% FBS added.
5.2.1.2 Cattle
3 Friesian animals, 1 heifer and 2 castrated males, were obtained from the IAH farm,
Compton. These animals ranged from 3 to 10 months, were healthy and had not
previously been used for any scientific investigation. The animals were chosen
based on their MHC haplotypes, which had been assigned by parentage studies, i.e.
A14/A10 (animals 495 and 506) and A18/A31 (animal 313). 2 A14/A10 animals
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were used in order to compare their results to give an indication of animal to animal
variability. Following infection with T. parva (section 5.2.2.1) the animals were
housed in MAFF category 2 medium security units for 3 weeks p.i. to ensure
clearance of all piroplasms. Following this they were moved to low security units.
5.2.1.3 Flow cytometry materials
PBS obtained from tissue culture department, IAH, Compton was supplemented with
1% w/v bovine serum albumin (BSA, BDH, Poole) and 0.1% w/v sodium azide
(NaN3, Sigma) for use as a washing and dilution buffer.
Cells were labelled with a secondary goat anti-mouse immunoglobulin (H+L) FITC
conjugated antibody (Southern Biotechnology Associates Inc., Alabama, USA) to
allow detection.
All primary antibodies used in flow cytometric analysis were supplied by the
monoclonal antibody department, Compton (see table 5.1), with the exception of the
class I antibody ILA-88 which was supplied by Dr N.D MacHugh, University of
Edinburgh.
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Table 5.1: Monoclonal antibodies used for phenotyping cell lines
Antibody name Epitope recognised Isotype Source, Antibody
medium
ILA-88
(Toye et al., 1990)
Bovine MHC class I
molecules, conformation
independent
IgG2a ILRI, ascitic fluid
MM1A
(Davis et al., 1993)
CD3 marker on T
lymphocytes





B cell marker (Ig light
chain)





CD4 marker on CD4+ T
cells





CD8 marker on CD8+ T
cells





WC1 marker for bovine yS
T cell subset





MHC class II IgG2a IAH: tissue culture
supernatant
TRT1




IgGl IAH: tissue culture
supernatant
TRT6




IgG2a IAH: tissue culture
supernatant
5.2.2 Methods
5.2.2.1 Infection and treatment
This method, which allows the animal to develop a protective immune response and
become resistant to the immunising strain of parasite, was carried out essentially as
Radley et al. (1975) with some alterations. Animals were given a subcutaneous
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injection of 1ml of tick stabilate (Muguga strain, the kind gift of Dr. Alan Walker,
Centre for Tropical Veterinary Medicine, Edinburgh) above the prescapular lymph
node followed by intramuscular treatment with lml/lOkg oxytetrin 20LA (Schering-
Plough Ltd.). The stabilate was stored in liquid nitrogen at a concentration of 2.5
tick equivalents (te)/ml with 1ml per vial. Before use, it was thawed quickly and
made up to 5ml with Eagles Minimal Essential Medium (EMEM, tissue culture
department, Compton), 3.5% BSA and 7.5% glycerol (BDH) giving a final
concentration of 0.5 te/ml.
Animals were inspected every day until 18 days p.i. for clinical symptoms including
fever and enlargement of prescapular lymph nodes. Following onset of fever, lymph
node biospies were taken every second day by aspirating the lymph node using an
18-gauge needle attached to a 1ml syringe. Samples of these were smeared onto
glass slides, air dried then tested with a T. parva-specific antibody for presence of
macroschizonts.
5.2.2.2 Establishing homozygous and heterozygous T. parva lines
T. parva-infected cell lines were produced from PBM from the three heterozygous
animals mentioned above. In addition lines were also made from animals
homozygous for the A14, A10, A31 and A18 MHC haplotypes.
PBM were isolated from each of the animals as described in section 2.2.1,
resuspended at lxlO6 cells/ml in culture medium and 2ml added to each well of a 24
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well plate. Concanavalin A (ConA) was then added to a final concentration of
5pg/ml and the plates incubated for 5 days. Cells were then harvested and counted
as in section 2.2.2. 5xl06 viable cells were collected into a universal and pelleted by
centrifugation at 400xg for 5 min. The supernatant was removed and stored until
further use. 1 vial of tick stabilate (1ml) was quickly thawed in a 37°C water bath
and resuspended using a pipette. 200pl was then added slowly to the ConA blasts,
the tube was gently shaken, then incubated at 37°C for 2 hours with shaking every 15
minutes. A small amount of the stabilate was added to 2ml of media and incubated
to check for fungal growth. Following this the cells were washed twice in tissue
culture media at 400xg for 5 min, resuspended in 18ml fresh media (15% FBS) and
18ml of the old supernatant, and 1.5ml distributed into each well of a 24 well plate.
To prevent contamination plates were incubated at 37°C in ethanol-washed boxes
with the lids were kept slightly ajar to allow for CO2 flow. The plates were checked
every day for contamination and the appearance of infected lymphoblasts, which
generally began to grow between 7 and 10 days. Following this cells were harvested
by aspiration using a pipette, spun down at 400xg, then resuspended in 15ml and
incubated at 37°C in T25 tissue culture flasks. Once cell lines were growing well
they were maintained by passaging with fresh media every 4 days (4 parts fresh
media to 1 part cell culture).
5.2.2.3 CTL assays - CTL production
PBM, isolated from 60ml blood, were counted and resuspended at 4xl06 cells/ml in
media, then distributed into 24 well plates, 1ml per well. Autologous T. parva
infected cells were resuspended at 2xl05 cells/ml and irradiated with 5000 rads of
gamma radiation using a l37Caesium Gammacell (Mordion International Inc.,
Ontario). These were added to the PBM at 1ml per well and the plates incubated at
37°C for 7 days. Following this, the cells were harvested, counted, then made up to
2xl06 cells/ml and distributed at 1ml/well into 24 well plates. T. parva cells were
irradiated as previously, resuspended at 4xl05 cells/ml and 1ml added to each of the
wells. Autologous PBM were obtained from the animals, irradiated as above and
added to the wells at 2xl06 cells/well to act as filler cells. All further rounds of
stimulation were carried out in the same way.
5.2.2.4 CTL assays - target labelling
All CTL assays were carried out at day 6 post stimulation. T. /?arva-infected targets
were passaged the day before and were considered to be healthy and growing well at
the time of the assay. lxlO6 target cells were labelled with lOOpCi sodium chromate
(51Cr, Amersham, New Jersey) at 37°C for 90 min, washed 3 times in cytotoxicity
medium and resuspended at 5xl03 cells/ml.
5.2.2.5 CTL assays - effector (CTL) preparation
Cells from the restimulated cultures were harvested and their viability determined by
Trypan blue exclusion. Cells were then made up to lxl07cells/ml in cytotoxicity
medium and distributed into a round bottom 96 well plate in triplicate at the
following densities, 7.5, 5, 2.5, 1.25 and 0.625xl05 cells per well (lOOpl volume).
178
5.2.2.6 CTL assays - assay
50yil of the target cells were added to each of the wells containing effector cells
giving final effector to target ratios of 30:1, 20:1, 10:1, 5:1 and 2.5:1. Targets were
also added to wells containing medium alone in order to determine background 51Cr
release. Plates were then incubated for 4 hours at 37°C. In order to measure
maximum release, 50yil of labelled targets were added to 1 OOyil water in 1.5ml
eppendorf tubes and subjected to 3 rounds of rapid freezing in dry ice followed by
slow thawing at room temperature, which effectively lyses cells. These samples
were then added to the test plates.
After 4 hours incubation plates were removed and the samples mixed on a plate
shaker for 5 min to facilitate release of all51Cr into the medium. The cells were then
pelleted at 400xg for 5 min. 25pi of supernatant was harvested from each using a
finnpipette, loaded onto a betaplate filter mat (Wallac, Finland) and allowed to dry
overnight. The next morning mats were sealed in plastic bags with scintillant and
placed in a Wallac 1205 Betaplate to be read.
Percentage cytotoxicity was calculated as follows:
% cytotoxicity = (test release-spontaneous release)/(maximum release-spontaneous
release) x 100.
Percentage spontaneous lysis was calculated by:
(spontaneous release/maximum release)/100.
The coefficient of variation was calculated by (standard deviation/mean) x 100 for
each set of triplicates, including those of spontaneous and maximum release.
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5.2.2.7 Flow cytometric analysis - one colour (indirect) staining
Single cell suspensions of between 0.5 and lxlO6 cells were added to round bottom
wells of a 96 well plate and pelleted for 2 min at 400xg. Supernatant was removed
by inverting and gently flicking the plate. 25pi of primary antibody diluted in buffer
was added (neat if culture fluid, 1/500 dilution in buffer - 5.2.1.3 - if ascities) to the
cells and mixed by pipetting. The plate was then incubated at 4°C for 30 minutes to
allow binding of the antibody. Following this the cells were washed twice by adding
lOOpl of the wash buffer and pelleted as above. 25pl of the secondary, FITC-
conjugated antibody was then added (1/250 dilution) and the cells incubated for a
further 30 min in darkness at 4°C. Following two rounds of washing the cells were
made up to lOOpl with washing buffer and added to FACS tubes (Micronic systems,
Holland) containing 400pl of PBS. Samples were then analysed on a FACScan Flow
Cytometer (Becton Dickinson, California) using the FACScan program. Further
analysis was carried out using the FCSexpress program. Initially cells were gated on
forward and side scatter followed by plotting of the data on a histogram of
fluorescent intensity detected by the FL-1 channel. Isotype controls (see antibody
list) were included to indicate positive from negative staining.
5.2.2.8 PCR
Typing of cell lines was carried out using primers that have previously been shown
to be allele-specific, with generic primers Bov 7 and 11 also included as positive
controls (Ellis et al., 1998, see table 5.2). PCR from cDNA was set up as described
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in section 2.2.8.2 and run under the following conditions; 5 cycles of 95°C for 1
minute (min), 65°C for 1 min, 72°C for 2 min followed by 25 cycles of 95°C for 1
min, 65°C for 1 min and 72°C for 2 min. Following this 5pl of PCR product was
added to lpl 6x loading buffer and loaded onto a 1% agarose gel. Electrophoresis
conditions were as previously described (section 2.2.9).
Table 5.2 Primers used for typing cell lines
The allele-specific primers shown below were used to type the T. parva cell lines
(Ellis et al., 1998). Bov7 and Bovll are generic primers which amplify all bovine
class I genes. These were included as positive controls.
Target Primer name Sequence (5' - 3') Tm (°C)
D18.1 FD18.1A CCGGCCCGGCCTCGA 56
RD18.4B CAAAGACTCAGCATAACCTT 56
D18.4 FD18.4' CCGTGGATAGAGAAGGAA 54
RD18.4B
D18.5 FD18.5A GGACGACACGCAGTTCACA 60
RD18.5B TCCTCTCGCCCTCCGCAGC 62
HD1 FHD1A ACGACACGCAGTTTCGTGT 58
RHD1B CGCACTCGCCCTCCAC 56
HD7 F HD7A' GAGCCGCGCTTCATCTCT 58
RHD7B CCCTCCAGGTAGTTCCTT 56
HD6 F HD6A' CCGGGATCCGAGGACT 54
R HD6B* CTCCATCTTGCGTTTGGA 54
A10 F A10A CTCCCACTCGATGAGGTAT 54
(JSP1) R A10B ATCTGAGCCATCGTCTCCA 54
Class I F Bov 7 GGC TAC GTG GAC GAC ACG 55
R Bov 11 CCC TCC AGG TAG TTC CT 49
5.2.2.9 Freezing cell stocks
Prior to freezing cells 1ml of FBS with 10% DMSO per 5xl06 cells was prepared and
kept on ice. Cells were pelleted by centrifugation at 300xg for 5 min, supernatant
removed, resuspended in 1ml of the freezing solution and rapidly aliquotted into 1ml
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Cryovials (Greiner, labortechnik). Vials were frozen at -80°C for short term storage
or in liquid Nitrogen (-110°C) for storage of longer than one month.
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5.3 Results
5.3.1 Confirmation of expressed Class I genes on cell lines
Prior to attempting CTL assays it was necessary to confirm the typing of the animals
and the cell lines made from these to ensure all further results in this study were
valid. cDNA was produced from each of the lines as described in sections 2.2.5 and
2.2.6 and the genes amplified using PCR-SSP with primers which have previously
been shown to be allele-specific (Ellis et al., 1998). In addition the generic primer
pair Bov 7 and 11 which amplify exons 2 and 3 of all class I alleles were included as
a positive control. As can be seen in fig.5.1 the primers amplified products of the
correct size for each cell line. Since the specificity of these primers has already been
determined no sequencing of products was required. Amplification using the D18.5
and Bov primers from 495, 506 and A14 gave rise to two bands, one of the correct
size and one approximately 200bp larger. Sequencing of this larger band showed the
inclusion of intron sequence indicating the presence of genomic DNA contamination
in these cDNA preparations.
5.3.2 Phenotyping cell lines
Theileria-infectod cell lines established for use in this study were phenotyped using a
range of monoclonal antibodies described in table 5.1. The results of this
phenotyping are summarised in table 5.3 and the histogram profiles in appendix b.
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Figure 5.1: Confirmation of MHC class I typing by PCR-SSP
Standard PCR reactions using allele-specific primers (section 5.2.2.8, table 5.2) were
carried out on cDNA from seven 77ze//m'a-infected cell lines to ensure correct typing
of their MHC class I alleles.
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We found that all of the cell lines were positive for the T cell marker CD3 but only
two, A10 and 313, appeared to be expressing CD3 on all cells. Staining for surface
immunoglobulin (Ig) was negative for all lines but this was not surprising
considering the previous observation that B cells lose this over extended culture
(Morrison et al., 1989). Staining against an alternative B cell marker BoWC4
(antibody CC55, Naessens and Howard, 1991) was also negative which suggests that
all the lines were T cells but some had lost CD3 expression. Alternatively there may
be natural killer cells or null cells present which have no surface Ig and do not
express any T cell markers but can be infected with T. parva (Baldwin et al., 1988).
These data fit in with previous studies which have shown that while T. parva
sporozoites can infect T cells and B cells with similar efficiency in vitro, over time
the T cell population greatly outgrows the B cells (Morrison et al., 1996).
Staining for CD4 and CD8 markers showed that three of the lines contained CD8 T
cells, while one, 313, contained CD4 T cells. Two of the lines, A14 and A10,
expressed both. Previous observations have shown that CD4+ infected cells can gain
expression of CD8+ but not the reverse (Baldwin et al., 1988), suggesting that those
cells expressing both markers were originally CD4+ CD8-. Alternatively these may
be mixed populations with both CD4+ and CD8+ T cells present. This could be
determined by double staining the lines with both antibodies but unfortunately time
restrictions prevented this.
Only two of the lines, A10 and 495, were negative when tested for the y8 T cell
marker, with the remainder staining positive. A18 was negative for CD4 and CD8
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indicating that this line may be a pure y8 T cell line since they do not express either
of these co-receptors (Clevers et al., 1990). As y8 T cells represent a large
proportion of T cells in ruminants (Hein and Mackay, 1991) the presence of them in
the lines here is not surprising.
The most important result from this phenotyping was the positive staining of all cell
lines for MHC class I since this is essential for use of the cells as stimulators and
targets in CTL assays. MHC class II staining was slightly more variable with some
cell lines only being partially positive e.g. Al 8 and 313. It is not known whether this
will affect the cells stimulatory capacity.
5.3.3 CTL assays
PBM were isolated from three animals immune to T. parva and stimulated at weekly
intervals using autologous T. parva infected cell lines for one to three weeks.
Following each stimulation cytotoxicity against a range of cell lines was assayed in
order to determine if MHC restricted killing was occurring. Targets included
autologous cells, homozygous cells expressing either the maternal or paternal
haplotype (partially matched) and total mismatches i.e. not sharing either MHC
haplotype. While cells were numerous enough to carry out assays up to three
stimulations it was generally found that they were too depleted to do a fourth since
such a large amount of cells were required for each assay. Unfortunately Home
Office limits with the amount of blood that could be sampled meant that larger
stimulations could not be carried out.
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Two factors were used to indicate how well the assays had worked: spontaneous lysis
and the coefficient of variation. Spontaneous release of less than 30% indicates good
labelling on healthy cells which we found with the majority of assays shown here.
Although this value is incorporated into each of the assays to remove background
counts we have chosen to show them to indicate those targets where the value is
more than 30% and the data is considered unreliable. The coefficient of variation
gives an indication of the level of variation between the triplicates of each data point
with less than 10% considered a good assay (Siliciano et al., 1985). These data are
summarised in appendix c. In general most triplicates fell below 15% although there
were some spurious results which could be due to pipetting errors.
5.3.3.1 Animal 313 (A18/A31) results
Assay results using CTL derived from animal 313 are shown in fig. 5.2 (A-D) with
the corresponding number of times stimulated and spontaneous release from targets
indicated. Only charts A and C are with the same CTL population, the others
represent different sets of CTL. Although these CTL assays are not quantitative it
should be possible to detect trends with the assumption that more stimulations should
lead to an increase in specific CTL and levels of killing. This was hampered
however due to problems encountered with attempting sequential assays using the
same CTL. Comparing A and C there appears to be an increase in levels of
cytotoxicity following another round of stimulation which is most obvious at low
effector to target ratios. Levels of killing appeared to increase most against
autologous targets (note different effector to target ratios on charts). Levels of
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killing against A31 also increased suggesting that there is an increase in a population
of A31-specific CTL. Since this population will also recognise the A31 class I
molecules on the autologous cells they may explain the increase in killing against
autologous targets. However it is important to note the high level of spontaneous
release from the A31 targets in panel A. Overall the general trend seems to indicate
that A18 is the dominant haplotype with a larger proportion of CTL generated being
restricted by this thus explaining the higher levels of killing seen against A18 than
A31 targets.
This is surprising considering that this haplotype carries only one classical class I
gene, HD6. In addition it is surprising to see that in most cases higher levels of
killing are seen against A18 than autologous targets. This may be due to the number
of HD6 class I molecules present on the surface of the different targets. A previous
PhD student attempted to quantify the number of different class I molecules on the
cell surface in cattle using a quantitative indirect immunofluorescence kit in
conjunction with allele-specific antibodies (Smith, 2000). She found that cells from
A31 and A18 homozygotes carried the same total number of class I molecules as
A18/A31 heterozygotes. Taking into consideration that the A31 homozygote has four
class I genes expressed while A18 has two this suggests that half the molecules on
the A18/A31 cells are HD6, with the other half being a combination of HD1 and
HD7. Thus A18/A31 cells express half the amount of HD6 that A18 homozygous
cells do and will not be recognised as efficiently by A18-restricted CTL.
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HD6 is similar to FJ101, an allele carried on the African haplotype A6 which was
found to be the most dominant haplotype in restricting the CTL response to 71 parva
in African animals studied (Taracha et al., 1995). This indicates that HD6 and other
similar alleles are forming immunodominant complexes with antigenic peptides.
Figure 5.2: CTL assay results from animal 313 (A18/A31)
CTL generated from animal 313 (A18/A31) were tested for cytotoxicity against a
panel of Theileria-mfected cell lines including autologous cells (match), cells with
no shared MHC class I haplotypes (mismatch) and targets homozygous for either the
maternal or paternal haplotypes (partial). The results for four different assays A-D
are shown. Note the different range of effector to target (E:T) ratios used in panel A.
Levels of cytotoxicity are shown as % specific lysis and % spontaneous release
indicates the background amount of
as described in section 5.2.2.6.























































5.3.3.2 Animal 506 (A14/A10) results
The CTL results from animal 506 are shown in fig. 5.3. As can be seen the amount
of spontaneous release of these targets was much lower than in the 313 assays. In all
cases 506 autologous targets were recognised and killed, however killing on A18
mismatch targets was quite high in three of the assays shown. cDNA was produced
from the 506 T. parva line and checked with HD6 primers to ensure the correct
typing of this animal but no amplicon was detected which confirms the presence of
both MHC-restricted and unrestricted CTL. Comparison of the levels of cytotoxicity
against A14 and A10 targets shows that values are approximately the same in 3 of
the 4 charts with no obvious dominant haplotype.
5.3.3.3 Animal 495 (A14/A10) results
The CTL results from animal 495 show a marked contrast to those from 506 with
only MHC restricted CTL being generated during stimulation (fig 5.4). Highest
levels of killing were seen against the autologous cell line in each assay although it is
clear that the assays are highly variable as indicated by the vast changes in lysis from
approximately 20% (assay A) up to 70% (assays C and E). In three out of the five
assays, C, D and E, levels of killing against A14 targets were higher than A10
targets. Interestingly these were the assays where good levels of killing (greater than
40%) were seen against the autologous line, suggesting that this is a valid result.
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Figure 5.3: CTL assay results from animal 506 (A14/A10)
CTL generated from animal 506 (A14/A10) were tested for cytotoxicity against a
panel of Theileria-inkcted cell lines including autologous cells (match), cells with
no shared MHC class I haplotypes (mismatch) and targets homozygous for either the
maternal or paternal haplotypes (partial). The results for four different assays A-D
are shown. Note the different range of effector to target (E:T) ratios used. Levels of
cytotoxicity are shown as % specific lysis and % spontaneous indicates the
background amount of
section 5.2.2.6.
51Cr chromium release. These were calculated as described in
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Figure 5.4: CTL assay results from animal 495 (A14/A10)
CTL generated from animal 495 (A14/A10) were tested for cytotoxicity against a
panel of Tftez'/er/a-infected cell lines including autologous cells (match), cells with
no shared MHC class I haplotypes (mismatch) and targets homozygous for either the
maternal or paternal haplotypes (partial). The results for five different assays A-E
are shown. Note the different range of effector to target (E:T) ratios used in panels D
and E. Levels of cytotoxicity are shown as % specific lysis and % spontaneous
indicates the background amount of
as described in section 5.2.2.6.
51Cr chromium release. These were calculated









































































The aim of this set of experiments was to determine if there was a bias in MHC
restriction of T. parva-specific CTL derived from heterozygous animals to either the
maternal or paternal haplotype. This work differs to that previously carried out by
various groups (Goddeeris et al., 1986, Taracha et al., 1995) in that we are studying
animals whose MHC haplotypes have been fully characterised, with all the classical
class I molecules identified. In addition we have chosen to look at bulk CTL
responses rather than CTL clones since this more accurately reflects what is
happening within the animal unlike CTL clones which represent a highly selected
part of the CTL population (Morrison et al., 1987).
Three animals were chosen for this study, one A18/A31 animal and two A14/A10
animals. Following infection of the animals with T. parva and treatment with
oxytctracycline CTL were generated by in vitro re-stimulation with autologous
infected cells and assayed for cytotoxicity against a panel of targets. CTL from each
animal were found to be genetically restricted with killing evident against autologous
cells but not against those with different haplotypes. Only CTL from animal 506
contained a non-specific element as shown by killing against a total mismatch.
Comparing the levels of cytotoxicity against targets homozygous for each parental
haplotype allowed us to determine if there was any bias in MHC restriction
occurring. Levels of killing were generally 5 to 10% higher on A18 targets than on
A31 targets indicating this to be the dominant haplotype in the A18/A31 animal.
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Assays involving the two A14/A10 animals were less clear-cut, with their CTL
appearing to differ in terms of MHC restriction. CTL from animal 495 appeared to
be restricted by A14 while there was no discernible difference in restriction between
A10 and A14 with CTL from 506.
One major problem with this set of experiments was the variation in levels of
cytotoxicity observed between assays, even those using CTL that had undergone the
same number of stimulations. Although these assays were all executed in the same
manner a number of factors such as the quality of the stimulator cells and labelling
efficiency of the targets could cause assay to assay variation. It is most likely
however that CTL were not proliferating sufficiently due to the small number of
stimulations carried out as a result of limitations on the starting volume of blood.
Previous investigations encountered problems with the presence of non-specific
cytotoxic cells when stimulating CTL in a mixed lymphocyte reaction after one or
two rounds of stimulation (Pearson et al., 1979, Pearson et al., 1982, Emery and Kar,
1983). Goddeeris et al. (1986b) found these could be removed by increasing the
rounds with an increase in the levels of cytotoxicity observed between each round of
stimulation. This suggests that the cells in our assays should have been repeatedly
stimulated at least three or four times prior to use rather than assaying at an early
stage. It may also be the case that at one year p.i. the number of circulating memory
cells may have rapidly decreased although it has been documented that T. parva
specific CD8+ CTL can be detected three years p.i. by in vitro stimulation (Burridge
et al., 1972, Taracha et al. 1992).
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The quality of the stimulations would also have a major influence on assays with the
state of the infected cells and the CTL being stimulated affecting this, although the
viability of these cells was tested prior to use and found to be good. It may be that
another cell type e.g. y8 T cells are proliferating rather than CD8+ cells which has
been shown to be a problem when trying to generate CTL against RSV (Roy Cook,
IAH, personal communication). In most of the assays attempted it was found that
CTL were killing autologous targets but not total mismatches indicating that the
killing is specific and MHC restricted. This suggests that 78 contamination is not a
problem although they may be present and potentially masking a much higher level
of killing by interfering with cell to cell contact. In order to confirm this,
phenotyping of the CTL following stimulation is required.
The animal to animal variation observed could be due to different numbers of
lymphocyte subpopulations present in the blood from which CTL are generated or
alternatively due to phenotypic differences between the autologous stimulators.
Analysis of the 506 Theileria line showed it to be a combination of CD8+ and y8 T
cells compared to the 495 line that was mostly CD8+ T cells. Although both cell
lines had similar levels of class I expression it may be that the y8 cells confer some
disadvantage to CTL proliferation.
CTL were not cleaned up between each assay and stimulation to remove dead cells
and debris which may also have affected the assays by reducing cell to cell contact
and CTL to target ratios. Filler cells were included in stimulations based on
observations by Goddeeris et al. (1986b) who found them to be beneficial in aiding
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good proliferation. In contrast Taracha et al. (1991) found no benefit in their use
when stimulating CTL so it may be that they were having a negative effect by
preventing CTL from interacting with the stimulators.
While it is difficult to draw any definite conclusions from this work the results seem
to indicate that a bias in MHC restriction is occurring, with A18 and A14 appearing
to be dominant haplotypes. Ideally this work should be repeated using larger
volumes of blood with only effector to target ratios of 40:1 or more being tested. In
addition the CTL should be stimulated three or more times prior to assay as it has
previously been shown that at 95 weeks post immunization no cytotoxicity is
observed but following five stimulations in vitro levels of 95% are obtained at
effector to target ratio of 15:1 (Goddeeris et al., 1986). IL-2 or 7 could also be
included to ensure the presence of a specific CD8+ population.
Inclusion of animals with a wider range of MHC haplotypes and animals
heterozygous for A18/A14 would also provide useful information potentially
allowing the detection of a hierarchy of dominance amongst the A14, A10, A31 and
A18 haplotypes. Further analysis of the A14 haplotype is described in chapter 6.
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Chapter 6
Further analysis ofMHC restriction
involving the A14 haplotype
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6.1: Introduction
Based on the work described in chapter 5 for animal 495 it appears that the haplotype
A14 may be dominant over A10 in its ability to restrict the CTL response. The A14
haplotype is known to express three classical class I genes, D18.1, D18.4 and D18.5.
It is possible that the dominant restriction observed is due to the CTL recognising the
products of one of these genes presenting antigenic peptides (i.e. is
immunodominant) or alternatively it may be due to a cumulative effect with CTL
generated against all three. In this chapter we aimed to examine this restriction
further through the use of T. parva-infected transfectants as targets for an A14-
specific CTL clone produced from the animal 495. As no D18.5-specific antibody is
available at present we chose to exclude this gene from the study. Alternative
methods of screening for positive transfectants with D18.5 are discussed later in this
chapter but unfortunately time restrictions prevented these being tested.
Previous attempts to transfect genes, particularly MHC class I genes, into T. parva
cell lines have proved difficult (Prof. D. McKeever, personal communication), with
optimisation of the electroporation conditions required for each individual recipient
cell type in order for the transfection to be successful. Eichorn and Dobbelaere
(1995) were successfully able to permanently transfect the IL-2 receptor into a T.
parva-infected T cell line using G418 to select for positive transfectants. Within our
laboratory optimisation of this method has overcome the problems associated with
transfecting class I genes allowing analysis of the role of individual class I genes in
restricting the CTL response.
199
6.2 Methods
6.2.1 Production of transfectants
D18.1 and D18.4-containing plasmids (prepared by Dr S. Ellis IAH, Compton) were
transfected into A31 homozygous T. parva-infected cell lines by electroporation.
2xl06 actively growing healthy cells were washed and resuspended in 0.5ml FBS-
free RPMI medium. 20pg of the pcDNA3 plasmid containing either D18.1 or D18.4
was added and the cells mixed gently. They were then transferred to a sterile 0.4cm
cuvette and electroporated at 270V, 500uFD using a Biorad Gene pulser. The cells
were then placed on ice for 30 min to recover. Following this the cell suspension
was added slowly to 24ml warm media containing 10% FBS, the tube was gently
tilted to disperse the cells, and 1ml of the cell suspension was added to each well of a
24 well plate, and incubated for 24 hours at 37°C. 1ml ofmedia containing 8mg/ml
G418 sulphate (Sigma) was then added to each well to select for positive
transfectants and the plate further incubated at 37°C. The cells were observed daily
for signs of growth. Any wells that appeared to grow were allowed to expand in
media containing 2mg/ml G418 and the cells then tested for expression by flow
cytometry (section 5.2.2.7) using the mAbs ILA-35 (Ellis et al., 1999) and CC218
(unpublished), which see D18.4 and D18.1 respectively (IAH tissue culture
department, Compton). Positive wells were then cloned in 96 well flat bottom
microtitre plates at densities of 100, 10, 1 and 0.5 cells per well. Any clones which
grew were picked and transferred to 24 well plates for expansion. These were again
tested by flow cytometry to confirm expression. Cells were then maintained in
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media containing 10% FBS and 2mg/ml G418 and passaged with fresh media every
3 to 4 days.
6.2.2 CTL clone
A T. parva-specific A14-restricted CTL clone derived from animal 495 was kindly
provided by D.Ngugi, University of Edinburgh. This was produced based on the
method described by Goddeeris and Morrison, 1988. MHC restriction of the clone
had been determined by testing in CTL assays with A14 and A10 homozygous T.
parva-infected cells as targets. The CTL clone was stimulated every 7 to 21 days by
plating at lxl03 cells per well of a 96 well plate and adding lxl04 irradiated
autologous T. parva-infected cells and lOU/ml recombinant human interleukin-2 (IL-
2, Sigma) in a final volume of 200pl. For larger restimulations lxlO5 cloned cells
were mixed with lxlO6 stimulators and lOU/ml IL-2 in 24 well plates with a final
volume of 2ml per well. All CTL assays were carried out as described in chapter 5,
however duplicates rather than triplicates of each effector to target ratio were used.




D18.1 and D18.4 transfectants were screened for positive expression both before and
after cloning. Three D18.4 (A3, A4.1, A4.2) and two D18.1 transfectants (B4 and
Bl) were chosen for cloning which was required to ensure homogenous cultures
containing only one population of cells were obtained. From these four positive
clones showing good expression were obtained, D18.1(B1)E8, D18.1(B4)F10,
D18.4(A4.2)F7 and D18.4(A4.2)D8. These results are illustrated in fig. 6.1.
6.3.2 CTL assays with a CTL clone
CTL assay results from animal 495, typed as A14/A10, indicated that there is a bias
in the MHC restriction of the CTL produced in response to T. parva infection to the
A14 haplotype. Following on from this we chose to use Theileria-infected cells
transfected with either D18.1 or D 18.4 as targets for an A14-restricted CTL clone
derived from animal 495 to determine if either of these genes were restricting the
CTL response. Two separate assays were carried out, the results ofwhich are shown
in fig. 6.2 and 6.3. As in chapter 5 two factors were used as indicators of assay
quality, spontaneous lysis of the targets and coefficient of variation. Less than 30%
spontaneous release and less than 10% variation between results indicates a good
assay.
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Figure 6.2: CTL assay 1
An A14-restricted clone was tested for cytotoxicity in a 51Cr release assay against an
autologous T. parva-infected cell line, a mismatched line, and two lines transfected
with D18.1or D18.4 both of which are found on the A14 haplotype. Effector to
target ratios from 20:1 to 2.5:1 were tested.
















A14/A10 A18 D18.1 D18.4




20:1 1.9 0.8 3.2 4.8
10:1 2.9 8.3 5.1 0.3
5:1 0.4 1.6 2.6 8.3
2.5:1 1.0 2.2 3.6 2.0





20:1 10:1 5:1 2.5:1
ET ratios
D18.4 - 35%
Figure 6.3: CTL assay 2
See figure 6.2 for explanation






A14/A10 A18 D18.1 D18.4
min 8.9 10.5 18.5 20.8
20:1 14.3 3.3 17.9 13.9
10:1 13.4 16.7 21.6 10.5
5:1 10.7 0.34 14.6 5.3
2.5:1 25.5 1.0 13.4 15.3







In both assays the MHC restriction of the clone 495.7 was proven, with high levels of
killing observed against the MHC matched target A14/A10 cell line but little to no
cytotoxicity against the A18 mismatch. With assay 1 no killing of either the D18.1
or D18.4 transfectants occurred. In contrast in the second assay these transfectants
were recognised and killed, albeit at low levels, with more cytotoxicity observed
against D18.4. By comparing the % spontaneous release it can be seen that the
transfectants were clearly in better condition for the second assay however the
coefficient of variation values were higher than in the first assay. As only duplicates
rather than triplicates of each effector to target ratio were included this suggests the
data may be unreliable. In addition the recognition of both D18.1 and D18.4
transfectants indicates that the clone may not be a homogenous population of cells all
expressing the same TCR.
6.4 Discussion
It is obvious from these preliminary experiments that more work needs to be carried
out in order to investigate the A14 haplotype more fully. While the differences
observed between the two assays make it difficult to interpret this data further, the
results in assay two could be discarded. This is based on the fact that the CTL clone
should in theory have only one type of TCR and therefore not be able to recognise
two different MHC molecules. However the recognition of both could be possible if
the two molecules were very similar in al and a2 and presented similar peptides
since these are the major points of interactions with the TCR (Bjorkman et al.,
1987a). Comparison of the D18.1 and D18.4 sequences identified 18 aa differences
205
in al but only two in a2 (see fig. 6.4) while HD1, which appears to be an allele of the
same gene as D18.4, has 21 aa differences most of which are in a2. When D18.1 is
modelled based on a human MHC class I molecule with the Swiss PDB package
(Guex and Peitsch, 1997) most of the aa differences in al are located in the (3 sheet
of the binding groove of the molecule. This could affect the peptide binding motif
resulting in D18.1 presenting very different peptides to D18.4, with different side
chains pointing out of the groove preventing the same TCR from binding.
Alternatively the TCR may have more interactions with the a helices as seen with the
mouse H-2Kb molecule when modelled with the dEV8 self-peptide and 2C TCR
(Garcia et al., 1996, 1998). Thus the clone may be capable of recognising both
D18.1 and D18.4 molecules resulting in the similar levels of cytotoxicity seen in
assay two.
In order to study this further the use of either bulk CTL or a panel of CTL clones
should be considered. In addition a better mismatch target would be an A31 T. par\>a
infected cell line since this is the parent line into which D18.1 and D18.4 are
transfected. The inclusion of this would then allow the detection of any specific
killing against either transfectant as a result of CTL recognition of either gene
product. If the results from these assays were similar to assay one it suggests that the
restricting element is something other than D18.1 or 4 i.e. D18.5. Ideally D18.5
should also be included to allow a full study of this haplotype. While no specific
mAb has been raised against this molecule various methods could be employed to
test transfectants. A blocking assay, whereby the class I molecules on the parent line
are blocked with a specific mAb then the transfectants tested by flow cytometry with
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either ILA-88 or W6/32 which recognise all bovine class I molecules could be used.
By comparing the results to untransfected parent cells which had also been blocked it
would be hoped that the reactivity of the class I antibodies would be less in the
untransfected cells indicating that the antibodies are still recognising class 1
molecules on the surface which do not belong to the parent cells i.e. the transfected
gene products. This approach however relies on the specific mAb and the class I Ab
recognising the same epitope on the parent class I molecules. This may be unlikely
since the mAb is recognising a specific element on the parent MHC molecules while
both ILA-88 and W6/32 recognise an epitope found on all bovine MHC class I
molecules.
Alternatively cDNA from transfected cells could be tested using D18.5-specific
primers. While this does not prove expression of D18.5 it should be indicative. It
may also be possible to screen for positive transfectants by incorporating a tag into
the D 18.5 construct.
Analysis of the A14 haplotype identified two genes which are thought to be non-
classical, X and Z (Di Palma et al., 2002). While little is known about Z, X has
been shown to be expressed and is thought to be present on y8 T cells which are
found in the A14 T. parva line, albeit at low levels (Dr. S. Ellis, personal
communication, appendix b). It may be that the clone used here is restricted by this
and so does not recognise either D18.1 or D18.4.
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While G418 is included to ensure selection of cells containing the transfected
plasmids it can be quite toxic to the cells and cause them to become quite leaky and
poor in quality. As a result transfectants were removed from G418-containing media
24 hours prior to assay. It is possible that this time is not long enough to allow the
cells to recover, so they label poorly with 51Cr. Also long term culture of the
transfectants may cause them to lose expression of the transfected genes over time
although these cells were regularly tested for expression as in 6.3.1 and did not show
any reduction. G418 is an aminoglycoside which attaches to the ribosome binding
site and prevents transcription in cells without neomycin resistance genes. The
amounts used here were four times the amount normally required for transfection
into T. parva cells. It is possible that the G418 may be killing the parasite since it
does not have the resistant gene which could result in no antigen being available for
presentation by the class I molecules. This could be tested by checking for parasite
viability through either the use of a specific mAb or giemsa staining or by RT-PCR
of the polymorphic immunodominant molecule found on the surface of the parasite
(Toye et al., 1991). However it should be noted that previous investigations have
shown that by killing the parasite infected cells are unable to continue replicating and
resort to a resting state or die by apoptosis unless exogenous growth factor is added





7.1 Summary of achievements
We have successfully identified locus-specific primers for four out of the six putative
bovine class I genes. These primers allowed us to test the potential of RSCA as an
effective method for typing the class I MHC. We were successful in typing animals for
HD1, D18.5, D18.3, A10 and MAN2 and identified 19 new alleles, 6 for group 1, 3 for
group 3 and 10 for group 3. The results obtained from this study indicate RSCA, with
further optimisation, will be a formidable method for class I typing in cattle and will
have a significant impact on future studies of the class I genes.
In the second component of this study we have been able to detect a bias in the MHC
restriction of CTL by different class I haplotypes and have further investigated this at the
individual gene level for the A14 haplotype.
7.2 Study of introns 1 and 3 in class I genes
Investigations of the MHC class I in cattle have identified more than 50 serological
specificities in a range of breeds indicating that polymorphism is a feature of these genes
however only 40 alleles have actually been sequenced. Lack of locus-specific
characteristics in the coding region has prevented accurate assignment of these
sequences to individual loci. Previous work in humans identified bases in introns 1 and
3 of class I gene sequences which were locus-specific. Primers designed around these
then allowed locus-specific amplification of products used for RSCA. We sequenced
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introns 1 and 3 from ten class I genes found within the herd at IAH, Compton and
identified conserved bases for four of the six putative bovine class I loci. Primers were
designed around the bases and tested for specificity against a panel of previously typed
DNA samples. From this we were able to choose a pair for each locus for use in RSCA.
The locus-specific nature of the introns in humans appears to be due to homogenisation
as a result of recombination and genetic drift over time (Cereb et ah, 1997). In addition
the formation of new alleles by intra-locus recombination with little inter-locus
recombination occurring ensures little or no sequence from other loci is inherited
(Hughes et al., 1993, Parham et ah, 1995). In cattle however inter-locus recombination
appears to be playing a significant part in creating diversity (Holmes et ah, 2003). As a
result it may be expected that locus-specific bases are absent in the introns or are present
with reduced frequency compared to the human sequences. This did not seem to be the
case however as conserved bases between alleles of the same group were found in both
introns 1 and 3. HD7 was the main exception identified here. This allele, which is
classified as group 2, appears to be a result of recombination between groups 2 and 4
since it has group 4-specific nucleotides in intron 1 and group 2-specific bases in intron
3. As a result the group 2 primers cannot amplify HD7. It is highly likely that there are
more alleles like this. These could be detected either by amplification of the al and a2
domains from cDNA with generic primers followed by sequencing or by using different
combinations of the forward and reverse group-specific primers. When further alleles
for each of the groups become available it should be possible to align the sequences,
including introns, and identify points at which recombination between genes has
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occurred. This will then allow us to determine if any of the other locus-specific primers
are likely to be affected in their ability to detect all alleles of a gene.
As stated in chapter 3 priority was given to ensure the primer pairs amplified the alleles
identified in the Compton herd rather than the BS alleles previously identified since little
information other than coding sequence is available for these. However they have been
amplified from cDNA and so some are likely to represent classical alleles (Garber et al.,
1993, 1994). Comparison of their sequences to the specific primers shows that the
group 2 primers will amplify BSN, while the group 1 sequences do not amplify BSX
(fig. 3.3 and 3.4). The group 3 forward primer has three nucleotide differences from
BSA, but does share the specific base at the 3' end, while the reverse primer is identical.
Thus the primer pair may amplify BSA if the annealing temperature is low in the PCR
reaction, although this would encourage non-specific binding to other genes present.
Based on these findings some effort should be made to attempt to optimise the other
previously designed primers which do have conserved bases in the BS sequences to
allow amplification of the BS alleles. It is likely however that even by including these
alleles we will miss others.
Human class I and class II introns have been studied in an attempt to understand the
evolution and diversification mechanisms of the MHC genes. Links between intron
polymorphism and allelic lineages were identified, with low levels of sequence diversity
between alleles of the same lineages (Kotsch et al., 1997, Gomez-Casado et al., 1997,
213
Blasczyk et al., 1998). Based on this it would be interesting to sequence the introns of
any new alleles identified in cattle in an attempt to define alleles of the same lineage.
7.3 Establishing RSCA and future work
Using the group-specific primers we were successful in establishing RSCA as a method
for typing bovine class I genes. We assigned mobility values to known alleles and were
able to type random animals which proved positive for these alleles. In addition, we
have identified a number of new alleles for each group by sequencing products with
different mobility values to those previously found. These can now be included in future
typing.
From the results presented here the majority of samples when amplified by group-
specific primers and analysed with RSCA have only one heteroduplex. This would
normally indicate either a sample homozygous for that gene or alternatively
heterozygous with one allele matching the FLR (although this would be confirmed by
the use of a second FLR). In cattle there is the added alternative of gene deletion which
is the most likely option when single heteroduplexes are seen with this frequency.
RSCA has been shown to be a useful tool for typing MHC genes (both class I and II) in
a number of species with the ability to manipulate duplex formation and assign a unique
mobility value allowing, in theory, the detection of all alleles. By continuing the
development of RSCA the scope for analysis of the bovine MHC is wide. For example,
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incorporation of the remaining groups and wide-scale comparison of different breeds
will likely lead to the identification of differences between breeds as found with the cat
and dog studies (Kennedy et al., 2002, 2003) and will allow us to determine the
frequency of different genes and alleles. Haplotypes with different gene configurations
to those previously observed may be found which will give a better idea of how the
number of genes varies between haplotypes. These configurations may help in the
detection of alleles missed by the group-specific primers. For example if it is found that
the group 1 gene is always on the same haplotype as group 4 then the presence of an
amplicon with group 1 primers but absence with the others indicates that a group 4 allele
has been missed. RSCA could also easily be adapted for typing the MHC class II genes
in cattle since much more information about these is available.
From the sequencing results in chapter 4 lineages of alleles are already becoming
apparent. It is likely that by identifying and sequencing new alleles we will find
additional lineages of alleles within each group. It may then be possible to define
supertypes for each gene as in humans (Sidney et al., 1995, Sette and Sidney, 1999).
These supertypes incorporate families of alleles with overlapping peptide-binding motifs
and are potentially useful for the design of peptide-based vaccines, overcoming the issue
of polymorphism affecting the use of such vaccines (discussed below).
Until more alleles have been found it is necessary to continue the approach used here by
combining RSCA and sequencing to define new alleles, with all sequencing
incorporating the entire al and a2 regions to ensure accurate identification of alleles.
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Once the method has been optimised and the error limits defined for each allele's
mobility value a database of mobility values can be established allowing typing by
RSCA alone.
7.4 MHC restriction of CTL responses to T. parva
Analysis of the CTL response to T. parva in Bos taurus and Bos indicus animals found it
to be almost entirely restricted by either the maternal or paternal haplotype (Goddeeris et
al., 1990). In this study we chose to compare the A14 haplotype to A10 and A18 to A31
by infecting animals heterozygous for these with T. parva and then testing CTL derived
from them against homozygous infected cell lines in vitro. We were unable to determine
any clear dominance of the haplotypes studied here but did detect some differences in
their ability to restrict the CTL response to with A18 appearing to be partially dominant
over A31 while there was some evidence for A14 being dominant over A10 in one
animal but not another. Further analysis of the A14 haplotype using T. parva cells
transfected with either D18.1 or D18.4 as targets for an A14 restricted CTL clone
provided inconclusive results, with killing of the targets in one assay but not another.
7.5 Alternative methods for measuring cytotoxicity
From the results obtained in both sets ofCTL experiments it is obvious that our methods
need refining, while it is imperative that a shorter amount of time lapses between
immunisation of animals and the assays taking place. The 51Cr release assay used in
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these studies is the traditional approach for quantitating cell-mediated cytotoxicity.
While this method is sensitive and acts as a direct indicator of killing activity problems
including the isotopes' long half life and restriction of usage, the labour-intensive nature
of the method, difficulty with cell labelling and high spontaneous release and the need
for a relatively large number of fresh cells in good condition has led to the development
of a range of alternative techniques which could be used in future. Examples of these
include flow cytometric assays, ELISpot, and the use of tetramers.
A large number of flow cytometric assays have been devised which tend to involve
measuring fluorochrome release from or retention by either pre-labelled effectors or
targets. Examples of these labels include carboxyfluorescein diacetate and calcein
(McGinnes et al., 1986, Papadopoulos et al., 1994). These labels do not affect the
morphology or function of the labelled cells, have low toxicity, allow the user to
distinguish between effectors and targets (thus giving a more accurate effector to target
ratio) and also allow the exclusion of cell debris and dead cells. Elowever problems with
poor labelling and high spontaneous release have been identified as well as a need for
complex analysis with the flow cytometry data. Attempts have been made to improve
these methods through the testing of alternative fluorochromes such as
carboxyfluorescein diacetate succinimidyl ester), PKH-26 and 7-amino actinomycin D
(Sheehy et al., 2001, Lecoeur et al., 2001) to identify those that do not have labelling or
leakage problems. When compared to the 51Cr release assay these assays are found to
have similar or higher specificity and with the routine use of flow cytometers in research
represent a good potential alternative for measuring cytotoxicity.
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ELISpot measures another function of effector CD8+ T cells, namely cytokine secretion
in a system based on the ELISA methodology. PBMC or in-vitro stimulated CTL are
added along with infected cells or antigenic peptides to a plate coated with anti-cytokine
antibodies then following incubation a second enzyme-linked cytokine-specific antibody
and the enzyme substrate are added. This results in the formation of a coloured (or
fluorescent) spot, with each spot corresponding to a cytokine producing CTL and the
total number of spots indicating the number of CTL present in the effector population.
The advantages ofELISpot include its high sensitivity and easy usage, while automation
of the spot counting reduces problems associated with manual counting and enhances
reproducibility. However there are still some problems with high background in some
which can make detecting effector cells at low numbers difficult (Miyahira et al., 1995,
Hickling, 1998). Despite this ELISpot offers the most likely alternative to the 51Cr
release assay and is becoming an increasingly popular method.
Tetramer staining uses flow cytometry to assay directly the number of CD8+ T cells
present in PBMC that can recognise a specific antigenic peptide. Tetramers consist of
four identical biotinylated MHC-peptide complexes which are bound together by
streptavidin. When the tetramer is mixed with cells, any T cells with a TCR specific for
the MHC-peptide complex is bound with high affinity. The inclusion of a fluorochrome
attached to the streptavidin then allows the binding to T cells to be monitored by flow
cytometry. The main advantages of this method is that it allows direct measurement of
T cells with TCR specific for particular epitopes without the need for prior stimulation,
is highly sensitive and quantitative (Altman et al., 1996, Gallimore et al., 1998).
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However prior knowledge of peptide sequence and MHC type is required and so this
method will only be of use when further data on T. parva antigens and dominant MHC
class I molecules is available.
7.6 MHC and disease associations
One of the major stimuli for studying MHC in farm animals is to improve knowledge
regarding the association between alleles and potential resistance to disease, thereby
allowing development of effective breeding strategies and vaccines. The MHC has been
found to be more associated with disease than any other genetic region and is linked to
all or most autoimmune diseases. Pathogens are believed to be the driving force behind
selection of MHC polymorphism and heterozygosity which helps to increase the hosts'
ability to fight infection against diverse pathogens and those capable of antigenic
variation. However there is little actual evidence to support this theory. The most often
quoted study is that by Hill et al., (1991) with the finding that the allele HLA-B*5301 is
associated with lowered susceptibility to malaria in West African communities.
However this association has not been found in East Africa. It may be that the human
MHC is too complicated to allow large scale detection of such associations with strong
linkage disequilibrium between genes making it difficult to assign susceptibility or
resistance to particular class I or II genes and to rule out the involvement of other genes
here (Goldsworthy et al., 2000). In addition because there is effectively no wild type of
class I and II alleles it is generally found that those alleles linked to disease naturally
occur at high frequency in the population but for some reason e.g. contributory factors
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such as the environment disease only occurs in a fraction of the population. For
example HLA-B27 is found to be associated with ankylosing spondylitis and while it
occurs in 95% of the population only 3% of Caucasians with this allele actually develop
the disease (Edwards et al., 2000).
In chickens the MHC is much smaller and simpler than mammals with many common
haplotypes having only one dominantly expressed class I molecule and the level of class
I surface expression varying between haplotypes. As a result it is much easier to
establish connections between the MHC and disease. An association between the B21
haplotype which has a low level of expression and resistance to Marek's disease virus
has been identified. In contrast chickens with the B19 haplotype which is expressed at
high levels are highly susceptible to this virus (Kaufman and Salomonsen, 1997). In
addition an alternative class I molecule with reduced peptide binding ability has been
shown to be linked to susceptibility to Rous sarcoma virus (Kaufman, Volk and Wallny,
1995).
Cattle herds potentially provide a good population structure for studying the role of
alleles in disease resistance since a single bull can give rise to a large number of
offspring allowing the effects of a single allele or haplotypes to be traced. However, as
with the human MHC, proving linkage may be difficult due to the large number of genes
within this region and their tight linkage (Di Palma et al., 2002). The existence of single
gene MHC class I haplotypes such as A18 in cattle populations may however allow
associations to be detected. Possible future studies linking RSCA and T. parva could
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involve typing the class I genes in cattle from an area endemic for Theileriosis to
examine the frequency of different class I alleles. Through this it may be possible to
identify a link between expressed genes and resistance to disease. It may also be
interesting to type buffalo which are carriers of T. parva but are resistant to the parasite
to determine if they have unusual class I alleles which may be involved in resistance.
Determination of the sequence of antigenic peptides which elicit a strong CTL response
when presented by MHC class I molecules allows for the development of potentially
highly efficacious vaccines. In addition, the definition of HLA supertypes aids vaccine
design by allowing good population coverage without the need for a particular allele
being present at a high frequency. A huge effort has gone into defining peptides from
various human pathogens such as HIV and Epstein-Barr virus (Hollsberg, 2002, Day et
al., 2001) and attempts have also been made to identify antigenic peptides from a
number of infectious agents affecting cattle including respiratory syncytial virus and
bovine herpesvirus 1 (BHV1, Gaddum et al., 1996, Hegde et al., 1999). Thus by
developing a method for typing MHC class I genes with wide-scale application in cattle
this will allow us to determine the frequency of the class I alleles these epitopes are
specific for and potentially allow the definition of supertypes through the identification
of new alleles.
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Coefficient of variation results from Chromium release assays in chapter 5.
The coefficient ofvariation was calculated by (standard deviation/mean)xlOO for the
minimum, maximum and test samples in each assay. In most cases standard
deviation was deduced for triplicate repeats. The letter above each indicates which
graph they refer to.
313 Cr assay results coefficient of variations
A
313match 495mismatch A18partial A31partial
min 3.1 1.7 11.6 7.4
40:1 15.1 25.8 6.4 6.6
30:1 6.5 2.6 30.0 9.9
20:1 22.3 31.2 7.6 15.8
10:1 6.9 22.1 6.6 8.0
5:1 25.2 29.6 22.6 1.0
max 22.2 OO06 2.3 5.2
B
313match 495mismatch A18partial A31partial
min 5.2 6.5 8.7 15.7
20:1 4.9 2.1 5.7 5.4
10:1 20.1 4.7 7.6 6.3
5:1 5.5 14.5 6.5 11.9
2.5:1 19.6 7.1 1.7 10.2
max 16.9 3.0 0.6 24.7
C
313match 495mismatch A18partial A31partial
min 5.7 3.1 55.9 3.2
20:1 3.5 9.9 10.9 3.3
10:1 6.1 10.4 15.9 9.8
5:1 11.7 10.4 13.2 8.2
2.5:1 5.2 3.0 5.5 14.0
max 3.9 11.7 11.8 5.7
D
313match 495mismatch A18partial A31partial
min 11.2 11.1 8.2 6.7
20:1 12.9 14.2 4.7 8.1
10:1 48.0 8.2 18.4 14.2
5:1 20.7 12.0 19.4 20.3
2.5:1 8.2 3.4 5.2 18.5
max 15.5 33.8 6.5 24.9
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506 Cr assay coefficient of variations
A
506match A18mismatch A14partial AlOpartial
min 8.2 4.6 11.4 14.3
30:1 L9 9.3 5.7 11.5
20:1 3.6 73.4 0.5 9.1
10:1 2.7 45.5 4.5 3.5
5:1 4.1 19.3 5.2 6.8
2.5:1 0.5 12.1 6.0 14.6
max 15.0 24.5 20.1 13.2
B
506match al8mismatch A14partial AlOpartial
min 19.7 10.2 36.2 30.0
20:1 3.9 13.3 18.6 9.4
10:1 1.9 10.8 3.4 15.2
5:1 2.0 2.0 12.9 7.5
2.5:1 18.8 6.6 7.1 13.5
max 6.7 0.6 24.6 4.1
C
506match A18mismatch A14partial AlOpartial
min 11.1 4.0 2.9 12.0
30:1 4.8 3.7 3.8 2.6
20:1 1.5 5.6 8.1 11.2
10:1 5.0 8.4 2.4 5.7
5:1 3.5 0.0 14.5 9.8
2.5:1 3.4 1.7 8.9 24.2
max 10.8 23.3 8.9 3.1
D
506match al8mismatch A14partial A31partial
min 11.1 12.5 23.1 7.2
20:1 6.3 11.7 1.9 6.0
10:1 17.5 11.2 5.9 6.6
5:1 13.5 7.7 8.8 11.9
2.5:1 2.5 1.3 2.6 9.5
max 6.8 11.8 6.4 1.5
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495 Cr assay results - coefficients of variation
A
495match 313mismatch A14partial AlOpartial
min 13.6 8.0 8.9 8.6
20:1 3.4 5.8 13.7 10.7
10:1 3.9 17.8 7.6 8.5
5:1 13.8 8.2 10.4 11.0
2.5:1 12.3 7.2 4.7 15.3
max 3.0 16.9 24.6 4.1
B
495match 313mismatch A14partial AlOpartial
min 18.5 18.0 31.7 13.6
20:1 11.3 57.2 12.3 9.4
10:1 21.5 56.7 8.4 22.2
5:1 8.4 5.0 11.9 12.1
2.5:1 21.5 30.2 12.2 20.6
max 33.8 15.5 8.7 6.7
C
495match 313mismatch A14partial AlOpartial
min 4.5 1.2 7.5 4.0
20:1 6.5 4.9 17.3 1.5
10:1 12.3 7.3 18.7 1.1
5:1 2.1 8.9 13.1 14.7
2.5:1 4.7 5.7 2.7 5.5
max 11.7 3.9 6.4 1.5
D
495match 313mismatch A14partial AlOpartial
min 27.9 9.2 13.4 12.9
30:1 3.5 4.2 19.0 21.9
20:1 9.3 19.7 14.5 13.8
10:1 22.9 14.6 9.4 6.5
5:1 14.1 20.9 20.0 11.6
2.5:1 57.3 7.6 13.2 6.7
max 4.4 13.5 8.9 3.1
E
495match 495mismatch A14partial AlOpartial
min 4.3 5.4 4.6 7.1
30:1 10.6 17.0 3.9 5.0
20:1 7.9 14.1 0.8 6.5
10:1 8.7 21.8 6.9 8.3
5:1 10.0 16.9 13.2 21.7
max 2.2 3.0 6.2 1.9
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